-
Annual Statements
-
»
Companies
-
»
Leatt Corp
-
»
Annual Report: 2015 (Form 10-K)
Leatt Corp - Annual Report: 2015 (Form 10-K)
Leatt Corp.: Form 10-K - Filed by newsfilecorp.com
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 10-K
(Mark One)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: December 31, 2015
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____________to _____________
Commission File No. 000-54693
LEATT CORPORATION
(Exact name of registrant as specified in its charter)
Nevada |
20-2819367 |
(State or other jurisdiction |
(I.R.S. Employer Identification No.)
|
of incorporation or organization) |
|
50 Kiepersol Drive, Atlas Gardens
Contermanskloof
Road,
Durbanville, Western Cape
South Africa,
7441
(Address of Principal Executive Offices; Zip Code)
+(27) 21-557-7257
(Registrants telephone
number, including area code)
Securities registered pursuant to Section 12(b) of the Exchange
Act: None
Securities registered pursuant to Section 12(g) of the Exchange
Act: Common Stock
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes [
] No [X]
Indicate by check mark if the registrant is not required to
file reports pursuant to Section 13 or Section 15(d) of the Act. ?
Yes
[ ] No [X]
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes [X] No
[ ]
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Website, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation
S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files).
Yes [X] No [ ]
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K is not contained herein, and will not be
contained, to the best of registrants knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. [X]
- 1 -
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of large accelerated filer,
accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act.
Large Accelerated Filer [ ] |
Non-Accelerated Filer [ ] |
Accelerated Filer [ ] |
Smaller reporting company [X] |
|
(Do not check if a smaller |
|
|
|
reporting company) |
|
|
Indicate by check mark whether registrant is a shell company
(as defined in Rule 12b-2 of the Act).
Yes [ ]
No [X]
As of June 30, 2015 (the last business day of the registrants
most recently completed second fiscal quarter), the aggregate market value of
the shares of the registrants common stock held by non-affiliates was
approximately $5,155,386. Shares of the registrants common stock held by each
executive officer and director and by each person who owns 10% or more of the
outstanding common stock have been excluded from the calculation in that such
persons may be deemed to be affiliates of the registrant. This determination of
affiliate status is not necessarily a conclusive determination for other
purposes.
Common Stock, $0.001 par value per share: 5,231,823 outstanding
as of March 7, 2016.
DOCUMENTS INCORPORATED BY REFERENCE
None.
- 2 -
Annual Report on Form 10-K
For the Year
ended December 31, 2015
TABLE OF CONTENTS
- 3 -
Special Note Regarding Forward Looking Statements
This report contains forward-looking statements that are
contained principally in the sections entitled Our Business, Risk Factors,
and Managements Discussion and Analysis of Financial Condition and Results of
Operations. These statements involve known and unknown risks, uncertainties and
other factors which may cause our actual results, performance or achievements to
be materially different from any future results, performances or achievements
expressed or implied by the forward-looking statements. These risks and
uncertainties include, but are not limited to, the factors described in the
section captioned Risk Factors above. In some cases, you can identify
forward-looking statements by terms such as anticipates, believes, could,
estimates, expects, intends, may, plans, potential, predicts,
projects, should, would and similar expressions intended to identify
forward-looking statements. Forward-looking statements reflect our current views
with respect to future events and are based on assumptions and subject to risks
and uncertainties. Given these uncertainties, you should not place undue
reliance on these forward-looking statements. These forward-looking statements
include, among other things, statements relating to:
|
|
our expectations regarding growth in the motor
sports market; |
|
|
our expectation regarding increasing demand for
protective equipment used in the motor sports market; |
|
|
our belief that we will be able to effectively
compete with our competitors and increase our market share; |
|
|
our expectations with respect to increased
revenue growth and our ability to achieve profitability resulting from
increases in our production volumes; and |
|
|
our future business development, results of
operations and financial condition. |
Also, forward-looking statements represent our estimates and
assumptions only as of the date of this annual report. You should read this
annual report and the documents that we reference and filed as exhibits to the
annual report completely and with the understanding that our actual future
results may be materially different from what we expect. Except as required by
law, we assume no obligation to update any forward-looking statements publicly,
or to update the reasons actual results could differ materially from those
anticipated in any forward-looking statements, even if new information becomes
available in the future.
Use of Certain Defined Terms
Except as otherwise indicated by the context, references in
this quarterly report to:
|
|
Leatt, we, us, our, the Registrant or
the Company are to the combined business of Leatt Corporation, a Nevada
corporation, its South African branch, Leatt SA, and its direct,
wholly-owned subsidiaries, Two Eleven, Leatt New Zealand and Three Eleven;
|
|
|
Leatt SA are to the Companys branch office
known as Leatt Corporation (Incorporated in the State of Nevada)
incorporated under the laws of South Africa with registration number:
2007/032780/10; |
|
|
Leatt USA are to Leatt USA, LLC, a Nevada
Limited Liability Company; |
|
|
Leatt New Zealand are to Leatt New Zealand
Limited, a New Zealand Company; |
|
|
NZD are to the legal currency of New Zealand.
For all NZD amounts reported, the dollar amount has been calculated on the
basis that $1=NZD1.4592 for its December 31, 2015 audited balance sheet.
|
|
|
PRC, and China are to the Peoples Republic
of China; |
|
|
Two Eleven refers to Two Eleven Distribution,
LLC, a California limited liability company; |
|
|
Three Eleven are to Three Eleven Distribution
(Pty) Limited, a South African Company; |
|
|
Securities Act are to the Securities Act of
1933, as amended, and to Exchange Act are to Securities Exchange Act of
1934, as amended; |
|
|
South Africa are to the Republic of South
Africa; |
|
|
U.S. dollar, $ and US$ are to the legal
currency of the United States. |
|
|
Xceed Holdings refers to Xceed Holdings cc.,
a close corporation incorporated under the laws of South Africa, and
wholly-owned by The Leatt Family Trust, of which Dr. Christopher J. Leatt,
the Companys chairman, is a Trustee and Beneficiary; and |
|
|
ZAR refers to the South African Rand, the
legal currency of South Africa. For all ZAR amounts reported, the dollar
amount has been calculated on the basis that $1 = ZAR15.3979 for its
December 31, 2015 audited balance sheet. |
- 4 -
PART I
ITEM 1. BUSINESS
Business Overview
Leatt designs, develops, markets and distributes personal
protective equipment for participants in all forms of motor sports and leisure
activities, including riders of motorcycles, bicycles, snowmobiles and ATVs, as
well as racing car drivers. The Company sells its products to customers
worldwide through a global network of distributors and retailers. Leatt also
acts as the original equipment manufacturer for neck braces sold by other
international brands.
The Companys flagship products are based on the Leatt-Brace®
system, a patented injection molded neck protection system owned by Xceed
Holdings, designed to prevent potentially devastating injuries to the cervical
spine and neck. The Company has the exclusive global manufacturing,
distribution, sale and use rights to the Leatt-Brace®, pursuant to a license
agreement between the Company and Xceed Holdings, a company owned and controlled
by the Companys Chairman and founder, Dr. Christopher Leatt. The Company also
has the right to use apparatus embodying, employing and containing the
Leatt-Brace® technology and has designed, developed, marketed and distributed
other personal protective equipment using this technology, as well as its own
developed technology, including the Companys expanding range of body protection
and helmet products which it markets under the Leatt Protection Range brand.
The Companys research and development efforts are conducted at
its research facilities, located at its executive headquarters in Cape Town,
South Africa. The Company employs 4 full-time employees who are dedicated
exclusively to research, development, and testing. The Company also utilizes
consultants, academic institutions and engineering companies as independent
contractors or consultants, from time to time, to assist it with its research
and development efforts. Leatt products have been tested and reviewed internally
and by external bodies. All Leatt products are compliant with applicable
European Union directives, or CE certified, where appropriate. Certain products,
such as the MRX PRO Head and Neck Restraint System, have been certified by SFI
Foundation (USA) and the Moto GPX was tested by BMW Motorrad (Germany) and
reviewed by KTM (Austria). The Company is also in discussions with governing and
racing bodies, such as the Fédération Internationale de l'Automobile (FIA), the
Fédération Internationale de Motocyclisme (FIM) and the National Association for
Stock Car Auto Racing (NASCAR), to have the Leatt-Brace® accredited by these
bodies.
Our products are manufactured in China under outsource
manufacturing arrangements with third-party manufacturers located there. The
Company utilizes outside consultants and its own employees to ensure the quality
of its products through regular on-site product inspections. Products purchased
through international sales are usually shipped directly from our manufacturers
warehouses or points of dispatch to customers or their import agents.
Leatt earns revenues through the sale of its products through
approximately 60 distributors worldwide, who in turn sell its products to
retailers. Leatt distributors are required to follow certain standard business
terms and guidelines for the sale and distribution of Leatt products. Two Eleven
and Leatt SA directly distribute Leatt products to retailers in the United
States and South Africa, respectively.
Our Corporate History and Structure
We were incorporated in the State of Nevada on March 11, 2005
under the name Treadzone, Inc. Until March 2006, we were a shell company with
little or no operations. Effective as of March 1, 2006, we acquired the
exclusive global manufacturing, distribution, sale and use rights to the
Leatt-Brace®, pursuant to a license agreement between the Company and Xceed
Holdings, a company owned and controlled by the Companys Chairman and founder,
Dr. Christopher Leatt. On May 25, 2005, we changed our name to Leatt Corporation
in connection with our anticipated acquisition of the Leatt-Brace® rights.
Leatt South Africa
The Company conducts business in South Africa as a foreign
registered branch known as Leatt Corporation (Incorporated in the State of
Nevada) registered under the laws of South Africa with registration number:
2007/032780/10. Based in Cape Town, South Africa, Leatt SA was formed on
November 14, 2007, for conducting the Companys business and operations in South
Africa. Our corporate headquarters and our research and development efforts are
based at Leatt SA.
- 5 -
Establishment of Two Eleven, Three Eleven and Leatt USA
On August 17, 2007, the Company established Two Eleven
Distribution, a California limited liability company, as its wholly-owned
subsidiary. Located in Santa Clarita, California, Two Eleven was formed to serve
as the Companys executive offices in the United States, as well as the
exclusive distributor of Leatt® products in the United States.
Southern Palace Investments 409 (Proprietary) Limited, a South
African company, was established on October 12, 2007, by the Company, to engage
in the manufacturing and distribution of sporting goods and protective gear. The
company was inactive until March 2009, when it acquired all intellectual
property rights related to an invention entitled the Helmet® from Xceed
Holdings, for an aggregate purchase price of ZAR 943,480 (approximately,
$90,000) pursuant to a patent assignment agreement, effective as of January 1,
2009, between Xceed Holdings and Southern Palace, doing business as Three Eleven
Distribution. On February 10, 2010, Southern Palace formally changed its name to
Three Eleven Distribution to reflect its business purpose.
On June 26, 2010, the Company established Leatt USA, LLC, a
Nevada Limited Liability Company, as our wholly-owned subsidiary and for the
purpose of holding our California subsidiary, Two Eleven Distribution. However,
as of the date of this annual report the Company had not moved forward with its
original plan and Leatt USA remains dormant.
Wind-up of Leatt New Zealand
On March 13, 2009, the Company established Leatt New Zealand
Limited, a New Zealand company, as its wholly-owned subsidiary. Leatt New
Zealand served as the exclusive distributor of Leatt-Brace® products in New
Zealand, until the fourth quarter of 2011 when it ceased operations and became
dormant. The Company has appointed an unrelated third party distributor to
distribute its products in the New Zealand market.
Settlement Agreement
As consideration for their founding of the Companys operations
in South Africa, we agreed to issue 20,000,000 shares of our common stock, and
19,200,000 shares of our preferred stock to Dr. Leatt, 5,000,000 shares of our
common stock and 4,800,000 shares of our preferred stock to Jean-Pierre De
Villiers, and 50,000 shares of our common stock to Ervian Jarrett. We issued the
common stock to Dr. Leatt, Mr. De Villiers and Ms. Jarrett in accordance with
the agreement, but we did not issue any preferred shares to Dr. Leatt or Mr. De
Villiers. On September 25, 2008, in settlement of our obligation to issue Dr.
Leatt and Mr. De Villiers shares of preferred stock, we entered into a
Settlement Agreement with them, pursuant to which they agreed to release us from
any and all liability arising out of or related to our failure to satisfy our
prior obligation to them, and we issued 16,800,000 shares of our common stock
and 2,400,000 shares of our Series A Preferred Stock to Dr. Leatt, and 4,200,000
shares of our common stock and 600,000 shares of our Series A Preferred Stock to
Mr. De Villiers. The Series A Preferred Stock entitles Dr. Leatt and Mr. De
Villiers to one hundred votes for each share of Series A Preferred Stock held
(voting with the common stock as a single class). The Series A Preferred Stock
converts into common stock, on a one-for-one basis, has a liquidation preference
equal to $0.001 par value per share and is redeemable by us at $0.001 par value
per share upon the occurrence of specified events, but it is subject to transfer
limitations and it does not entitle Dr. Leatt and Mr. De Villiers to dividends.
On September 20, 2012, we effected a 1-for-25 reverse stock split which reduces
the foregoing issuances on a 1:25 ratio.
Our Corporate Structure
The following chart reflects our organizational structure as of
the date of this annual report.
- 6 -
Our corporate headquarters are located at 50 Kiepersol Drive,
Atlas Gardens, Contermanskloof Road, Durbanville, Western Cape, South Africa,
7441. Our telephone number is +(27) 21-557-7257. We maintain a website at
www.leatt.com that contains information about our Company, but that information
is not incorporated into, or otherwise considered a part of, this annual report.
Our Industry and Market Trends
Off-Road Motorcycle Market
Our products have their roots in the off-road motorcycle
market. Our revolutionary neck brace was invented by Dr. Leatt to protect from
catastrophic neck injuries after he witnessed the death of a fellow off-road
motorcycle rider the weekend after his sons riding debut. As a result, our
original products target participants in off-road cycling activities such as BMX
racing and downhill racing. According to a Racer X Illustrated magazine reader
survey, available at http://mediakit.filterpubs.com/survey, approximately
52% of riders still do not own a neck brace for protection.
The same RacerX survey shows that we had an approximately 58.9%
market share for neck braces and 15.7% of the market share for chest protectors
in the U.S. off road motorcycle market, which represents approximately 50% of
the worldwide off road motorcycle market. We believe that we have gained our
market share, largely due to the innovation and quality of our products, the
growth of the market, our increased marketing efforts and our steps to secure
our international patents and protect our patents from infringement.
Other Recreational Markets
We also design and sell neck braces for use by participants in
other recreational sports such as ATV, go-kart and snowmobile users, race-car
drivers and participants in other sports where a full face helmet should be
worn. As a result, our overall performance in the market is also affected by the
performance of these industries, especially in jurisdictions where the use of
helmets are compulsory.
Our Products
The Company designs, develops, distributes and markets
protective gear, parts and accessories. The company's flagship protective
product is the Leatt-Brace®, a patented neck protection system for sports.
- 7 -
The Leatt-Brace®
The Leatt-Brace® is a prophylactic neck bracing system composed
of various combinations of carbon fiber, glass fiber, polycarbonate or Glass
Filled Nylon, which was designed to help prevent potentially devastating sports
injuries to the cervical spine (neck). The first LeattBrace® was designed for
motorcycle, high speed motor vehicle and ATV use, where there is little means of
protecting the neck in the event of an accident, but the Leatt-Brace® has been
designed in such a way as to offer neck protection to all who utilize a crash
helmet as a form of protection, including soldiers, law enforcement officers and
other professionals whose activities could result in cervical spine injury.
The Company currently markets and sells seven models of
Leatt-Brace® products which bring the safety benefits of the Leatt-Brace®
technology to a large group of sports participants: our GPX model for off- road
motorcycle use; our DBX model, for downhill and BMX bicycle use; our SNX model
for snowmobile use; our STX model for adventure riders, street commuters and
Speedway participants; our Kart model for go karting; and our Fusion model which
incorporates the neck brace with body protection.
The GPX models include the GPX 5.5, which is fully adjustable,
the GPX 4.5, which is less adjustable, and the GPX 6.5, which is a full carbon
brace. Our DBX models include the DBX 5.5, which are fully adjustable, the DBX
4.5 which are less adjustable, and the DBX 6.5 which is a full carbon brace.
Both the GPX and DBX ranges feature a 5.5 Junior neck brace designed for young
athletes. The STX models include the STX RR and STX Road, while the SNX model
includes the SNX Pilot and SNX Trophy, and the Fusion models include 3.0 version
designed for adults and 2.0 version designed for young athletes. The Company
offers various versions and colors of these products to appeal to different
clients and price points.
The following table sets out the type of neck braces currently
sold by the Company:
Product Category |
Models |
Description |
NECK BRACES: |
GPX |
These neck braces are designed
for off-road motorcycle riders. |
|
LEATT GPX 6.5 CARBON |
Totally new carbon chassis design by LEATT. MaxiWeave
Carbon matrix allows for increased rigidity while maintaining a lower
weight of ±620g. Lowered rim striking platform for increased head and
helmet movement. New on-board size adjusting. No parts needed. New folding
thoracic for easy storage. New 3-way adjustability for great comfort and
fit. New design chest strap included to use as optional. CE certified as
Personal Protective Equipment 89/686/EEC. |
|
LEATT GPX 6.5 |
Totally new carbon chassis design by LEATT. New MaxiWeave
Carbon matrix allows for increased rigidity while maintaining a lower
weight. New helmet rim striking platform profile. New improved helmet side
clearance. New on-board size adjusting. No parts needed. New great fit
with sliding front and rear. New folding thoracic. New on board 4-angle
rear thoracic adjustment. - 0, 5, 10 and 15°. New design clear strap
included to use as optional. 3-way adjustable for great comfort and fit.
CE certified as Personal Protective Equipment 89/686/EEC. Two adult sizes:
S/M and L/XL. |
|
LEATT GPX 5.5 |
Totally new chassis design by LEATT. New helmet rim
striking platform profile. New improved helmet side clearance. New
adjustable over the shoulder height. New on-board size adjusting. No parts
needed. New great fit with sliding front and rear. New folding thoracic.
New on board 4-angle rear thoracic adjustment. - 0, 5, 10 and 15°. New
design clear strap included to use as optional. 4-way adjustable for great
comfort and fit. CE certified as Personal Protective Equipment 89/686/EEC.
Two adult sizes: S/M and L/XL. |
|
LEATT GPX 5.5 Junior |
Totally new chassis design by LEATT. New helmet rim
striking platform profile. New improved helmet side clearance. New
adjustable over the shoulder height. New on-board size adjusting. No parts needed. New great fit with sliding front and
rear. New folding thoracic. New on board 4-angle rear thoracic adjustment.
- 0, 5, 10 and 15°. New design clear strap included to use as optional.
4-way adjustable for great comfort and fit. CE certified as Personal
Protective Equipment 89/686/EEC. One junior size. |
- 8 -
|
LEATT GPX 4.5 |
The 4.5 is the new entry level brace in this category.
Totally new chassis design by LEATT. New helmet rim striking platform
profile. New improved helmet side clearance. New folding thoracic. New on
board 4-angle rear thoracic adjustment. - 0, 5, 10 and 15°. New design
clear strap included to use as optional. 2-way adjustable for great
comfort and fit. CE certified as Personal Protective Equipment 89/686/EEC.
Two adult sizes: S/M and L/XL. |
DBX |
These neck braces are for downhill
bicycle and BMX riders. |
|
LEATT DBX 6.5 CARBON |
Totally new carbon chassis design by LEATT. MaxiWeave
Carbon matrix allows for increased rigidity while maintaining a lower
weight of ±620g. Lowered rim striking platform for increased head and
helmet movement. New on-board size adjusting. No parts needed. New folding
thoracic for easy storage. New 3-way adjustability for great comfort and
fit. New design chest strap included to use as optional. CE certified as
Personal Protective Equipment 89/686/EEC. |
|
LEATT DBX 6.5 |
Totally new carbon chassis design by LEATT. New MaxiWeave
Carbon matrix allows for increased rigidity while maintaining a lower
weight. New helmet rim striking platform profile. New improved helmet side
clearance. New on-board size adjusting. No parts needed. New great fit
with sliding front and rear. New folding thoracic. New on board 4-angle
rear thoracic adjustment. - 0, 5, 10 and 15°. New design clear strap
included to use as optional. 3-way adjustable for great comfort and fit.
CE certified as Personal Protective Equipment 89/686/EEC. Two adult sizes:
S/M and L/XL |
|
LEATT DBX 5.5 |
A totally new chassis design. New helmet rim striking
platform profile. New improved helmet side clearance. New adjustable over
the shoulder height. New on-board size adjusting. No parts needed. New
great fit with sliding front and rear. New folding thoracic. New on board
4-angle rear thoracic adjustment: - 0, 5, 10 and 15°. New design clear
strap included to use as optional. 4-way adjustable for great comfort and
fit. CE certified as Personal Protective Equipment 89/686/EEC. Two adult
sizes: S/M and L/XL |
|
LEATT DBX 5.5 Junior |
Totally new chassis design by LEATT. New helmet rim
striking platform profile. New improved helmet side clearance. New
adjustable over the shoulder height. New on-board size adjusting. No parts
needed. New great fit with sliding front and rear. New folding thoracic.
New on board 4-angle rear thoracic adjustment. - 0, 5, 10 and 15°. New
design clear strap included to use as optional. 4-way adjustable for great
comfort and fit. CE certified as Personal Protective Equipment 89/686/EEC.
One junior size. |
|
LEATT DBX 4.5 |
The 4.5 is the new entry level brace in this category.
Totally new chassis design by LEATT. New helmet rim striking platform
profile. New improved helmet side clearance. New folding thoracic. New on
board 4-angle rear thoracic adjustment. - 0, 5, 10 and 15°. New design
clear strap included to use as optional. 2-way adjustable for great
comfort and fit. CE certified as Personal Protective Equipment 89/686/EEC.
Two adult sizes: S/M and L/XL. |
- 9 -
STX |
These neck braces are for street
commuters. |
|
LEATT STX Road |
This product is intended for use by all types of street
riders. It features a quick and easy no- tool adjustable fit, with folding
scapula wings that permit easy storage and adapt to an outside back
protector and hump, and a molded padding solution for an extra low
profile. The neck brace fits over or under a garment. Skin coated padding
for improved durability. CE certified as Personal Protective Equipment
89/686/EEC. Three adult sizes: S/M, L/XL and XXL. |
|
LEATT STX RR |
The New STX RR design is for road racing and sport
riding. The neck brace has a new folding front for full tuck down.
Platform shaped for sport and race riding. Light-weight 620g carbon
construction. Race adopted front construction for tucking behind the
windscreen. Improved side clearance for race cornering. Swiveling rear
scapula's for perfect fit over any hump. CE certified as Personal
Protective Equipment 89/686/EEC. One adult size: L/XL. |
SNX |
These neck braces are for snowmobile
riders. |
|
LEATT SNX Pilot |
This neck brace features the AFC Artic Fusion Compound
- Special low temperature resin material with exclusive clip-on padding
which resists snow sticking. It fits under the riders jacket and armor.
It includes a brace sock which is a waterproof and breathable barrier
against winter elements for improved comfort. It has fully adjustable
front and rear tables. CE certified as Personal Protective Equipment
89/686/EEC. Two adult sizes: S and M. |
|
LEATT SNX Trophy |
This neck brace features the AFC Artic Fusion Compound
- Special low temperature resin material with exclusive clip-on padding
which resists snow sticking. It fits over the riders jacket and armor. It
has molded padding for low profile and adjustable height for optimal
helmet clearance. It has folded scapula wings for easy storage and side
padding recess for improved helmet movement. CE certified as Personal
Protective Equipment 89/686/EEC. Three adult sizes: S/M, L/XL and XXL.
|
Kart |
These neck braces are for go-kart
riders. |
|
LEATT Kart |
This neck brace features a special Kart angle for
improved function and fit. It features bio foam lycra padding. It also has
fully adjustable front and rear tables. CE certified as Personal
Protective Equipment 89/686/EEC. Two adult sizes: S and M. |
Moto |
These neck braces are for restrained
torso car drivers |
|
LEATT MRX PRO |
This head and neck restraint is SFI 38.1 tested and
approved for optimum protection at over 70G. It has an exclusive flexible
chassis and single collar angle design for greater comfort. It fits all
types of 2" and 3" harnesses, has fire retardant Nomex® washable padding
and the chassis is made of an advanced, fire retardant, high tensile PC
composite as well as a quick release fire retardant Kevlar® tether system
for both frontal and side impact protection. It has an Anchor post kit
with wrench included. |
Fusion |
These neck braces incorporate upper
body protection |
|
LEATT Fusion vest 3.0 |
This product combines CE certified LEATT neck brace
technology together with LEATT 3DF AirFit CE certified back, shoulder and
chest impact protection. Chest protection: EN1621-3 Level 1; Back
protection: EN1621-2 Level 1 and Shoulder protection EN1621-1. This is a
comfortable, lightweight and vented product. This product incorporates
LEATT 3DF AirFit impact foam for premium body protection. 3 dimensional
designed for perfect fit. Light weight. Great comfort. Well
ventilated. Three adult sizes: S/M, L/XL and XXL. |
- 10 -
|
LEATT SNX Fusion vest 3.0 |
This product combines CE certified LEATT neck brace
technology together with LEATT 3DF AirFit CE certified back, shoulder and
chest impact protection. Chest protection: EN1621-3 Level 1; Back
protection: EN1621-2 Level 1 and Shoulder protection EN1621-1. This is a
comfortable, lightweight and vented product. This product incorporates
LEATT 3DF AirFit impact foam for premium body protection. 3 dimensional
designed for perfect fit. Light weight. Great comfort. Well ventilated.
Three adult sizes: S/M, L/XL and XXL. |
|
LEATT Fusion vest 2.0 Junior |
This product combines CE certified LEATT neck brace
technology together with LEATT 3DF AirFit CE certified back, shoulder and
chest impact protection. Chest protection: EN1621-3 Level 1; Back
protection: EN1621-2 Level 1 and Shoulder protection EN1621-1. This is a
comfortable, lightweight and vented product. This product incorporates
LEATT 3DF AirFit impact foam for premium body protection. 3 dimensional
designed for perfect fit. Light weight. Great comfort. Well ventilated.
Three junior sizes: S/M, L/XL and XXL. |
Leatt Helmet Range
In 2015 the Company launched its helmet range and commenced
shipment of its new helmet. The Company currently sells two models of helmet
products which the Company believes redefines head and brain protection with its
groundbreaking 360 degree Turbine technology for concussion and brain rotation
safety. These helmets offer superior head and brain protection in a shell that
is smaller, very lightweight and super ventilated, even at low speeds. The
Helmet range currently includes our two GPX models for off- road motorcycle use.
The following table sets out the type of helmets currently sold
by the Company:
Product Category |
Models |
Description |
HELMETS: |
GPX |
These helmets are designed for
off-road motorcycle riders. |
LEATT GPX 6.5 CARBON |
This race-ready Carbon off-road, light weight and super
ventilated helmet is equipped with 360 Turbine concussion and brain
rotation safety technology. It has reduced outer shell volume, low
friction cheek pads for emergency removal. Visor with breakaway function
for rotational reduction in a crash. Hydration ready (with optional
hands-free kit). Moisture-wicking, breathable, antimicrobial and washable
liner. Certified and tested to ECE2205/DOT, ACU Gold. Six adult sizes: XS,
S, M, L, XL and XXL. |
|
LEATT GPX 5.5 COMPOSITE |
This race-ready composite off-road, light weight and
super ventilated helmet is equipped with 360 Turbine concussion and brain
rotation safety technology. It has reduced outer shell volume, low
friction cheek pads for emergency removal. Visor with breakaway function
for rotational reduction in a crash. Hydration ready (with optional
hands-free kit). Moisture-wicking, breathable, antimicrobial and washable
liner. Certified and tested to ECE2205/DOT, ACU Gold. Six adult sizes: XS,
S, M, L, XL and XXL. |
- 11 -
Leatt Body Armor Range
While we remain committed to the ongoing improvement and
enhancement of the Leatt-Brace®, we are also focusing on the development of
related and complimentary protection products. We now offer additional
protection products, such as chest protectors, that can be worn with or without
the Leatt-Brace®, as well as ancillary products such as clothing. Such products
have a wider range of uses including activities such as rugby, horseback riding,
snowboarding, skiing and any activity where researched technology can be applied
to help prevent injury.
In 2010 we launched the Leatt Body Armor Range with the
introduction of the Leatt Adventure Chest Protector, a hard shell chest
protector. In 2011 we introduced junior protectors, body vests and full body
protectors, since then we have extended our range further to include more body
protectors and vests, back protectors, elbow guards, knee guards and cooling
vest. All our protectors come standard with the Brace-On integration
system that attaches the protector to the Leatt-Brace® yet permits independent
movement of the brace and protector.
In 2014 we expanded our range of body protection to meet the
consumers need based on market feedback. We have expanded into new markets by
adding a shoulder brace and C-Frame knee brace to this category. We included
more products specifically for the youth and children. We have further added two
new products which combine back protectors with hydration packs.
In 2015 we expanded our range of body protection into new
markets by adding gloves to this category and we have updated our range based on
market feedback.
The Body Armor Range has seen an increase in sales since
inception. Revenue derived from Leatt protection products in 2015 was 47% of
total revenue, as compared to 42% of revenues in 2014. In November 2011, the
Leatt Adventure Chest Protector was awarded a perfect score (10/10) in a product
evaluation done on Motocrossgear.com, an industry publication.
The following table sets out the types of body armor products
currently sold by the Company:
Product Category |
Models |
Description |
CHEST PROTECTORS: |
|
Chest Protector LEATT 5.5 Pro HD |
Front, back, shoulder and flank safety multilayer multi
plate articulating design. Great fit and very comfortable by 3D design.
Consists of 53 ventilation slots for maximum airflow. It includes the
BraceOn neck brace fitting system. This product is Heavy Duty maximized
protection. New FlipFit front and rear function allows over and under the
shirt fitting with Leatt neck braces. Available also in XXL. It has a hard
shell outer shield made of High Density Poly Ethylene (HDPE). This product
includes 3DF impact foam. CE certified for impact protection: Shoulder
protection EN1621- 1, Back protection EN1621- 2 level 2, Chest protection
EN1621-3 level 2. Flank protection. Two adult sizes: Adult, Adult XXL.
|
|
Chest Protector LEATT 5.5 Pro HD Junior |
The Pro HD has added Hardshell flank padding. It consists
of 3D design with eight, multilayer, articulating plates, for a great fit.
It has also been designed to integrate perfectly with all Leatt® neck
braces although it works equally well without a neck brace. The BraceOn
strap system attaches the protector to the neck brace yet permits
independent movement of body, brace and chest protector. Fits over or
under the jersey. 47 ventilation slots for maximum cooling. Perforated 3DF
foam helps air flow. Hard shell outer shield made of High Density Poly
Ethylene (HDPE). CE certified for impact protection: Shoulder protection
EN1621-1, Back protection EN1621-2 level 1, and Chest protection EN1621-3
level 2, Flank protection. One junior size. |
|
Chest Protector LEATT 5.5 Pro |
Front, back, and shoulder safety. Multilayer multiplate
articulating design. Great fit and very comfortable by 3D design. 45
ventilation slots for maximum airflow. It includes the BraceOn® neck brace
fitting system. New FlipFit front and rear function allows over and under the shirt fitting
with Leatt neck braces. The absolute most protective and comfortable chest
protector ever. Available also in XXL. This products hard-shell outer
protective shield is made from LEATT® HDPE High Density
Poly Ethylene. This product includes 3DF impact foam. CE certified for
impact protection: Shoulder protection EN1621-1, Back protection EN1621-2
level 2, Chest protection EN1621-3 level 2. Two adult sizes: Adult and
Adult XXL. |
- 12 -
|
Chest Protector LEATT 5.5 Pro Junior |
This product is specifically designed to meet the highest
CE safety approvals for front and back impact protection. The 3D design
with eight, multi-layer, articulating plates, for a great fit. It has also
been designed to integrate perfectly with all Leatt® neck braces although
it works equally well without a neck brace. BraceOn strap system attaches
the protector to the neck brace yet permits independent movement of body,
brace and chest protector. Fits over or under the jersey. 41 ventilation
slots for maximum cooling. Perforated 3DF foam helps air flow. Hard shell
outer shield made of High Density Poly Ethylene (HDPE). CE certified for
impact protection: Shoulder protection EN1621-1, Back protection EN1621-2
level 1, and Chest protection EN1621-3 level 2. One junior size.
|
|
Chest Protector LEATT Lite SHOX |
The new SHOX design chest protector. HDPE High Density
Poly Ethylene hard shell outer protective shield with our 3D design
ensures a great fit that is very comfortable. Close fitting allows for
over or under the jersey use. This protector is designed to fit with the
Leatt neck brace. Includes BraceOn® brace strap and allows for individual
movement of body, brace and protector. CE certified for roost protection:
Chest EN 14021 approved. One adult size. |
|
Chest Protector LEATT Lite |
This protector has three dimensional design for perfect
fit and fit with the Leatt neck brace. It is made of tough HDPE High
Density Poly Ethylene hard shell outer protective shell and also includes
a BraceOn® brace strap to improve fit. CE certified as roost protection:
CE EN 14021. One adult size. |
|
Chest Protector LEATT Adventure |
This protector has three dimensional design for perfect
fit and fit with the Leatt neck brace. It is made of tough HDPE High
Density Poly Ethylene hard shell outer protective shell and also includes
a BraceOn® brace strap to improve fit. Upper arm roost protection.
Adjustable waist straps for great fit. CE certified for impact protection:
CE EN 14021. One adult size. |
|
Chest Protector LEATT Adventure Junior |
This protector is designed especially for children and is
designed to fit with the Leatt neck brace. It is made of tough HDPE High
Density Poly Ethylene hard shell outer protective shell and also includes
a BraceOn® brace strap to improve fit. CE certified for impact protection.
CE EN 14021. One junior size. |
|
Chest Protector LEATT 4.5 |
Front, back, and flank safety. Multilayer multi plate
articulating design. Great fit and very comfortable by 3D design.
Ventilation slots for maximum airflow. It includes the BraceOn® neck brace
fitting system. This products hard- shell outer protective shield is made
from LEATT® HDPE High Density Poly Ethylene. This
product includes 3DF impact foam. Removable front and rear plate function
allows over and under the shirt fitting with the neck brace. CE certified
for impact protection: Back protection EN1621-2
level 2, Chest protection EN1621-3 level 2. Two
adult sizes: Adult and Adult XXL. |
- 13 -
|
Chest Protector LEATT 4.5 Junior |
Front, back, and flank safety. Multilayer multi
plate articulating design. Great fit and very comfortable by 3D design.
Ventilation slots for maximum airflow. It includes the BraceOn® neck brace
fitting system. This products hard- shell outer protective shield is made
from LEATT® HDPE High Density Poly Ethylene. This product includes 3DF
impact foam. CE certified for impact protection: Back protection EN1621-2
level 1, Chest protection EN1621-3 level 2. One junior size. |
|
Chest Protector LEATT 4.5 Hydra |
This is a Body Protector which incorporates a
10 L back pack with 3l hydration pack. Integration with or without the
neck brace. Optimal Airline back ventilation. Removable brace plate to
wear under or over riding gear. Left and right hydration tube channeling.
Integrated buckle system. Waterproof removable cell phone pouch. CE
certified for impact protection. CE EN1621-2 level 2 back. CE EN1621-3
level 2 impact front. One adult size. |
|
Chest Protector LEATT 5.5 Pro Junior |
This protector is a HDPE High Density Poly
Ethylene hard shell outer protective shield with perforated 3DF AirFit
impact foam. It includes the BraceOn® brace strap and can be worn under or
over shirt fitting brace. CE certified for impact protection: EN 1621- 3
CE Level 2 chest, EN1621-1 shoulder and EN 1621-2 CE Level 1 back. One
junior size. |
|
Chest Protector LEATT 2.5 Junior |
This protector is a hard shell roost protection
designed for mini riders. Our 3D design ensures a great fit that is very
comfortable. Close fitting allows for over or under the jersey use.
Liberal venting helps keep rider cool. Recess areas in both front and back
integrates with Leatt® neck braces perfectly. Adjustable waist straps for
great fit. Ergonomically designed buckles for kids. CE tested and
certified as roost protection: Chest EN14021. One kids size. |
BODY PROTECTORS: |
|
Body Protector 3DF |
Three dimensional designed for perfect fit.
Lighter weight. Greater comfort. Moisture Cool wicking fabric to keep you
cooler. Easy to wear zip-up compression sock design should be worn next to
the skin for maximum evaporation. LEATT 3DF Foam for premium protection.
Removable foam for easy washing. CE certified for impact protection. CE EN
1621-1 elbow and arms. CE EN1621-2 level 2 back. CE EN1621-3 level 2
impact front. Three adult sizes: S/M, L/XL, XXL. |
|
Body Protector LEATT 3DF AirFit |
This Body Protector is Level Two soft
protection. Great fit with elastic waist belt. New thin chest impact
protection layer for non-brace riders. Super ventilation with 3DF AirFit
impact foam. Three dimensional designed for perfect fit. This product
includes Moisture Cool wicking fabric to keep you cooler. Easy to wear
zip-up compression sock design for maximum evaporation. BraceOn® flexible
neck brace connection. It has removable Impact foam for easy washing. CE
certified for impact protection. Elbow and arms protection EN1621-1, Back
protection EN1621-2 level 2, Chest protection EN1621- 3 level 2. Three
adult sizes: S/M 160-172cm, L/XL 172- 184cm, XXL 184-196cm. |
|
Body Protector LEATT 3DF Airfit Lite |
Light and slim body protector with Level One
soft protection. Mulit-layer Level One back protector and chest protector.
Extra chest impact protection layer on upper
chest for better protection for non neck brace users. Great fit with
elastic waist belt. Maximum ventilated and light weight 3DF AirFit impact
foam. Three dimensional design for perfect fit. This product includes
Moisture Cool wicking fabric to keep you cooler. Easy to wear zip-up
compression sock design for maximum evaporation. BraceOn® flexible neck
brace connection. It has removable Impact foam for easy washing. CE
certified for impact protection. Elbow and arms protection EN1621-1, Back
protection EN1621-2 level 1, Chest protection EN1621-3 level 1. Three
adult sizes: S/M 160- 172cm, L/XL 172-184cm, XXL 184-196cm. |
- 14 -
|
Body Protector LEATT 3DF Junior |
Three dimensional designed for perfect fit.
Lighter weight. Greater comfort. Moisture Cool wicking fabric to keep you
cooler. Easy to wear zip-up compression sock design should be worn next to
the skin for maximum evaporation. LEATT 3DF Foam for premium protection.
Removable foam for easy washing. CE certified for impact protection. CE EN
1621-1 elbow and arms. CE EN1621-2 level 2 back. CE EN1621-3 level 2
impact front. Two junior sizes: S/M 134-146 cm and L/XL 146-159. |
|
Body Vest LEATT 3DF Airfit Lite |
Light and slim body protector with Level One
soft protection. Mulitlayer Level One back protector and chest protector.
Extra chest impact protection layer on upper chest for better protection
for non-neck brace users. Great fit with elastic waist belt. Maximum
ventilated and light weight 3DF AirFit impact foam. Three dimensional
design for perfect fit. This product includes Moisture Cool wicking fabric
to keep you cooler. Easy to wear zip-up compression sock design for
maximum evaporation. BraceOn® flexible neck brace connection. It has
removable Impact foam for easy washing. CE certified for impact
protection. Back protection EN1621-2 level 1, Chest protection EN1621-3
level 1. Three adult sizes: S/M 160-172cm, L/XL 172-184cm, XXL 184-196cm.
|
|
Body Vest LEATT 3DF Airfit |
This Body Protector is Level Two soft
protection. Great fit with elastic waist belt. New thin chest impact
protection layer for non-brace riders. Super ventilation with 3DF AirFit
impact foam. Three dimensional designed for perfect fit. This product
includes Moisture Cool wicking fabric to keep you cooler. Easy to wear
zip-up compression sock design for maximum evaporation. BraceOn® flexible
neck brace connection. It has removable Impact foam for easy washing. CE
certified for impact protection. EN1621-2 level 2, Chest protection
EN1621-3 level 2. Three adult sizes: S/M 160-172cm, L/XL 172- 184cm, XXL
184-196cm. |
|
Body Protector LEATT 5.5 |
This product has a multilayer multi plate
articulating design with provides protection for front, bank and flank.
Ventilation slots that maximize airflow and Moisture Cool wicking fabric
to keep you cooler. BraceOn neck brace fitting system. New flipfit front
and rear function allows over and under the shirt fitting with a neck
brace. Protection is provided by 3DF foam for impact absorption and HDPE
High Density Poly Ethylene hard shell outer protective shell. CE certified
for impact protection. CE EN 1621-1 elbow and arms. CE EN1621-2 level 2
back. CE EN1621-3 level 2 impact front. Three adult sizes: S/M 160-172cm,
L/XL 172-184cm, XXL 184-196cm. |
|
Body Protector LEATT 5.5 Junior |
This product is maximized junior protection. It
has front, back, shoulder and elbow protection. It is a multilayer and
multi plate articulating design and great fit and
comfort. Ventilation slots that maximize airflow and Moisture Cool wicking
fabric to keep you cooler. BraceOn neck brace fitting system. New flipfit
front and rear function allows over and under the shirt fitting with a
neck brace. Protection is provided by 3DF foam for impact absorption and
HDPE High Density Poly Ethylene hard shell outer protective shell. CE
certified for impact protection. CE EN 1621-1 elbow and arms. CE EN1621-2
level 1 back. CE EN1621-3 level 2 impact front. Two junior sizes: S/M
134-146 cm and L/XL 146-159. |
- 15 -
|
Body Vest LEATT 5.5 |
This product has a multilayer multi plate articulating
design with provides protection for front, bank and flank. Ventilation
slots that maximize airflow and Moisture Cool wicking fabric to keep you
cooler. BraceOn neck brace fitting system. New flipfit front and rear
function allows over and under the shirt fitting with a neck brace.
Protection is provided by 3DF foam for impact absorption and HDPE High
Density Poly Ethylene hard shell outer protective shell. CE certified for
impact protection. CE EN1621-2 level 2 back. CE EN1621-3 level 2 impact
front. Three adult sizes: S/M 160-172cm, L/XL 172- 184cm, XXL 184-196cm.
|
|
Body Protector LEATT 4.5 |
This hard shell reinforced CE certified 3DF body
protector has HDPE High Density Poly Ethylene hard shell outer protective
shield. Perforated 3DF AirFit impact foam. Multi- layer multi-plate
articulating design. Our 3D design ensures a great fit that is very
comfortable. Ventilation slots for maximum airflow. CE tested and
certified as impact protection: Chest prEN1621-3 Level 2, Back EN1621-2
Level 2 and Elbow and Shoulder EN1621-1. Three adult sizes: S/M, L/XL and
XXL. |
|
Body Protector LEATT 4.5 Junior |
This hard shell reinforced CE certified 3DF body
protector has HDPE High Density Poly Ethylene hard shell outer protective
shield. Perforated 3DF AirFit impact foam. Multi- layer multi-plate
articulating design. Our 3D design ensures a great fit that is very
comfortable. Ventilation slots for maximum airflow. CE tested and
certified as impact protection: Chest prEN1621-3 Level 2, Back EN1621-2
Level 1 and Elbow and Shoulder EN1621-1.Two junior sizes: S/M and L/XL.
|
|
Body Vest LEATT 4.5 |
This hard shell reinforced CE certified 3DF body vest has
HDPE High Density Poly Ethylene hard shell outer protective shield.
Perforated 3DF AirFit impact foam. Multi-layer multi- plate articulating
design. Our 3D design ensures a great fit that is very comfortable.
Ventilation slots for maximum airflow. CE tested and certified as impact
protection: Chest prEN1621-3 Level 2, Back EN1621-2 Level 2. Three adult
sizes: S/M, L/XL and XXL. |
|
Body Tee LEATT 3DF Airfit Lite |
This 3DF AirFit Lite Tee offers light and slim CE Level 1
soft protection for your upper body. The flexible foam is light to wear
and very well ventilated, yet absorbs energy up on impact for optimal
safety. CE tested and certified as impact protection: Chest prEN1621-3
Level 1, Back EN1621-2 Level 1 and Shoulder EN1621-1. Three adult sizes:
S/M, L/XL, XXL and Junior L/XL. |
|
LEATT Roost Tee |
Ultra lightweight roost tee. Vented roost padding over
chest and upper arms. Moisture Cool wicking fabric to help keep
rider cool. Fits snug direct on the body. It comes in a
cool grey color which will not shine through the jersey. It has non-
aggressive over lock seams. It has a front, rear and side panel stretch
for ultimate fit. Long back cut. Three adult sizes: S/M, L/XL, XXL and
Junior L/XL. |
- 16 -
BACK PROTECTOR: |
|
Back Protector 3DF |
Three dimensional designed for perfect fit. Bio
engineered back with 3D contour shape like your spine. Light weight and
greater comfort. Moisture Cool wicking fabric to keep you cooler. Easy to
wear zip-up compression sock design should be worn next to the skin for
maximum evaporation. LEATT 3DF Foam for premium protection. Removable foam
for easy washing. CE certified for impact protection. CE EN1621-2 level 2
back. Three adult sizes: S/M, L/XL, XXL. |
|
Hydration Cargo 3.0 DBX |
This product incorporates back protector and hydration
pack in one. It has a 3l hydration pack with Leatt Flat CleanTech bladder.
The back pack has 10l volume with outer pocket for MTB helmet. Back
protector incorporates 3DF impact protection. Waterproof removable pouch
for cellphone. Inner and outer compartments for the back pack. Water
bottle holders and volume regulating straps on backpack. CE certified for
impact protection. CE EN1621-2 level 2 back. One adult size. |
|
Hydration Cargo 3.0 GPX Off- Road |
This product incorporates back protector and hydration
pack in one. It has a 3l hydration pack with Leatt Flat CleanTech bladder.
The back pack has 10l volume. Back protector incorporates 3DF impact
protection. Waterproof removable pouch for cell phone. Inner and outer
compartments for the back pack. Water bottle holders and volume regulating
straps on backpack. CE certified for impact protection. CE EN1621- 2 level
2 back. One adult size. |
|
Hydration Pack DBX Enduro Lite WP 2.0 |
Waterproof light bicycle hydration with back protector.
Fully welded waterproof lightweight bicycle hydration system with multi
impact level 1 back protector. The unique chest harness ensures a very
solid fit making the waist strap obsolete. Includes bottom
jacket/protector storage straps, heat resistant encapsulated bladder
pocket and a strap system for full face or/and MTB helmet. CE tested and
certified as impact protection: Back EN1621-2 Level 1. One size fit
XS-XXL. |
|
Hydration Pack DBX Mountain Lite 2.0 |
Slim and ultra-light bicycle hydration with back
protector with 2.0L Flat CleanTech bladder and 1.0L luggage. Unique light
weight chest harness for a rock solid fit. Mesh storage pocket inside the
bag. Optimal AirLine back ventilation. Heat reflective inner back panel to
keep liquid cool or hot. Lightweight helmet carrier system for full face
or/and MTB helmet. Dual hydration tube exit for 2-way routing. CE tested
and certified as impact protection: Back EN1621-2 Level 1. One size fits
all. |
SHOULDER BRACE: |
|
Shoulder Brace |
This shoulder brace has the correct anatomical pull
forces to help prevent a shoulder dislocation. It fits snug under the
riders jersey with adjustable compression. Three adult sizes: S/M, L/XL
and XXL. |
ELBOW GUARDS: |
|
Elbow Guard Airflex |
This is the slimmest, lightest elbow guard made by
Leatt®. The new super slim 6mm CE impact certified elbow guard
which weighs only 240 g grams per
pair. CE Certified for impact protection: Elbow EN 1621-1. Five adult
sizes: S, M, L, XL and XXL. |
- 17 -
|
Elbow Guard 3DF 5.0 |
The soft CE certified 3DF elbow
guard has premium elbow protection in a slimmer, softer, more flexible
design. This pure soft shell guard is big on protection yet lightweight
and very comfortable. Pre-curve design for better fit & function. Its
made with our innovative 3DF foam that absorbs energy on impact. CE tested
and certified as impact protection: Elbow EN1621-2 Five adult sizes: S, M,
L, XL, XXL and one junior size. |
|
Elbow Guard 3DF Hybrid |
This elbow guard combines soft
and comfortable 3DF foam with deflecting hard shell. Moisture Cool wicking
fabric to keep you cooler and silicone laminations keep protectors in
place. CE certified for impact protection. CE EN1621- 1. Three adult
sizes: S/M, L/XL and XXL and one junior size. |
|
Elbow Guard LEATT 3.0 |
The hard shell elbow guard is
comfortable and very easy to slip on and off with the X-straps and offers
a full hard shell elbow protection. Co-molded soft rubber edges for extra
comfort, 3D design for optimal fit with specific left and right sides and
vented plates for maximum airflow. Three adult sizes: S/M, L/XL and XXL.
|
|
Elbow Guard LEATT Contour |
The Contour elbow guard offers
full hard shell elbow protection with co-molded soft edges for comfort.
They are slim, lightweight and comfortable with a great fit and silicone
cuffed MoistureCool sock. Silicone printed non slip cuffs. CE certified
for impact protection: Elbow CE EN1621- 1. Three adult sizes: S/M, L/XL
and XXL and one junior size. |
|
Elbow Guard LEATT 3DF Junior |
Three dimensional designed for
perfect fit. Greater comfort. Moisture Cool wicking fabric to keep you
cooler. Abrasion resistant aramid fiber outer layer. Silicone laminations
keep protectors in place. LEATT 3DF Foam for premium protection. Can be
worn under or over the jersey. CE certified for impact protection. CE
EN1621-1. One junior size. |
|
Elbow Guard LEATT 3DF Kids |
Three dimensional designed for
perfect fit. Greater comfort. Moisture Cool wicking fabric to keep you
cooler. Abrasion resistant aramid fiber outer layer. Silicone laminations
keep protectors in place. LEATT 3DF Foam for premium protection. Can be
worn under or over the jersey. CE certified for impact protection. CE
EN1621-1. One kids size. |
KNEE BRACE |
|
LEATT C-Frame Carbon |
This knee brace has three point
force distribution with super stiff C-arm mono hinge construction. The
adjustable soft lockout prevents hyperextension of the knee. It has super
low profile inner knee for superior bike control. X-strap thigh and calf
fitment with adjustable inner knee load pad. Leatt InteliLink hinge with
double pivot points and ferro-ligaments control knee rotation and sheer.
CE certifies for knee impact protection. CE 1621-1. 3 Adult sizes: S/M,
L/XL and XXL. |
|
Knee Brace Sleeve |
This sleeve is manufactured using
Moisture Cool wicking fabric with flatlock stitching for extra comfort.
This extra sleeve folds over the knee brace and prevents slipping. Three
adult sizes: S/M, L/XL and XXL. |
KNEE GUARDS: |
|
Knee Guard LEATT 3DF |
Three dimensional designed for
perfect fit. Greater comfort. Moisture Cool wicking fabric to keep you cooler. Abrasion
resistant aramid fiber outer layer. Side padding protects knee from side
impact. Adjustable silicone laminated straps keeps protectors in place.
3DF Foam for premium protection. CE certified for impact protection. CE
EN1621-1. Three adult sizes: S/M, L/XL, XXL and one junior size. |
- 18 -
|
Knee Guard LEATT Dual Axis |
Three dimensional designed for perfect fit. Light Weight.
Greater comfort. Large vents help keep rider cool. Slim over or under the
pants design. Leatt HDPE (High Density Poly Ethylene) hard shell outer
protective shield. Anatomically correct dual pivot points. LEATT Foam for
premium protection. CE certified for impact protection. CE EN1621-1. Three
adult sizes: S/M, L/XL and XXL. |
|
Knee Guard LEATT Enduro |
This product consists of a hard shell sliding surface
with 3DF impact absorption body. Silicone laminated straps keeps protector
in place with maximum ventilation. The co-molded rubber edges increases
comfort. CE certified for impact protection. CE EN1621-1. Two adult sizes:
S/M, L/XL |
|
Knee Guard LEATT Airflex Pro |
This ultra slim AirFlex knee guard offers great impact
protection and a slim fit. 6mm CE impact certified profile. New side &
upper knee impact protection. New silicon printed cupped knee grip.
Silicone printed non slip cuffs. New single sizing for perfect fit. CE
tested and certified as impact protection: Knee EN1621-2. Five adult
sizes: S, M, L, XL and XXL. |
|
Knee Guard LEATT 3DF 5.0 |
This soft CE certified 3DF knee guard has increased side
protection. This pure soft shell guard is big on protection yet
lightweight and comfortable. Abrasion resistant Aramid outer layer for
durability, new wider silicone printed elastic cuffs, new 30mm low profile
elastic Velcro strap with easy pull suede finger tabs with MoistureCool
and AirMesh fabrics. CE tested and certified as impact protection: Knee
EN1621-2. Three adult sizes: S/M, L/XL and XXL. |
|
Knee Guard LEATT 3DF 5.0 Junior |
This soft CE certified 3DF knee guard has increased side
protection. This pure soft shell guard is big on protection yet
lightweight and comfortable. Abrasion resistant Aramid outer layer for
durability, new wider silicone printed elastic cuffs, new 30mm low profile
elastic Velcro strap with easy pull suede finger tabs with MoistureCool
and AirMesh fabrics. CE tested and certified as impact protection: Knee
EN1621-2. One junior size. |
|
Knee Guard LEATT 3DF Hybrid |
This protector consists of deflecting hard shell with
soft and comfortable 3DF foam. Moisture Cool wicking fabric to keep you
cooler. CE certified for impact protection. CE EN1621-1. Three adult
sizes: S/M, L/XL and XXL. |
|
Knee Guard LEATT 3DF Airflex |
This knee guard is super slim 6mm which weighs only 105
grams. It consists of Armourgels ultra slim impact absorbing gel.
Moisture Cool wicking fabric to keep you cooler. CE certified for impact
protection. CE EN1621-1. Three adult sizes: S/M, L/XL, XXL. |
|
Knee and Shin Guard LEATT EXT |
This product has full shin protection with BMX approved
extended length. It consists of a hard shell sliding surface with 3DF
impact absorption body. Silicone laminated straps keeps protector in place
with maximum ventilation. The co-molded rubber edges increases comfort. CE
certified for impact protection. CE EN1621-1. Two adult sizes: S/M, L/XL
and one junior size. |
- 19 -
|
Knee and Shin Guard LEATT 3DF Hybrid EXT |
This protector consists of deflecting hard shell with
soft and comfortable 3DF foam. Moisture Cool wicking fabric to keep you
cooler. CE certified for impact protection. CE EN1621-1. Three adult
sizes: S/M, L/XL, XXL and one junior size. |
|
Knee and Shin Guard LEATT 3.0 EXT |
This protector is a hard shell knee & shin guard
combined with 3DF impact absorbing body. It has 3D design for optimal fit
with specific left and right sides. Slim shin plate that also fit inside
boots. CE tested and certified as impact protection: Knee & shin
EN1621-2. Three adult sizes: S/M, L/XL, XXL. |
|
Knee Guard LEATT 3DF Kids |
Three dimensional designed for perfect fit. Greater
comfort. Moisture Cool wicking fabric to keep you cooler. Abrasion
resistant aramid fiber outer layer. Silicone laminated straps keeps
protector in place. CE certified for impact protection. CE EN1621-1.One
kids size. |
KIDNEY BELT: |
|
Kidney Belt LEATT 3DF 3.5 |
Kidney belt with CE certified lumbar impact protection.
Dual action elastic closure for maximum support, 3DF foam for impact
protection. Thermo foamed 3D air channels for maximum ventilation. Extra
wide and comfortable waist stretch. CE certified for impact protection.
Lumbar EN1621-2 Level 1. Four adult sizes: S/M, L/XL, XXL and XXXL.
|
COOLING WEAR: |
|
Cooling Vest LEATT Coolit |
This product is made from a patented HyperkewlTM
cooling fabric that is designed to lower the body temperature. It
fits snugly on the body under a body protector and is light-weight. Seven
adult sizes: XS, S, M, L, XL, 2XL, 3XL and one junior size. |
|
Cooling Tee LEATT Coolit |
This product is also made from a patented
HyperkewlTM cooling fabric that is designed to lower the body
temperature. It is the only product with sleeves in this range. It fits
snugly on the body under a body protector and is light-weight. Seven adult
sizes XS, S, M, L, XL, 2XL, 3XL and one junior size. |
|
Cooling Vest LEATT Pre-Cool |
This product is for cooling riders down before, after and
between races. Patented TechKewl cooling inserts. Keeps 14C or 58F
temperature for 3 hours. Lowers body temperature. Increases body
performance. Fits directly on body. Non- aggressive over lock seams.
Front, rear and side panel stretch for ultimate fit. Cool white/grey.
Three adult sizes: Adult S/M, L/XL, XXL and one junior size. |
GLOVES: |
|
Glove DBX 3.0 X-Flow |
This product is a super vented X-Flow mesh bicycle glove
with impact protection. The glove has 3D molded self- locating Armourgel
impact protection for knuckles. This glove has Genuine Clarino Japan palm:
Micro fiber technology, 3D intervened fiber layout, soft and flexible,
great dry and wet grip and two silicone finger grips. CE tested as impact
protection: Knuckle prEN 13594:2014. Six adult sizes: XS, S, M, L, XL and
XXL. |
|
Glove DBX 4.0 Lite |
This product is a vented bicycle glove. The glove has 3D
molded self-locating Armourgel impact protection for: knuckles, third
finger and fourth finger. The glove also features NanoGrip palm:
Ultra-thin for maximum bike feel, Nano fiber technology 7.500 thinner than
hair, very stretchy and flexible and has touch screen function. CE tested
as impact protection: Knuckle prEN 13594:2014. Six adult
sizes: XS, S, M, L, XL and XXL. |
- 20 -
|
Glove DBX 4.0 Windblock |
This product is a slim and protective windproof bicycle
glove. The glove has 3D molded self-locating Armourgel impact protection
for: knuckles, third finger and fourth finger. The glove also features
NanoGrip palm: Ultra-thin for maximum bike feel, Nano fiber technology
7.500 thinner than hair, very stretchy and flexible and has touch screen
function. CE tested as impact protection: Knuckle prEN 13594:2014. Six
adult sizes: XS, S, M, L, XL and XXL. |
|
Glove GPX 3.5 X-Flow |
This product is a super vented X-Flow mesh Off-Road glove
with impact protection. The glove has 3D molded self- locating Armourgel
impact protection for knuckles. This glove has Genuine Clarino Japan palm:
Micro fiber technology, 3D intervened fiber layout, soft and flexible,
great dry and wet grip and two silicone finger grips. CE tested as impact
protection: Knuckle prEN 13594:2014. Six adult sizes: XS, S, M, L, XL and
XXL. |
|
Glove GPX 4.5 Lite |
This product is a vented Off-Road glove. The glove has 3D
molded self-locating Armourgel impact protection for: knuckles, third
finger and fourth finger. The glove also features NanoGrip palm:
Ultra-thin for maximum bike feel, Nano fiber technology 7.500 thinner than
hair, very stretchy and flexible and has touch screen function. CE tested
as impact protection: Knuckle prEN 13594:2014. Six adult sizes: XS, S, M,
L, XL and XXL. |
|
Glove GPX 5.5 Lite |
This vented Off-Road glove with optimum protection. The
glove has 3D molded self-locating Armourgel impact protection for:
knuckles, fingers & thumb and upper hand. The glove also features
NanoGrip palm: Ultra-thin for maximum bike feel, Nano fiber technology
7.500 thinner than hair, very stretchy and flexible and has touch screen
function. CE tested as impact protection: Knuckle prEN 13594:2014. Six
adult sizes: XS, S, M, L, XL and XXL. |
|
Glove GPX 5.5 Windblock |
This product is a slim and protective windproof off-road
glove. The glove has 3D molded self-locating Armourgel impact protection
for: knuckles, fingers & thumb and upper hand. The glove also features
NanoGrip palm: Ultra-thin for maximum bike feel, Nano fiber technology
7.500 thinner than hair, very stretchy and flexible and has touch screen
function. CE tested as impact protection: Knuckle prEN 13594:2014. Six
adult sizes: XS, S, M, L, XL and XXL. |
Other Products, Parts and Accessories
The nature of our product is such that certain components
collapse and fail in a controlled mode to help prevent further bodily injury. In
light of this, we also provide aftermarket support for users of our products
through our global distribution network. Specific parts of the product or the
entire product may need to be replaced after a significant impact. Our
aftermarket support primarily entails the replacement of worn or damaged parts,
as well as sale of accessories, including hats and hydration kits. We also sell
clothing and outerwear.
The following table sets out the type of hydration products
currently sold by the Company:
HYDRATION SYSTEMS: |
|
Hydration Ultra 750 HF |
Ultra-light hydration for neck brace fit. Specially
developed liquid pack to fit Leatt neck braces. Easily strapped directly
onto the rear thoracic strut of any Leatt neck brace, giving a
well-balanced fit. This enables the rider to combine neck protection and a
hydration system in a very flexible way. |
|
Hydration Pack GPX Race HF 2.0 |
Slim, ultra-light, hands-free hydration system for off
road racing. The unique chest harness ensures a very solid fit making the
waist strap obsolete. Includes heat resistant encapsulated bladder pocket
with dual hydration tube exit for 2-way routing. One size fits all.
|
|
Hydration Pack GPX 2.0 Trail WP HF |
Waterproof light off-road hydration with 2.0L Flat
CleanTech bladder & 5L luggage. Fully welded waterproof lightweight
hydration system. The unique chest harness ensures a very solid fit making
the waist strap obsolete. Removable tool roll and neoprene hydration
pocket. |
- 21 -
Accolades
Leatt-Brace® products have attracted worldwide interest and we
have corresponded with global motorsports governing bodies such as the FIM,
Motorsport South Africa, NASCAR and the FIA, with motor racing teams such as the
KTM Racing Team, with automotive and motorcycle manufacturers, and with global
retailers and distributors of protective gear for motor and extreme sports. We
are also in discussions with the FIM, NASCAR and the FIA, to have the
Leatt-Brace® accredited.
Our Leatt-Brace® and chest protection products have acquired CE
certification where necessary to distribute and sell products in the EU
countries. The Leatt-Brace® products have won a series of awards and accolades
since 2007, including the following:
|
|
Motocross Action: Leatt-Brace GPX
awarded 5/5 Star Product Rating (2007) and Decades Most Significant
Product (awarded by an industry magazine based on comfort, fit and safety)
|
|
|
Transworld MX: Editors ChoiceLeatt
Brace Adventure awarded Best New Product of Year (2009) (selected by
editors of an industry magazine with no published criteria) |
|
|
ISPO Brandnew Awards: Leatt-Brace DBX
awarded Best Protection at Bike Expo (2010) (Bike Expo is an annual
gathering of industry participants) |
|
|
Transworld MX: Leatt GPX Pro Best
Product of the Year (2011) (selected by editors of an industry magazine,
based on comfort and safety) |
|
|
Motocrossgear.com: Perfect Score to New
2012 Leatt-Brace Chest Protector Adventure Pro (selected by an industry
website, based on looks, comfort and safety) |
|
|
Transworld Motorcross Magazine: Chest
Protector Leatt Pro Lite was awarded Product of the Year for 2012
(selected by editors of industry magazine based on testing and looks)
|
|
|
PPS Moto: This Motocross Product review website
awarded the Company the 2014 PPS Moto Protective Gear Company of the Year
Award. |
|
|
Mountainbike Magazine: The Leatt F4
Hydration System won the Design and Innovation Award for 2015. The product
was chosen from over 100 brands and vetted by an international jury
featuring top athletes, including Enduro World Series Winner, Nico Lau.
|
|
|
2015 Vital MX Audience Survey: The Leatt
Neck Brace was voted the number one Neck Brace to buy in the Vital MX
Audience Survey. |
|
|
Design & Innovation 2016 Awards: The
Leatt DBX 5.0 Composite Helmet won a Design and Innovation Award for 2016.
The Design & Innovation jury of bicycle industry experts seeks to
recognize bicycles and bicycle products. |
|
|
Design & Innovation 2016 Awards: The
Leatt DBX Enduro Lite WP 2.0 won a Design and Innovation Award for 2016.
The Design & Innovation jury of bicycle industry experts seeks to
recognize bicycles and bicycle products. |
We believe that the quality of Leatt-Brace® products has
resulted in increased sales since inception. We have sold in excess of 640 000
units of Leatt-Brace® products worldwide to date. Approximately 9% of our 2010
unit sales were from our DBX bicycle brace. This number increased to 10% of unit
sales in 2014 and has increased to 13% of unit sales in 2015. Our STX street
brace, which was introduced to the market in 2011, accounted for 1% of unit
sales in 2014 and 2% of unit sales in 2015.
- 22 -
Manufacturing
Our products are manufactured in China in accordance with our
manufacturing specifications, pursuant to outsource manufacturing arrangements
with third-party manufacturers located there. Our third-party manufacturers
usually have the capacity to produce more than 120,000 neck braces per year and
have the space to expand such capacity as required. We do not currently have
written agreements with our neck brace third-party manufacturers but will
include any such future written agreement with our periodic filings. We have a
manufacturing agreement with our Helmet manufacturer and will file agreements as
they become material. We generally offer a 2-year warranty on our products in
accordance with EU regulations. Products purchased through international sales
are usually shipped directly from our manufacturers warehouses or points of
dispatch to customers or their import agents.
Upon internal determination of order quantities, we order from
these third-party manufacturers by means of issuing a manufacturing purchase
order. The purchase price for each such order is negotiated with the
manufacturer and then a deposit of between 10 30% of the total purchase order
value is made with the manufacturer upon receipt of the manufacturers invoice
reflecting quantities ordered and negotiated price. The standard agreed on lead
time from order date to ship-ready date is 70 days, and our usually agreed on
shipping terms are FOB (Port). Products purchased through international sales
are usually shipped directly from our manufacturers warehouses or points of
dispatch to customers or their import agents.
During production, we measure the manufacturers on-time
performance to determine whether to continue our outsource relationship. We
utilize outside consultants and our own employees to ensure the quality of our
products through regular on-site product inspections. Such quality inspections
are conducted in conformance with ISO/IEC 17025 specifications at the
manufacturers premises and penalties are levied against a manufacturer if any
delay in shipment to customers or customer rejection or non-acceptance is caused
by quality issues. The balance of the open invoices is paid to the manufacturer
six weeks after successful inspection.
Raw Materials and Suppliers
Our products are manufactured from generally available
engineering materials, such as thermoset carbon fiber, glass fiber reinforced
nylon, high impact polycarbonate resin. The cost of materials used in our
products varies depending on the target market for, and the price of, our
products. The prices of these raw materials are determined based upon prevailing
market conditions and supply and demand and global conditions may impact the
supply of these raw materials and adversely affect the supply of our products.
We have not experienced any interruptions to our production due to shortage of
our raw materials.
Our third-party manufacturers arrange for the purchase of most
of the raw materials that are used to manufacture our products and they pay for
the cost of such materials. We may occasionally directly source and pay for
highly specialized protection materials, such as Armourgel, for use in the
production of our products. These protection materials are freely available. We
may also occasionally acquire raw materials on behalf of a third-party
manufacturer in order to secure and maintain a specified production capacity.
The expenses incurred for such materials for the years ended December 31, 2015
and 2014, were not material and we do not foresee these amounts being material
in the near future.
We have implemented certain protocols to check the quality of
raw materials used in the production process. Our third-party manufacturers are
required to perform prescribed strength testing on critical parts of certain
products. In addition, certain materials are tested by our research and
development staff at Leatt SA and by independent material laboratories for
compliance to manufacturing and material specification.
Our Customers
Leatt earns revenues through the sale of its products to
customers worldwide through a global network of distributors and retailers.
Leatt also acts as the original equipment manufacturer for neck braces sold by
certain international brands. Leatt sells its products directly to distributors
in South Africa (through Leatt SA), in the USA (through Two Eleven), and through
a network of 60 third-party distributors worldwide. Our distributors are
required to follow certain standard business terms and guidelines for the sale
and distribution of our products. Two Eleven also sells our products directly to
consumers through our online store available at www.leatt.com.
Products purchased through international sales are usually
shipped directly from our manufacturers warehouses or points of dispatch to
customers or their import agents. Revenue and related cost of revenue is
recognized at the time of shipment from the manufacturers port when shipping
terms are Free On Board (FOB) shipping point, Cost and Freight (CFR) or Cost and
Insurance to named place (CIP) as legal title and risk of loss to the product
pass to the customer.
We generate revenue both in the United States and
internationally. For the years ended December 31, 2015 and 2014, annual revenues
associated with international customers were $11,642,970 and $11,025,185, or 63%
and 60% of total revenue, respectively
- 23 -
We have derived a significant portion of our revenue from a
limited number of customers, however none of our customers account for more than
10% of our consolidated revenues for the year ended December 31, 2015. For the
year ended December 31, 2014, our U.S. revenue was concentrated in one customer
that accounted for approximately 13%, of annual U.S. revenue, with our largest
customer in the U.S. accounting for approximately 7 % of our U.S. sales for the
year ended December 31, 2015. As of December 31, 2015 and 2014, $0 or 0% and
$738,780, or 17% of our accounts receivable, was due from this customer.
For the years ended December 31, 2015 and 2014, our
international revenue (not including the U.S.) was earned from two customers
that accounted for approximately 24% and 24% of our annual international revenue
for the respective periods, with our largest international customer accounting
for approximately 17% and 12% of international sales for each of the respective
periods. As of December 31, 2015 and 2014, $344,589 or 11% and $699,127 or 16%
of our accounts receivable, respectively, were due from these international
customers.
Advertising and Marketing
We first gained market recognition through customer
word-of-mouth and later through third-party articles and reviews of the
Leatt-Brace® in motorcycle and racing magazines, and unsolicited and unpaid
endorsements from current and former celebrity motocross (and other) riders, but
we now advertise our products in various motorsport industry magazines and in
related online media. We also enhance our image through the sponsorship of
sporting events, teams and individuals.
We believe that, as a result of our marketing efforts, and
based on our internal marketing estimates, we have approximately 812 active
distributors and dealers who stock Leatt products in the U. S. and approximately
196 active distributors and dealers in South Africa. We expect that the number
of our distributors and dealers will also grow as the market segments that we
sell to and our product offering grows but we cannot guarantee that this will be
the case.
Our advertising and marketing expenses for the years ended
December 31, 2015 and 2014 were $1,498,307 and $1,442,450, respectively,
representing approximately 8% and 8% of our revenues for each period.
Our Growth Strategy
We are committed to growing our business in the coming years.
The key elements of our growth strategy are summarized below:
|
|
Regional Distributors. Our product range has
attracted the interest of global retailers and distributors of protective
gear for motor and extreme sports, as well as automotive and motorcycle
manufacturers and racing teams like the KTM teams. The resultant interest
and the expected demand for our products have prompted us to change our
production and distribution strategy in order to cater to this demand. In
November 2007, we established Two Eleven, our wholly owned California
subsidiary, to manage and control the distribution of our products,
particularly in the United States. We distribute products to international
consumers through a network of international distributors who are selected
by our management team based on their financial status and
creditworthiness, their location in major geographic locations, their
marketing and media presence, their portfolio of leading motorcycle brands
and accessories, and their reputation among industry players. We are also
in discussions with various suppliers of motor sports protective gear in
various regions throughout the world, including Europe, Asia, South
America and the Middle-East, in an effort to improve our network of
distributors and dealers worldwide, with emphasis on emerging markets in
the Middle-East and South America. We believe that regional distributors
will better promote our products in the designated regions and expand our
global customer base. |
|
|
|
|
|
OEM Manufacturers. We are seeking to expand our
OEM services to other brands utilizing our Intellectual Property rights.
With the launch of OEM agreements with other companies with their own
established distribution networks, there are opportunities for us to
greatly increase our regional distribution footprint globally. |
|
|
|
|
|
Industry Accreditation and Endorsements. We are
pursuing accreditation and endorsements of our products from global motor
sports governing bodies and industry organizations. We are in discussions
with governing racing bodies, such as the Commission Internationale de
Karting, or CIK, the FIM, the FIA, and NASCAR, to have the Leatt-Brace®
accredited. We believe that these accreditations and endorsements will
increase sales of our products and solidify our position as a leader in
safety products. SFI testing is compulsory for neck protection used in
automotive racing in the United States, therefore should neck protection
be compulsory we believe that such accreditations and endorsements will
additionally increase our sales. |
|
|
|
|
|
Efforts to Promote Use of Our Products. We intend
to promote the military use of our products to foreign governments
worldwide, as well as promote the passage of standards and regulations
prescribing the use of safety products such as ours by
riders in South Africa as well as in other markets where
we sell our products. We also intend to pursue large insurance carriers to
mandate or incentivize their insured riders and/or drivers to wear safety
products such as ours. |
- 24 -
|
|
Expanding our Portfolio of Products. We are always
looking for opportunities to introduce new products to reach a wider
audience and penetrate new markets. This will include extending our
product range to include both innovative protection products as well as
peripheral or accessory products such as clothing. In the 2015 first
quarter our Knee Brace was accepted for registration by both the United
States Food and Drug Administration (FDA) and the UKs Medicine and
Healthcare Regulatory Products Agency (MHRA), and our Shoulder Brace was
accepted by the FDA, as Class 1 Medical Devices. FDA and MHRA registration
will allow us take these products directly to market as medical devices
for patients (not just athletes) recuperating from injuries, surgery,
muscle tears or strains, dislocations, breaks or fractures. We also
launched two additions to our body armor product range, namely helmets and
gloves. We expect that our sales of peripheral or accessory products will
increase in line with brand awareness. |
Our Research and Development Efforts
Our Chairman and Founder, Dr. Christopher Leatt, is our primary
research and development consultant and heads the research and development
efforts conducted at our research facility, or Leatt Lab, located at our
executive headquarters in Cape Town, South Africa. The facility houses a team of
biomedical engineers and designers who ensure products are scientifically and
mechanically sound. This facility features state of the art testing and
prototyping equipment and sophisticated simulation models. Leatt also utilizes
other consultants, academic institutions and engineering companies from time to
time to assist us with our research and development efforts.
We believe that the development of new products and new
technology is critical to our success. We are continuously working to improve
the quality, efficiency and cost-effectiveness of our existing products. All our
products have achieved CE certification when necessary. We are working to
develop technology to expand our range of products with further innovation,
comfort, ergonomics and market appeal. We believe that our scientific and
medical approach to product development gives our products a competitive edge.
Our research and development expenses for the fiscal years
ended December 31, 2015 and 2014, amounted to $1,180,227 and $1,222,209,
respectively. These expenses included salaries for research and development
staff as well as other direct product development and research costs.
Competition
We compete with a small number of dominant competitors in the
neck brace and body protection market, some of whom have substantially greater
financial and other resources than we currently have. According to the RacerX
survey discussed elsewhere herein and available at
http://mediakit.filterpubs.com/survey, our major competitors in the neck
brace market is Atlas Brace USA, LLC, Alpinestars S.p.A and EVS Sports, and our
major competitors in the body protection market is Fox Racing.
Competition is based on quality, price reputation, industry
endorsements and certifications, as well as, on product design, brand names,
marketing support and distribution strategies. We believe that our products can
be distinguished from the products offered by our competitors due to the fact
that our products are innovative, safety tested, versatile, aesthetically
appealing, priced competitively and comfortable without compromising quality and
performance.
Our Competitive Strengths
We believe that our competitive strengths include the
following:
|
|
Intellectual Property. Licensed patented
technology allows us to provide a product that cannot easily be duplicated
by our competitors. We have invested extensive resources to patent our
products worldwide and have taken legal action to protect our intellectual
property rights from infringement. |
|
|
|
|
|
Diverse Multi-Cultural Skilled Management Team.
Our management team is knowledgeable and experienced in the personal
protective equipment industry, sports medicine and business development.
Our executive corporate management team consists of Mr. Sean Macdonald,
Dr. Christopher James Leatt, Mr. Erik Olsson and Mr. Todd Repsher. Mr.
Macdonald is our Chief Executive Officer, Chief Financial Officer,
President and Director, and is a Chartered Accountant with 9 years
experience in the financial and operational aspects of running sports
orientated growth companies. Dr. Leatt is our Founder, Chairman and
Research and Development consultant, who developed the Leatt-Brace® from
his study of the benefits and viability of a neck protection system for
helmet clad sport and recreational users. Mr. Olsson is our General
Manager and Head of International Distribution and has served as a
Sales and Product Manager for various companies in the power sports
industry for the past 16 years. Mr. Repsher is our US National Sales
Manager, who is an award-winning sales executive with over fifteen years
experience in the marketing and sales of sports orientated companies in
North America. |
- 25 -
|
|
Outsourced Manufacturing. We outsource our
manufacturing to third-party manufacturers in order to produce large
volumes of our products. The manufacturing process remains subject to our
strict quality control guidelines safeguarded by our employees and the
third party inspectors who we hire as consultants to ensure that these
guidelines are being implemented at the production point. While such
manufacturing arrangements pose a risk to our ability to safeguard our
property technologies and may lead to increased costs, as discussed under
the Risk Factors heading in this report, we expect that the increase in
expected sales volumes will contribute to a lower production cost per unit
and that this will translate to better margins for our distributors and
retailers. |
|
|
|
|
|
Research, Development, Certification and Marketing
Capabilities. We have in-house know how in the areas of product
development, testing and accreditation, particularly in the field of
personal protective equipment. With the experience and capabilities
developed and established in taking our product to market, we believe that
we are well positioned to develop, manufacture and market additional
products. With our medical and mechanical expertise, demonstrated research
and development capabilities, established outsource manufacturing
capacity, established brand and our dedicated, loyal and enthusiastic
distribution network, we believe that we have the components necessary to
bring new successful products to market. |
|
|
|
|
|
Industry Accreditation, Testing Standards and
Regulations. We are pursuing accreditation and endorsements of our
products from global motor sports governing bodies and industry
organizations. We have obtained homologations of our products from various
global racing authorities where objective standards have been set and we
are in discussions with governing racing bodies, such as the FIM, FIA,
CIK, and NASCAR, to have the Leatt-Brace® accredited. SFI testing is
compulsory for neck protection used in automotive racing in the U. S.,
therefore any of our competitors will also have to pass the certification
testing. Should industry accreditation become compulsory, we would be
ahead of our competitors in the market place. |
|
|
|
|
|
Brand Recognition. A RacerX survey discussed
elsewhere herein shows that Leatt had an approximately 58.9% market share
for neck braces. We believe that public recognition of the Leatt® brand
drives the sales of our products, regardless of the action of competitors
and competitive products. We expect that the reputation of our brand in
the market place, particularly our product testing and applicable CE
certification, will continue to ensure market acceptance and facilitate
market penetration of our new products. In order to bolster and grow the
Leatt® brand, stringent quality control and assurance are our highest
priority and our ongoing marketing, advertising and public relations
efforts continue to stress the quality, safety and innovation of our
products. |
Our Intellectual Property
We believe that the continued success of our business is
dependent on our intellectual property portfolio consisting of globally
registered trademarks, design patents and utility patents related to the
Leatt-Brace®. Most of these initial intellectual property rights are held by
Xceed Holdings, a corporation controlled by our Chairman, Dr. Christopher Leatt
and the rest of these rights are held by the Company and Three Eleven
Distribution, our South African subsidiary. We license most of our intellectual
property from Xceed Holdings, pursuant to a patent and royalty license
agreement, or Licensing Agreement, dated March 1, 2006, between the Company and
Xceed Holdings. Under the terms of the Licensing Agreement, we are obligated to
pay Xceed Holdings 4% of all our revenues from the Leatt-Brace®. In addition,
pursuant to a separate license agreement between us and Mr. De Villiers, we are
obligated to pay a royalty fee of 1% of all our billed and received sales
revenue, in quarterly installments, based on sales of the previous quarter, to a
trust that is beneficially owned and controlled by Mr. De Villiers. We also rely
on nondisclosure agreements and other methods to protect our intellectual
property rights. However, the steps we have taken may be inadequate to prevent
the misappropriation of our technology.
The following table lists the patents and designs licensed from
Xceed Holdings:
Country |
Application
No |
Patent No |
Filing Date |
Invention
Title |
Status |
Renewal
Date |
South Africa |
2006/05044 |
2006/05044 |
6/20/2006 |
Neck Brace |
Granted |
11/26/2016 |
Brazil |
PI0416971-9 |
|
5/26/2006 |
Neck Brace |
Pending |
11/26/2016 |
Canada |
2,547,855 |
2,547,855 |
5/26/2006 |
Neck Brace |
Granted |
11/26/2016 |
China |
20048003507 2.4 |
|
5/26/2006 |
Neck Brace |
Granted |
11/26/2016 |
Indonesia |
W002006014 67 |
IDP0030269 |
6/19/2006 |
Neck Brace |
Granted |
2/28/2017 |
Israel |
175931 |
175931 |
6/19/2006 |
Neck Brace |
Granted |
11/26/2018 |
Japan |
2006541524 |
4553903 |
5/26/2006 |
Neck Brace |
Granted |
7/22/2016 |
South Korea |
10-2006- 7012173 |
10-0904041 |
6/19/2006 |
Neck Brace |
Granted |
6/19/2016 |
Morocco |
PV29105 |
28229 |
6/15/2006 |
Neck Brace |
Granted |
11/26/2016 |
Mexico |
JL/a/2006/000 026 |
301465 |
5/26/2006 |
Neck Brace |
Granted |
11/26/2016 |
Malaysia |
PI 20062407 |
MY-145683-A |
5/25/2006 |
Neck Brace |
Granted |
3/15/2016 |
Singapore |
200808773-6 |
148205 |
5/26/2006 |
Neck Brace |
Granted |
11/26/2016 |
USA |
11/440,576 |
7,993,293 |
5/25/2006 |
Neck Brace |
Granted |
2/9/2019 |
USA (Broad) |
11/690,412 |
8,002,723 |
3/23/2007 |
Neck Brace |
Granted |
2/23/2019 |
USA (Continuation) |
13/206,312 |
8,562,551 |
8/9/2011 |
Neck Brace |
Granted |
4/22/2017 |
Eurasia |
200601049 |
10815 |
6/26/2006 |
Neck Brace |
Granted |
11/26/2016 |
- 26 -
Australia |
2004293118 |
2004293118 |
6/23/2003 |
Neck Brace |
Granted |
11/26/2016 |
India |
2315/CHENP/ 2006 |
|
6/26/2006 |
Neck Brace |
Granted |
11/26/2016 |
Norway |
20062971 |
327461 |
6/26/2006 |
Neck Brace |
Granted |
11/30/2016 |
New Zealand |
548068 |
548068 |
6/22/2006 |
Neck Brace |
Granted |
11/26/2016 |
Vietnam |
1-2006-01015 |
|
6/26/2006 |
Neck Brace |
Granted |
2/9/2016 |
Germany |
04816084.0 |
6020040259 75,6 |
6/22/2006 |
Neck Brace |
Granted |
11/30/2016 |
France |
04816084.0 |
1696842 |
6/22/2006 |
Neck Brace |
Granted |
11/26/2016 |
UK |
04816084.0 |
1696842 |
6/22/2006 |
Neck Brace |
Granted |
11/30/2016 |
Switzerland |
04816084.0 |
1696842 |
6/22/2006 |
Neck Brace |
Granted |
11/30/2016 |
Spain |
04816084.0 |
2342402 |
6/22/2006 |
Neck Brace |
Granted |
11/26/2016 |
Italy |
04816084.0 |
1696842 |
6/22/2006 |
Neck Brace |
Granted |
11/30/2016 |
Netherlands |
04816084.0 |
1696842 |
6/22/2006 |
Neck Brace |
Granted |
11/30/2016 |
Taiwan |
97109256 |
I 359009 |
3/17/2008 |
SSS Brace |
Granted |
2/28/2016 |
Brazil |
PI07180047 |
|
4/27/2009 |
SSS Brace |
Pending |
10/26/2016 |
China |
2007 80047024.0 |
ZL200780047024 .0 |
6/19/2009 |
SSS Brace |
Granted |
10/26/2016 |
Japan |
2009-534037 |
|
4/27/2009 |
SSS Brace |
Granted |
03/13/2017 |
USA |
12/447,452 |
8,484,768 |
4/27/2009 |
SSS Brace |
Granted |
1/16/2017 |
New Zealand |
577131 |
577131 |
5/21/2009 |
SSS Brace (clip) |
Granted |
10/26/2016 |
New Zealand |
592116 |
592116 |
5/21/2009 |
SSS Brace (tether) |
Granted |
10/26/2016 |
USA |
12/812,596 |
8,439,042 |
7/12/2010 |
MRX Brace |
Granted |
14/11/2016 |
Australia |
2009321240 |
2009321240 |
6/8/2011 |
MRX Brace |
Granted |
11/26/2016 |
China |
20098014755 8.X |
ZL200980147558 .X |
5/26/2011 |
MRX Brace |
Granted |
11/26/2016 |
Austria |
09801554.8 |
EP 2376032 |
5/31/2011 |
MRX Brace |
Granted |
11/30/2016 |
France |
09801554.8 |
EP 2376032 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
Germany |
09801554.8 |
60 2009 029 841.0 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
Italy |
09801554.8 |
EP 2376032 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
Spain |
09801554.8 |
EP 2376032 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
Sweden |
09801554.8 |
EP 2376032 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
Netherlands |
09801554.8 |
EP 2376032 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
UK |
09801554.8 |
EP 2376032 |
11/26/2009 |
MRX Brace |
Granted |
11/30/2016 |
Japan |
2011-537006 |
5643960 |
5/19/2011 |
MRX Brace |
Granted |
11/14/2017 |
Switzerland |
09165346.9 |
2113231 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
Germany |
09165346.9 |
602004035367.1 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
Spain |
09165346.9 |
2377592 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
France |
09165346.9 |
2113231 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
UK |
09165346.9 |
2113231 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
Italy |
09165346.9 |
2113231 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
Netherlands |
09165346.9 |
2113231 |
7/13/2009 |
Neck Brace |
Granted |
11/30/2016 |
USA |
29/224,261 |
D552,742 |
2/28/2005 |
Moto-R Brace |
Registered |
|
USA |
29/225,477 |
D542,919 |
3/17/2005 |
Moto-GPX Brace |
Registered |
|
Europe |
000 312 061- 0001 |
000 312 061-0001 |
3/17/2005 |
Moto-GPX Brace |
Registered |
3/17/2020 |
New Zealand |
405978 |
405978 |
3/16/2005 |
Moto-GPX Brace |
Registered |
|
South Africa |
F2006/01661 |
F2006/0166 1 |
10/26/2006 |
SSS Brace |
Registered |
|
USA |
29/279,249 |
D631,167 |
4/24/2007 |
SSS Brace |
Registered |
|
Europe |
000 711 130- 0001 |
000 711 130- 0001 |
4/20/2007 |
SSS Brace |
Registered |
4/20/2017 |
USA |
29/284,258 |
D592,310 |
9/4/2007 |
Moto-GPX Brace 2006 |
Registered |
|
Europe |
000 785 373- 0001 |
000 785 373- 0001 |
9/6/2007 |
Moto-GPX Brace 2006 |
Registered |
9/30/2017 |
USA |
29/325,870 |
D633,623 |
10/7/2008 |
Damper Brace |
Registered |
|
- 27 -
The following table lists our own patents and designs:
Country |
Application No |
Patent No |
Filing date |
Invention Title |
Status |
Renewal Date |
Held by Leatt Corporation |
South Africa |
2013/01921 |
2013/01921 |
10/1/2010 |
Chest Protector |
Granted |
10/01/2016 |
South Africa |
2015/00206 |
|
01/13/2015 |
Shoulder Brace |
Accepted |
|
USA |
14/894,237 |
|
11/25/2015 |
Knee Brace |
Pending |
|
Europe |
14737320.3 |
|
12/3/2015 |
Knee Brace |
Pending |
5/26/2016 |
Canada |
2,823,461 |
|
3/22/2013 |
Golf Club |
Pending |
9/22/2016 |
Japan |
2013-529753 |
|
3/22/2013 |
Golf Club |
Pending |
|
China |
201180055504.8 |
|
5/17/2013 |
Golf Club |
Granted |
9/22/2016 |
UK |
2498155 |
|
4/22/2013 |
Golf Club |
Pending |
9/30/2016 |
South Korea |
10-2013-7010255 |
|
4/22/2013 |
Golf Club |
Pending |
|
Australia |
2011306375 |
|
4/18/2013 |
Golf Club |
Pending |
9/22/2016 |
PCT |
PCT/IB2015/050954 |
|
2/09/2015 |
MX DH Helmet |
Pending |
|
PCT |
PCT/IB2015/053735 |
|
5/21/2015 |
Turbine Helmet |
Pending |
|
UK |
1522642.6 |
|
12/22/2015 |
Boot |
Pending |
|
UK |
1522062.7 |
|
12/15/2015 |
Helmet |
Pending |
|
UK |
1603129.6 |
|
02/23/2016 |
Neck Brace |
Pending |
|
UK |
GB 1421423.3 |
|
12/02/2014 |
Mini Turbine Helmet |
Pending |
|
USA |
29/381,768 |
D649,649 |
12/22/2010 |
STX Brace |
Registered |
|
Europe |
001 251 508- 0001 |
001 251 508- |
12/23/2010 |
STX Brace |
Registered |
12/23/2020 |
Australia |
15733/2010 |
334789 |
12/23/2010 |
STX Brace |
Registered |
12/23/2016 |
Japan |
2010-031383 |
1422456 |
12/28/2010 |
STX Brace |
Registered |
8/4/2016 |
USA |
29/297,349 |
D609,815 |
11/08/2007 |
Leatt Sock Kit |
Registered |
|
USA |
29/510,597 |
|
12/02/2014 |
Visor Screw |
Pending |
|
USA |
29,509,338 |
|
11/17/2014 |
Hydration System |
Pending |
|
Europe |
2588 970 |
|
12/2/2014 |
Visor Screw & Hydration System |
Pending |
2/12/2019 |
Held by Three Eleven Distribution (Pty)
Ltd. |
India |
1863/KOLNP/ 2008 |
|
5/8/2008 |
Helmet |
Pending |
|
Germany |
06809017.4 |
60 2006 010 418.9-08 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
France |
06809017.4 |
1933656 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
UK |
06809017.4 |
1933656 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
Italy |
67618/BE/201 0 |
1933656 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
Netherlands |
06809017.4 |
1933656 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
Austria |
06809017.4 |
AT-E 0447866 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
Spain |
06809017.4 |
1933656 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
Sweden |
06809017.4 |
1933656 |
3/31/2008 |
Helmet |
Granted |
10/13/2016 |
____________________
* The Patent Cooperation Treaty, or
PCT, is an international agreement for filing patent applications having effect
in up to 117 countries. Under the PCT, an inventor can file a single
international patent application in one language with one patent office in order
to simultaneously seek protection for an invention in up to 117 countries
throughout the world.
- 28 -
Patents applicable to specific products extend for varying
periods according to the date of patent application filing or patent grant and
the legal term of patents in the various countries where patent protection is
obtained. The actual protection afforded by a patent, which can vary from
country to country, depends upon the type of patent, the scope of its coverage
and the availability of legal remedies in the country. Issued patents or patents
based on pending patent applications or any future patent applications may not
exclude competitors or may not provide a competitive advantage to us. In
addition, patents issued or licensed to us may not be held valid if subsequently
challenged and others may claim rights in or ownership of such patents. In
addition, the validity and breadth of claims in protective gear technology
patents involve complex legal and factual questions and, therefore, the extent
of their enforceability and protection is highly uncertain.
The following table lists our licensed and/or registered and
pending trademarks:
Country |
Trademark |
TM Class |
Application No |
Registration No |
Filing Date |
Renewal Date |
Status
|
China |
Leatt-Brace |
10 |
6287826 |
6287826 |
21/09/2007 |
20/02/2020 |
Registered |
China |
Leatt |
10 |
6287824 |
6287824 |
21/09/2007 |
20/02/2020 |
Registered |
China |
The Helmet for your Neck Device |
10 |
6287823 |
6287823 |
21/09/2007 |
20/02/2020 |
Registered |
CTM |
Leatt-Brace |
9 |
6313993 |
6313993 |
19/09/2007 |
19/09/2017 |
Registered |
CTM |
The Helmet for your neck |
9 |
6314009 |
6314009 |
19/09/2007 |
19/09/2017 |
Registered |
CTM |
Leatt |
9 |
6314017 |
6314017 |
19/09/2007 |
19/09/2017 |
Registered |
CTM |
Device (The Helmet for your neck) |
9 |
6314132 |
6314132 |
19/09/2007 |
19/09/2017 |
Registered |
USA |
ALPT |
9 |
77/742,823 |
3,926,378 |
22/05/2009 |
01/03/2021 |
Registered |
USA |
Alternative Load Path Technology |
9 |
77/742,826 |
3868833 |
22/05/2009 |
26/10/2020 |
Registered |
CTM |
Alternative Load Path Technology |
9 |
8358046 |
8358046 |
11/06/2009 |
11/06/2019 |
Registered |
CTM |
Alternative Load Path |
9 |
8358061 |
8358061 |
11/06/2009 |
11/06/2019 |
Registered |
CTM |
ALPT |
9 |
8358079 |
8358079 |
11/06/2009 |
11/06/2019 |
Registered |
USA |
Leatt Device |
9 |
77/765,739 |
3,861,760 |
23/06/2009 |
12/10/2020 |
Registered |
CTM |
Leatt Device |
9 |
8444168 |
|
23/07/2009 |
23/07/2019 |
Registered |
Australia |
Leatt |
9,10, 28 |
1372902 |
1372902 |
16/07/2010 |
16/07/2020 |
Registered |
Japan |
Leatt |
9, 10, 28 |
2010-056635 |
5432253 |
16/07/2010 |
12/08/2021 |
Registered |
Japan |
Leatt |
25 |
2010-74427 |
5403909 |
22/09/2010 |
01/04/2021 |
Registered |
CTM |
Leatt |
25 |
9395997 |
9395997 |
23/09/2010 |
23/09/2020 |
Registered |
Brazil |
Leatt Brace |
10 |
829468323 |
829468323 |
03/11/2010 |
03/11/2020 |
Registered |
- 29 -
Brazil |
Leatt Brace (Special Script) |
9 |
829994920 |
829994920 |
24/11/2008 |
08/02/2021 |
Registered |
Brazil |
Leatt Brace (Special Script) |
25 |
829994939 |
829994939 |
24/11/2008 |
08/02/2021 |
Registered |
Brazil |
Leatt (Special Script) |
9 |
830409432 |
830.409.432 |
05/11/2009 |
09/10/2022 |
Registered |
Brazil |
Leatt and Device |
9 |
830409440 |
830.409.440 |
05/11/2009 |
09/10/2022 |
Registered |
Brazil |
Leatt (Special Script) |
10 |
902094165 |
902.094.165 |
05/11/2009 |
09/10/2022 |
Registered |
Brazil |
Leatt and Device |
10 |
902094149 |
|
05/11/2009 |
|
Published |
Brazil |
Leatt (Special Script) |
25 |
902094238 |
902.094.238 |
05/11/2009 |
09/10/2022 |
Registered |
Brazil |
Leatt and Device |
25 |
902094190 |
902.094.190 |
05/11/2009 |
09/10/2022 |
Registered |
Canada |
LEATT |
25 |
1535498 |
841,643 |
13/07/2011 |
29/01/2028 |
Registered |
USA |
BraceOn |
9 |
85/429,145 |
4,276,706 |
22/09/2011 |
15/01/2023 |
Registered |
Australia |
BraceOn |
28 |
1450772 |
1450772 |
23/09/2011 |
23/09/2021 |
Registered |
CTM |
BraceOn |
9, 28 |
10288405 |
10288405 |
23/09/2011 |
23/09/2021 |
Registered |
NZ |
Leatt |
9 |
829603 |
829603 |
30/08/2010 |
30/08/2020 |
Registered |
NZ |
Leatt |
25 |
831034 |
831034 |
27/09/2010 |
27/09/2020 |
Registered |
NZ |
Leatt |
28 |
831035 |
831035 |
27/09/2010 |
27/09/2020 |
Registered |
NZ |
Leatt |
10 |
831036 |
831036 |
27/09/2010 |
27/09/2020 |
Registered |
Brazil |
Device |
10 |
902.094.084 |
902.094.084 |
05/11/2009 |
09/10/2022 |
Registered |
Brazil |
Device |
25 |
902.094.157 |
902.094.157 |
05/11/2009 |
09/10/2022 |
Registered |
Brazil |
Device |
9 |
830.409.416 |
830.409.416 |
05/11/2009 |
09/10/2022 |
Registered |
CTM |
Device |
9, 25, 28 |
13289822 |
13289822 |
23/09/2014 |
23/09/2024 |
Registered |
USA |
THREE L DEVICE |
9, 25, 28 |
86445638 |
|
5/11/2014 |
|
Pending |
USA |
LEATT |
9, 25, 28 |
86551815 |
|
3/3/2015 |
|
Pending |
USA |
Leatt |
25 |
85135308 |
4,202,879 |
22/09/2010 |
4/09/2021 |
Registered |
SA |
DEVICE (NEW LOGO) |
9 |
2009/11856 |
2009/11856 |
26/06/2009 |
26/06/2019 |
Registered |
SA |
DEVICE (NEW LOGO) |
10 |
2009/11857 |
2009/11857 |
26/06/2009 |
26/06/2019 |
Registered |
SA |
DEVICE (NEW LOGO) |
28 |
2009/11858 |
2009/11858 |
26/06/2009 |
26/06/2019 |
Registered |
SA |
Leatt-Brace (Special Script) |
10 |
2004/08584 |
2004/08584 |
28/05/2004 |
28/05/2014 |
Registered |
SA |
Leatt |
10 |
2006/22761 |
2006/22761 |
26/09/2006 |
26/09/2016 |
Registered |
SA |
The Helmet for your Neck |
10 |
2006/22760 |
2006/22760 |
26/09/2006 |
26/09/2016 |
Registered |
SA |
Helmet for your Neck Device |
10 |
2007/15892 |
2007/15892 |
19/07/2007 |
19/07/2017 |
Registered |
SA |
Helmet for your Neck Device |
28 |
2007/15893 |
2007/15893 |
19/07/2007 |
19/07/2017 |
Registered |
SA |
Adventure Leatt and Device |
9 |
2008/15403 |
2008/15403 |
04/07/2008 |
04/07/2018 |
Registered |
SA |
Adventure Leatt and Device |
10 |
2008/15404 |
2008/15404 |
04/07/2008 |
04/07/2018 |
Registered |
SA |
Adventure Leatt and Device |
28 |
2008/15405 |
2008/15405 |
04/07/2008 |
04/07/2018 |
Registered |
SA |
Adventure Brace |
9 |
2008/28131 |
2008/28131 |
01/12/2008 |
01/12/2018 |
Registered |
SA |
Adventure Brace |
10 |
2008/28132 |
2008/28132 |
01/12/2008 |
01/12/2018 |
Registered |
SA |
Adventure Brace |
28 |
2008/28133 |
2008/28133 |
01/12/2008 |
01/12/2018 |
Registered |
USA |
Leatt-Brace |
9 |
77227507 |
3483439 |
11/07/2007 |
12/08/2018 |
Registered |
USA |
The Helmet For Your Neck Device |
9 |
77236512 |
3483523 |
23/07/2007 |
12/08/2018 |
Registered |
USA |
The Helmet For Your Neck |
9 |
77264171 |
3483644 |
24/08/2007 |
12/08/2018 |
Registered |
- 30 -
USA |
LEATT |
9 |
77264178 |
3483646 |
24/08/2007 |
12/08/2018 |
Registered |
CTM |
Adventure Brace |
9, 10, 28 |
8224479 |
8224479 |
26/03/2009 |
26/03/2019 |
Registered |
China |
Leatt-Brace |
9 |
7668832 |
7668832 |
09/03/2009 |
06/03/2021 |
Registered |
China |
LEATT |
9 |
7668830 |
7668830 |
03/09/2009 |
06/03/2021 |
Registered |
China |
The Helmet For Your Neck Device |
9 |
7668857 |
7668857 |
03/09/2009 |
06/03/2021 |
Registered |
China |
Leatt |
25 |
8706821 |
870682 |
28/09/2010 |
28/09/2021 |
Registered |
___________________
* A Community Trade Mark or CTM, is any
trademark which is pending registration or has been registered in the European
Union as a whole (rather than on a national level within the EU). The CTM system
creates a unified trademark registration system in Europe, whereby one
registration provides protection by being enforceable in all member states of
the EU.
____________________
From time to time, we have had to enforce our intellectual
property rights through litigation and we may be required to do so in the
future. Reverse engineering, unauthorized copying or other misappropriation of
our technologies could enable third parties to benefit from our technologies
without paying us. We cannot assure you that our competitors have not developed
or will not develop similar products, will not duplicate our products, or will
not design around any patents issued to or licensed by us. We believe that a
loss of these rights would harm or cause a material disruption to our
business and, our corporate strategy is to aggressively take legal action
against any violators of our intellectual property rights, regardless of where
they may be.
- 31 -
Our Employees
As of December 31, 2015, we employed 39 full-time employees, 7
independent contractors and
no part-time employees. The following table sets forth the number of our
full-time employees by function as of December 31, 2015.
Employee Function |
Number |
Executive |
2 |
Internet Technology |
2 |
Product |
4 |
Marketing |
5 |
Finance |
4 |
Operations and Distributions/Logistics |
5 |
Research and Development / Leatt Lab |
4 |
Legal and Compliance |
2 |
Sales/Customer Services |
9 |
Support Staff (Receptionist/Cleaners/Driver) |
2 |
Independent Contractors |
7 |
Total |
46 |
We are required to pay UIF, or unemployment insurance, for each
of our South African employees. We are also required to withhold income taxes
for our South African and U.S. based employees. We generally provide health care
benefits and other standard benefits to our employees. We do not have any
pension or retirement plans for any of our employees.
We believe that we maintain a satisfactory working relationship
with our employees and we have not experienced any significant labor disputes or
any difficulty in recruiting staff for our operations.
Regulations
The 2012 JOBS Act
We qualify as an emerging growth company, as defined in Title
I of the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). An
emerging growth company is defined as an issuer, including a foreign private
issuer, with less than $1 billion of total annual gross revenues during the most
recently completed fiscal year. The SEC has interpreted total annual gross
revenues to mean total revenues as presented on the income statement
presentation under U.S. GAAP, which for the Company was $18.6 million for the
fiscal year ended December 31, 2015. We will retain our status as an emerging
growth company until the earlier of: (1) the fifth anniversary of the date we
first sell securities pursuant to an IPO registration statement; (2) the last
day of the fiscal year in which we first exceed $1 billion in annual gross
revenues; (3) the time we become a large accelerated filer (an SEC registered
company with a public float of at least $700 million); or (4) the date on which
we have issued, within the previous three years, $1 billion of nonconvertible
debt, whether issued in a registered or unregistered offering and whether or not
it is still outstanding at the determination date.
The JOBS Act provides scaled disclosure provisions for us,
including, among other things: (a) permitting us to include only two years of
audited financial statements in a registration statement filed under the
Securities Act of 1933 for an IPO of common equity securities; (b) allowing us
to comply with the smaller reporting company version of Item 402 of Regulation
S-K (Executive Compensation); and (c) removing the requirement that our
independent registered public accounting firm attest to the effectiveness of our
internal control over financial reporting in accordance with Section 404(b) of
the Sarbanes-Oxley Act of 2002. The JOBS Act also exempts us from the following
additional compensation-related disclosure provisions that were imposed on U.S.
public companies pursuant to the Dodd-Frank Act: the advisory say-on-pay vote
on executive compensation required under Section 14A(a) of the Exchange Act; the
Section 14A(b) requirements relating to shareholder advisory votes on golden
parachute compensation; the Section 14(i) requirements for disclosure relating
to the relationship between executive compensation and financial performance of
the issuer; and the requirement of Dodd-Frank Act Section 953(b)(1), which
will require disclosure as to the relationship between CEO and median employee
pay.
- 32 -
Under Section 102(b)(1) of the JOBS Act, "emerging growth
companies" can also delay adopting new or revised accounting standards until
such time as those standards apply to private companies. However, we have
irrevocably elected not to avail ourselves of this extended transition period
for compliance with new or revised accounting standards and, therefore, we will
be subject to the same new or revised accounting standards as other public
companies that are not "emerging growth companies.
European Union Directives
All our products are compliant with applicable European Union
directives, or CE certified, where appropriate. All Leatt Personal Protective
Equipment (PPE) products are CE Certified showing compliance with European
Economic Community (EEC) directive 89/686/EEC that imposes mandatory
accreditation of all Personal Protective Equipment products offered for sale in
the EEC. This includes the Companys Leatt-Brace® and body protection products.
This means that as a minimum these products must comply with:
the basic Health and Safety requirements of the directive; certain chemical
innocuousness tests prescribed in EN 340:2003 - Protective clothing General
Requirements; and the requirements relating to usage, care,
cleaning, sizing and other information to be supplied with the product.
Accordingly, all Leatt-Braces®, chest protectors and body protection products
are CE certified. Only our peripheral products such as jackets, clothing, and
caps are not covered.
In addition to the minimum requirements the Company complies
with the European Standards, or EN (European Norm), specific to certain
categories of PPE. An EN is a standard that has been adopted by one of the three
recognized European Standardization Organizations (ESOs): CEN, CENELEC or ETSI.
It is produced by all interested parties (including manufacturers, users,
consumers and regulators of a particular material, product, process or service)
through a transparent, open and consensus based process. In the Companys case
these are the applicable EN standards: EN 14021 Stone Shields; EN 1621-1 Limb
Protectors; EN 1621-2 Back Protectors; and CE EN1621-3 level 2 impact front
Chest Protectors. These standards are more performance related and, among other
things, measure the performance of PPE at various intensity levels and under
different environmental conditions. They also prescribe product labeling, tests
for user comfort and ease of use. Also, where no specific standards exist such
as with the brace, the Notifying Body (responsible for CE evaluation and
certification).
FDA and MHRA Registration
In the 2015 first quarter our Knee Brace was accepted for
registration by both the FDA and the MHRA, and our Shoulder Brace was accepted
by the FDA, as Class 1 Medical Devices. FDA and MHRA registration will allow us
take these products directly to market as medical devices for patients (not just
athletes) recuperating from injuries, surgery, muscle tears or strains,
dislocations, breaks or fractures. The Companys FDA registration included the
contract manufacturer of the braces, a Good Manufacturing Practices (GMP)
vendor. For the initial registration period, which expires in December 31, 2015,
we will be required to maintain logs of complaints or problems, and to provide
appropriate labeling for medical uses. We have renewed our registration until
December 31, 2016. The MHRA registration of the knee brace is open-ended,
subject to the Companys continued monitoring of product performance in the
market place and delivery of prompt responses to the MHRA as necessary.
Other Accreditation
We have also obtained certification for certain of our
products, such as the MRX head and neck restraint system, by the SFI Foundation
(USA), or the SFI. To attain SFI certification, a safety device must, every five
years, pass a series of impact sled tests with an instrumented crash test dummy
at a SFI accredited test lab, as well as flammability tests on various parts of
the safety device. These tests are done according to the SFI38.1 specification
that can be found at http://www.sfifoundation.com. SFI 38.1 accreditation is
mandatory for any safety device that is used by participants in SFI sanctioned
events worldwide. We also voluntarily submitted our Moto GPX neck brace to be
tested by the in-house engineers of BMW Motorrad (Germany) and to be reviewed by
KTM (Austria). We believe that such testing, while not mandatory, provides
validation for our products performance.
We are also in discussions with governing and racing bodies,
such as the FIA, the FIM and NASCAR, to have the Leatt-Brace® accredited by
these bodies. To acquire NASCAR accreditation, the safety device must obtain SFI
38.1 accreditation, discussed above, and be recertified every 5 years. In
addition, the safety device must undergo review and a series of NASCAR specific
tests by NASCARs technical panel to ensure that it meets all the NASCAR safety
requirements. NASCAR accreditation is mandatory for any safety device that is
used by participants in NASCAR events. To acquire FIA accreditation, the safety
device must obtain SFI 38.1 accreditation, discussed above, and be recertified
every 5 years. In addition, the device must undergo review by a FIA technical
panel, which assesses the device in accordance with FIA standards for frontal
head restraint (FHR) systems and conduct more product specific testing if necessary. To achieve FIA standards, the
device must pass certain FIA stress tests for the FHR, the tethers and end
fittings, and the attachments included on the protective helmet. FIA
accreditation is mandatory for any safety device that is used by participants in
FIA sanctioned events worldwide. While there is currently no official
accreditation for FIM sanctioned events, we have submitted test documents for
FIM review. We cannot guarantee that we will secure any of these
accreditations.
- 33 -
ITEM 1A. RISK FACTORS
An investment in our common stock involves a high degree of
risk. You should carefully consider the risks described below, together with all
of the other information included in this report, before making an investment
decision. If any of the following risks actually occurs, our business, financial
condition or results of operations could suffer. In that case, the trading price
of our common stock could decline, and you may lose all or part of your
investment. You should read the section entitled Special Note Regarding
Forward-Looking Statements above for a discussion of what types of statements
are forward-looking statements, as well as the significance of such statements
in the context of this report.
RISKS RELATED TO OUR BUSINESS
The ongoing global economic turmoil could negatively
affect our business, results of operations, and financial condition.
The ongoing turmoil in the global economy, especially in the
U.S., South America and Europe, may have an impact on our business and our
financial condition, and we may face challenges if economic conditions do not
improve. These economic conditions impact levels of consumer spending, which
have deteriorated and may remain depressed for the foreseeable future. If demand
for our products fluctuates as a result of these economic conditions or
otherwise, our revenue and gross margin could be harmed.
In order to grow at the pace expected by management, we
may require additional capital to support our long-term growth strategies. If we
are unable to obtain additional capital in future years, we may be unable to
proceed with our plans and we may be forced to curtail our
operations.
We currently meet our working capital requirements with cash
flow provided by our operating activities and we expect to continue doing so for
the foreseeable future. However, in the future we may require additional working
capital to support our long-term growth strategies, including identifying
suitable targets for horizontal or vertical mergers or acquisitions so as to
enhance the overall productivity and benefit from economies of scale. If the
uncertainty arising out of domestic and global economic conditions and the
ongoing tightening of domestic credit markets persist, we may not be able to
generate adequate cash flows or obtain adequate levels of additional financing,
whether through equity financing, debt financing or other sources. Even if we
are able to get additional financing, it might not be on terms that are
favorable to the Company. Furthermore, additional financings could result in
significant dilution to our earnings per share or the issuance of securities
with rights superior to our current outstanding securities, including
registration rights. If we are unable to raise additional financing, we may be
unable to implement our long-term growth strategies, develop or enhance our
products and services, take advantage of future opportunities or respond to
competitive pressures on a timely basis, if at all. In addition, a lack of
additional financing could force us to substantially curtail operations.
A substantial amount of our sales revenue is derived from
sales to a limited number of customers, and our business will suffer if sales to
these customers decline.
We have derived a significant portion of our revenue from a
limited number of customers, however none of our customers account for more than
10% of our consolidated revenues. For the year ended December 31, 2014, our U.S.
revenue was concentrated in one customer that accounted for approximately 13%,
of annual U.S. revenue, with our largest customer in the U.S. accounting for
approximately 7 % of our U.S. sales for the year ended December 31, 2015. As of
December 31, 2015 and 2014, $0 or 0% and $738,780, or 17% of our accounts
receivable, was due from this customer.
For the years ended December 31, 2015 and 2014, our
international revenue (not including the U.S.) was earned from two customers
that accounted for approximately 24% and 24% of our annual international revenue
for the respective periods, with our largest international customer accounting
for approximately 17% and 12% of international sales for each of the respective
periods. As of December 31, 2015 and 2014, $344,589 or 11% and $605,077 or 19%
of our accounts receivable, respectively, were due from these international
customers.
We do not have long term contractual arrangements or regular
negotiation with most of these wholesale customers. The loss of one or more of
these customers could damage our business, financial condition and results of
operations.
- 34 -
We engage in international sales, which expose us to
trade restrictions that could harm our business and competitive
position.
For the years ended December 31, 2015 and 2014, annual revenues
from product sales to international customers were $11,642,970 and $11,025,185,
or 63% and 60% of our total revenue, respectively. As a result, we are subject
to risks associated with shipping products across borders, including shipping
delays, customs duties, export quotas and other trade restrictions that could
have a significant impact on our revenue and profitability. While we have not
encountered significant difficulties in connection with the sales of our
products in international markets, if we cannot deliver our products on a
competitive and timely basis, our relationships with international customers
will be damaged and our financial condition could also be harmed. Furthermore,
the future imposition of, or significant increases in, the level of custom
duties, export quotas or other trade restrictions could have an adverse effect
on us. We cannot assure you that the laws of foreign jurisdictions where we sell
and seek to sell our products afford similar or any protection of our
intellectual property rights as may be available under U.S. laws. We are
directly impacted by the political, economic, military and other conditions in
the countries where we sell or seek to sell our products.
Significant fluctuations in fuel prices could have an
adverse impact on our business and operations.
A significant portion of our revenue is derived from
international sales and so significant fluctuations in fuel prices could
adversely affect our business and operations. While fluctuations in fuel prices
could lead to higher commuter costs which may encourage the increased use of
motorcycles and bicycles as alternative modes of transportation and lead to an
increase in the market for our protection products, significant fluctuations in
world fuel prices could significantly increase the price of shipping or
transporting our products which we may not be able to pass on to our customers.
Expansion of our business may put added pressure on our
management, financial resources and operational infrastructure impeding our
ability to meet any increased demand for our products and possibly hurting our
operating results.
Our business plan is to significantly grow our operations to
meet anticipated growth in demand for existing products, and by the introduction
of new product offerings. Our planned growth includes the construction of
several new production lines to be put into operation over the next five years.
Growth in our business may place a significant strain on our personnel,
management, financial systems and other resources. We may be unable to
successfully and rapidly expand sales to potential customers in response to
potentially increasing demand or control costs associated with our growth.
To accommodate any such growth and compete effectively, we may
need to obtain additional funding to improve information systems, procedures and
controls and expand, train, motivate and manage our employees, and such funding
may not be available in sufficient quantities, if at all. If we are not able to
manage these activities and implement these strategies successfully to expand to
meet any increased demand, our operating results could suffer.
We rely on patent and trade secret laws that are complex
and difficult to enforce and we may not be able to prevent others from
unauthorized use of our intellectual property. If we are not able to adequately
secure and protect our patent, trademark and other proprietary rights our
business may be materially affected.
The continued success of our business is dependent on our
intellectual property portfolio consisting of globally registered trademarks,
design patents and utility patents related to the Leatt-Brace®. We also rely on
nondisclosure agreements and other methods to protect our intellectual property
rights. However, the steps we have taken may be inadequate to prevent the
misappropriation of our technology. In addition, the validity and breadth of
claims in protective gear technology patents involve complex legal and factual
questions and, therefore, the extent of their enforceability and protection is
highly uncertain. Issued patents or patents based on pending patent applications
or any future patent applications may not exclude competitors or may not provide
a competitive advantage to us. In addition, patents issued or licensed to us may
not be held valid if subsequently challenged and others may claim rights in or
ownership of such patents. Reverse engineering, unauthorized copying or other
misappropriation of our technologies could enable third parties to benefit from
our technologies without paying us. We cannot assure you that our competitors
have not developed or will not develop similar products, will not duplicate our
products, or will not design around any patents issued to or licensed by us.
We believe that a loss of these rights would harm or cause a
material disruption to our business and, our corporate strategy is to
aggressively take legal action against any violators of our intellectual
property rights, regardless of where they may be.
We depend on key personnel, and turnover of key employees
and senior management could harm our business.
Our future business and results of operations depend in
significant part upon the continued contributions of our key technical and
senior management personnel, including specifically, Dr. Christopher Leatt, our
Chairman and Research and Development Consultant, Sean Macdonald, our Chief
Executive Officer and President, and Erik Olsson, our International General
Manager. They also depend in significant part upon our ability to attract and retain
additional qualified management, technical, marketing and sales and support
personnel for our operations. To address this risk we have taken out key man
insurance on Key Staff members such as Dr. Leatt. However, if we lose a key
employee or if a key employee fails to perform in his or her current position,
or if we are unable to attract and retain skilled employees as needed, our
business could suffer. Significant turnover in our senior management could
significantly deplete our institutional knowledge held by our existing senior
management team. We depend on the skills and abilities of these key employees,
as well as the intellectual property owned by Dr. Leatt, in managing the
development, manufacturing, technical, marketing and sales aspects of our
business, any part of which could be harmed by further turnover.
- 35 -
We face an inherent business risk of exposure to product
liability claims that could have a material adverse effect on our operating
results.
Because of the nature of our products, we face an inherent
business risk of exposure to product liability claims arising from the claimed
failure of our products to prevent the types of personal injury or death against
which they are designed to protect. Plaintiffs may also advance other legal
theories supporting claims that our products or actions resulted in harm to
them. We maintain product liability insurance policies with a self-insured
retention to attempt to manage this risk worldwide. We are currently defending
against 1 such claim which we have a fair expectation will be resolved in our
favor. But although we maintain product liability insurance coverage, there can
be no absolute assurance that our coverage limits will be sufficient to cover
any successful product liability claims made against us now or in the future.
Furthermore, our insurance coverage does not include damages which may be
assessed against us for willful and/or intentional injury, or for exemplary or
punitive damages. Any claim or aggregation of claims substantially in excess of
our insurance coverage, or any substantial claim not covered by insurance, could
have a material adverse effect on our financial condition and results of
operations. These aforementioned claims also have a negative impact on the
renewal our product liability insurance policy and the premiums.
We may not be able to adequately finance the significant
costs associated with the development of new protective equipment products.
The products in the protective equipment market can change
dramatically with new technological advancements. We are currently conducting
research and development on new products, which requires a substantial outlay of
capital. To remain competitive, we must continue to incur significant costs in
product development, equipment, facilities and invest in research and
development of new products. These costs may increase, resulting in greater
fixed costs and operating expenses.
In addition to research and development costs, we could be
required to expend substantial funds for and commit significant resources to the
following:
|
|
additional engineering and other technical
personnel; |
|
|
advanced design, production and test equipment;
|
|
|
manufacturing services that meet changing
customer needs; |
|
|
technological changes in manufacturing
processes; |
|
|
working capital and; |
|
|
manufacturing capacity |
Our future operating results will depend to a significant
extent on our ability to continue to provide new and competitive products that
compare favorably on the basis of cost and performance with the design and
manufacturing capabilities of competitive third-party technologies. We will need
to sufficiently increase our net sales to offset these increased costs, the
failure of which would negatively affect our operating results.
We may be exposed to potential risks relating to our
internal controls over financial reporting and our ability to have those
controls attested to by our independent auditors.
As directed by Section 404 of the Sarbanes-Oxley Act of 2002,
or SOX 404, the SEC adopted rules requiring public companies to include a report
of management on the companys internal controls over financial reporting in
their annual reports, including Form 10-K. Under current law, we became subject
to the requirements of SOX 404 beginning with our annual report for the fiscal
year ended December 31, 2012 and since becoming a U.S. public company, we have
evaluated our internal control systems in order to allow our management to meet
these requirements, including for this annual report for the fiscal year ended
December 31, 2015. We can provide no assurance that we will comply with all of
the requirements imposed thereby in the coming years. In the event that we ever
identify significant deficiencies or material weaknesses in our internal
controls that we cannot remediate in a timely manner, investors and others may
lose confidence in the reliability of our financial statements.
- 36 -
We are an "emerging growth company," and have availed
ourselves of scaled public company reporting requirements and requirements for
stockholder approval and advice applicable to emerging growth companies, which
could make our common stock less attractive to investors.
We are an "emerging growth company," as defined in the
Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For as long as we
remain an emerging growth company, we may take advantage of certain exemptions
from various reporting requirements that are applicable to public companies that
are not emerging growth companies, including not being required to comply with
the independent auditor attestation requirements of Section 404 of the
Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously
approved. We intend to take advantage of these reporting exemptions and
requirements of stockholder advisory votes and approvals until we are no longer
an emerging growth company.
We could be an "emerging growth company" for up to five years
after the first sale of our common equity securities pursuant to an effective
registration statement under the Securities Act, which we expect will be
pursuant to a Registration Statement on Form S-8 or on Form S-1. However, if
certain events occur prior to the end of such five-year period, including if we
become a "large accelerated filer," our annual gross revenues exceed $1 billion
or we issue more than $1 billion of non-convertible debt in any three year
period, we would cease to be an "emerging growth company" prior to the end of
such five year period. We cannot predict if investors will find our common stock
less attractive if we choose to rely on these exemptions. If some investors find
our common stock less attractive as a result of any choice we make to reduce
future disclosure, there may be a less active trading market for our common
stock and our stock price may be more volatile.
RISKS RELATED TO OUR INDUSTRY
We may not be able to maintain or improve our competitive
position because of strong competition in the personal protective equipment
industry, and we expect this competition to continue to intensify.
We face competition from other global manufacturers and
distributors who provide personal protective equipment to users of motorcycles,
ATVs, snowmobiles, motor racing cars and other helmeted sports. Some of our
international competitors are larger than we and possess greater name
recognition, assets, personnel, sales and financial resources. These entities
may be able to respond more quickly to changing market conditions by developing
new products and services that meet customer requirements or are otherwise
superior to our products and services and may be able to more effectively market
their products than we can because they have significantly greater financial,
technical and marketing resources than we do. They may also be able to devote
greater resources than we can to the development, promotion and sale of their
products. Increased competition could require us to reduce our prices, result in
our receiving fewer customer orders, and result in our loss of market share. We
cannot assure you that we will be able to distinguish ourselves in a competitive
market. To the extent that we are unable to successfully compete against
existing and future competitors, our business, operating results and financial
condition would be materially adversely affected.
If we are unable to develop competitive new products our
future results of operations could be adversely affected.
Our future revenue stream depends to a large degree on our
ability to utilize our technology in a way that will allow us to offer new types
of safety products to a broader client base. We will be required to make
investments in research and development in order to continue to develop new
products, enhance our products and achieve market acceptance. We may incur
problems in the future in innovating and introducing new and innovative products
or, if developed, such products may not achieve significant customer acceptance.
If we are unable to successfully define, develop and introduce competitive new
products or improve on existing ones, our future results of operations would be
adversely affected.
The value of our brand and sales of our products could be
diminished if we, the individuals who use our products or the sport and activity
categories in which or products are used, are associated with negative
publicity.
Our success depends on the value of our brand. Our brand could
be adversely affected if our public image or reputation were to be tarnished by
negative publicity. Many athletes and other public individuals use our products
and actions taken by such persons that harm the reputations of activities they
participate in could also harm our brand image and result in a material decrease
in our revenues and net income, which could have a negative effect on our
financial condition and liquidity. In addition, negative publicity resulting
from severe injuries or death occurring in the sports or activities in which our
products are used and negatively impacts the popularity of such sport or
activity, could have a subsequent negative effect on our net sales of products
used in that sport or activity.
We may not be able to receive certain industry
certifications and accreditation for our products.
- 37 -
We have obtained certification and approvals for certain of our
products, including certification of our MRX head and neck restraint system by
the SFI, and approval of our new knee brace as a Class 1 medical device by both
the U.S. FDA and the UKs Medicine and Healthcare Regulatory Products Agency
(MHRA), and approval of our shoulder brace as a Class 1 medical device by the
U.S. FDA. We also voluntarily submitted our Moto GPX neck brace to be tested by
the in-house engineers of BMW Motorrad (Germany) and to be reviewed by KTM
(Austria). We believe that such testing, while not mandatory, will provide
validation for our products performance. There is no guarantee that our
products will receive SFI certification or meet BMW testing standards.
We are also in discussions with governing and racing bodies,
such as the FIA, FIM and NASCAR, to have the Leatt-Brace® accredited by these
bodies. To acquire NASCAR accreditation, the safety device must obtain SFI 38.1
accreditation, discussed above, and be recertified every 5 years. In addition,
the safety device must undergo review and a series of NASCAR specific tests by
NASCARs technical panel to ensure that it meets all the NASCAR safety
requirements. NASCAR accreditation is mandatory for any safety device that is
used by participants in NASCAR events. To acquire FIA accreditation, the safety
device must obtain SFI 38.1 accreditation, discussed above, and be recertified
every 5 years. In addition, the device must undergo review by a FIA technical
panel, which assesses the device in accordance with FIA standards for frontal
head restraint (FHR) systems and conduct more product specific testing if
necessary. To achieve FIA standards, the device must pass certain FIA stress
tests for the FHR, the tethers and end fittings, and the attachments included on
the protective helmet. FIA accreditation is mandatory for any safety device that
is used by participants in FIA sanctioned events worldwide. While there is
currently no official accreditation for FIM sanctioned events, we have submitted
test documents for FIM review. We cannot guarantee that we will secure any of
these accreditations.
RISKS RELATED TO DOING BUSINESS IN NON-US JURISDICTIONS
We face risks associated with doing business in non-US
jurisdictions.
We have affiliates, and our products are manufactured in and
distributed from facilities, located in foreign countries, including countries
in Asia and South Africa. International operations are subject to certain risks
inherent in doing business abroad, including:
|
|
Exposure to political, social and economic
instability; |
|
|
Expropriation and nationalization; |
|
|
Withholding and other taxes on remittances and
other payments by subsidiaries; |
|
|
Difficulties in enforcement of contract and
intellectual property rights; |
|
|
Exposure to foreign current exchange rates,
interests rates and inflation; |
|
|
Investment restrictions or requirements; and
Export and import restrictions. |
We are highly dependent on our foreign affiliates for their
production capabilities and increasing our foreign operations and business
relationships are important elements of our strategy. As a result, our exposure
to the risks described above may be greater in the future. The likelihood of
such occurrences and their potential impact on us varies from country to country
and are unpredictable.
Our operations and assets in China are subject to
significant political and economic uncertainties.
Our products are manufactured and shipped from production
facilities in China. If our manufacturing in China is disrupted, our overall
capacity could be significantly reduced and sales or profitability could be
negatively impacted. Furthermore, changes in PRC laws and regulations, or their
interpretation, or the imposition of confiscatory taxation, restrictions on
currency conversion, imports and sources of supply, devaluations of currency or
the nationalization or other expropriation of private enterprises could have a
material adverse effect on our business, results of operations and financial
condition. Under its current leadership, the Chinese government has been
pursuing economic reform policies that encourage private economic activity and
greater economic decentralization. There is no assurance, however, that the
Chinese government will continue to pursue these policies, or that it will not
significantly alter these policies from time to time without notice.
We may have limited legal recourse under PRC law if
disputes arise under our outsourcing manufacturing arrangements with third
parties.
The Chinese government has enacted some laws and regulations
dealing with matters such as corporate organization and governance, foreign
investment, commerce, taxation and trade. However, their experience in
implementing, interpreting and enforcing these laws and regulations is limited,
and our ability to enforce commercial claims or to resolve commercial disputes
is unpredictable. If our outsourcing manufacturing arrangements are unsuccessful
or other adverse circumstances arise from these arrangements, we face the risk
that our third-party manufacturers may dishonor our purchase orders or unwritten
arrangements. The resolution of these matters may be subject to the exercise of
considerable discretion by agencies of the Chinese government, and forces
unrelated to the legal -merits of a particular matter or dispute may influence their
determination. Any rights we may have to specific performance, or to seek an
injunction under PRC law, in either of these cases, are severely limited, and
without a means of recourse by virtue of the Chinese legal system, we may be
unable to prevent these situations from occurring. The occurrence of any such
events could have a material adverse effect on our business, financial condition
and results of operations.
- 38 -
Our potential inability to adequately protect our
intellectual property during the outsource manufacturing of our products in
China could negatively impact our performance.
Our products are manufactured primarily in China through
third-party outsource manufacturing arrangements. We rely on our third-party
manufacturers to implement customary manufacturer safeguards onsite, such as the
use of confidentiality agreements with employees, to protect our proprietary
information and technologies during the manufacturing process, however, these
safeguards may not effectively prevent unauthorized use of such information and
technical knowhow, or prevent such manufacturers from retaining them. The legal
regime governing intellectual property rights in China is relatively weak and it
is often difficult to create and enforce intellectual property rights or protect
trade secrets there. We face risks that our proprietary information may not be
afforded the same protection in China as it is in countries with well-developed
intellectual property laws, and local laws may not provide an adequate remedy in
the event of unauthorized disclosure of confidential information. Costly and
time-consuming litigation could be necessary to enforce and determine the scope
of our proprietary rights in China, and failure to obtain or maintain trade
secret protection could adversely affect our competitive business position.
We may be exposed to liabilities under the Foreign
Corrupt Practices Act and Chinese anti-corruption laws, and any determination
that we violated these laws could have a material adverse effect on our
business.
We are subject to the Foreign Corrupt Practice Act, or FCPA,
and other laws that prohibit improper payments or offers of payments to foreign
governments and their officials and political parties by U.S. persons and
issuers as defined by the statute, for the purpose of obtaining or retaining
business. We have operations and agreements with third parties worldwide and
such activities create the risk of unauthorized payments or offers of payments
by the employees, consultants, sales agents or distributors of our Company, even
though they may not always be subject to our control. It is our policy to
implement safeguards to discourage these practices by our employees. However,
our existing safeguards and any future improvements may prove to be less than
effective, and the employees, consultants, sales agents or distributors of our
Company may engage in conduct for which we might be held responsible. Violations
of the FCPA or Chinese anti-corruption laws may result in severe criminal or
civil sanctions, and we may be subject to other liabilities, which could
negatively affect our business, operating results and financial condition. In
addition, the U.S. government may seek to hold our Company liable for successor
liability in connection with FCPA violations committed by companies in which we
invest or that we acquire.
Fluctuations in currency exchange rates could negatively
affect our performance.
Unanticipated currency fluctuations in the South African Rand
could lead to lower reported consolidated results of operations due to the
translation of these currencies into U.S. dollars when we consolidate our
financial results. Our research and marketing operations in South Africa utilize
South African labor sources. A decrease in the value of the U.S. dollar in
relation to the South African Rand could increase our cost of doing business in
South Africa.
Furthermore since 63% of our sales is derived outside the U.S.
where the U.S. dollar is not the primary currency, significant fluctuations in
exchange rates such as the strengthening of the dollar versus our customers
local currency can adversely affect our ability to remain competitive in those
areas.
Your ability to bring an action against us, and those of
our officers and directors who are based in South Africa, or to enforce a
judgment against us or recover assets in our possession may be difficult since
any such action or recovery of assets would be an international matter,
involving South African laws and geographic and temporal
disparities.
We conduct substantial operations in South Africa through our
foreign registered branch and a substantial portion of our assets are located
outside of the United States. In addition, all but two of our management
personnel reside in South Africa. As a result, it may be difficult or impossible
for you to bring an action against us or these individuals in the United States
in the event that you believe that your rights have been violated under
applicable law or otherwise. Even if an action of this type is successfully
brought, the laws of the United States and of South Africa may render a judgment
unenforceable.
- 39 -
RISKS RELATING TO OUR COMMON STOCK
There is not now, and there may not ever be, an active
market for our common stock and we cannot assure you that the common stock will
become liquid or that it will be listed on a securities exchange.
There currently is no active market for our common stock. We
plan to list our common stock as soon as practicable. However, we cannot assure
you that we will be able to meet the initial listing standards of any stock
exchange, or that we will be able to maintain any such listing. Until our common
stock is listed on an exchange, we expect that it would be eligible to continue
being quoted in the over-the-counter market maintained by the OTC Markets Group
Inc. In this venue, however, an investor may find it difficult to obtain
accurate quotations as to the market value of the common stock and trading of
our common stock may be extremely sporadic. For example, several days may pass
before any shares may be traded. A more active market for the common stock may
never develop. In addition, if we failed to meet the criteria set forth in SEC
regulations, various requirements would be imposed by law on broker-dealers who
sell our securities to persons other than established customers and accredited
investors. Consequently, such regulations may deter broker-dealers from
recommending or selling the common stock, which may further affect its
liquidity. This would also make it more difficult for us to raise additional
capital.
We are subject to penny stock regulations and
restrictions that may affect our ability to sell our securities on the secondary
market.
The SEC has adopted regulations that generally define penny
stock to be an equity security that has a market price of less than $5.00 per
share, subject to specific exemptions. The market price of our common stock is
less than $5.00 per share and therefore is a penny stock. Brokers or dealers
effecting transactions in penny stock must disclose certain information
concerning the transaction, obtain a written agreement from the purchaser and
determine that the purchaser is reasonably suitable to purchase the securities.
These rules may restrict the ability of brokers or dealers to sell our common
stock and may affect your ability to sell shares.
Our holding company structure may limit the payment of
dividends.
We have no direct business operations, other than our ownership
of our subsidiaries. While we have no immediate intention of paying dividends,
should we decide in the future to do so, as a holding company, our ability to
pay dividends and meet other obligations depends upon the receipt of dividends
or other payments from our operating subsidiaries and other holdings and
investments. In addition, our operating subsidiaries, from time to time, may be
subject to restrictions on their ability to make distributions to us, including
as a result of restrictive covenants in loan agreements, restrictions on the
conversion of local currency into U.S. dollars or other hard currency and other
regulatory restrictions as discussed below. If we determine that we will pay
dividends to the holders of our common stock, we cannot assure that such
dividends will be paid on a timely basis. As a result, you will not receive any
return on your investment prior to selling your shares in our company and, for
the other reasons discussed in this Risk Factors section, you may not receive
any return on your investment even when you sell your shares in our company and
your shares may become worthless. If future dividends are paid in ZAR,
fluctuations in the exchange rate for the conversion of ZAR into U.S. dollars
may reduce the amount received by U.S. stockholders upon conversion of the
dividend payment into U.S. dollars.
The management team collectively has the power to make
all major decisions regarding the company without the need to get consent from
any stockholder or other person. This discretion could lead to decisions that
are not necessarily in the best interests of minority shareholders.
Our management team collectively owns 41.53% of our common
stock (including our preferred stock which converts on a one-for-one basis to
common stock). Management, therefore, has the power to make all major decisions
regarding our affairs, including decisions regarding whether or not to issue
stock and for what consideration, whether or not to sell all or substantially
all of our assets and for what consideration and whether or not to authorize
more stock for issuance or otherwise amend our charter or bylaws. The management
team is in a position to elect all of our directors and to dictate all of our
policies.
ITEM 1B. UNRESOLVED STAFF COMMENTS.
None.
ITEM 2. PROPERTIES.
Our corporate headquarters are located in a 948 square meter
space located at 50 Kiepersol Drive, Atlas Gardens, Contermanskloof Road,
Durbanville, Western Cape, South Africa, 7441. Approximately 25% of the space is
used by our finance, legal and operations teams, 35% is used for warehousing and
South African distribution and the remaining 40% is used by Leatt Lab and our
research and development team. We occupy these premises pursuant to a lease
agreement, dated December 12, 2014, between Leatt SA and AJ Brutus Investments
cc, which expires on December 15, 2016. The lease agreement requires us to pay a
monthly rent of $3,795.
- 40 -
Two Eleven, our California subsidiary, leases a 14,101 square
foot space in Santa Clarita, California, pursuant to a lease agreement between
Two Eleven and Centre Pointe Properties, LLC, dated September 11, 2012, as
amended. Two Eleven uses approximately 9% of the office space for executive
offices and the remaining 91% of the space for warehousing. The lease agreement
required an initial monthly base rent of $4,583 from November 1, 2012 that
increased to $9,166 from May 1, 2013 and subsequently increased to $9,441 from
May 1, 2014 and expired on the April 30, 2015. This lease was renewed on March
16, 2015 and continues through April 30, 2016. The lease agreement calls for a
monthly base rent in the amount of $9 734. The lease was further renewed on
March 1, 2016 to be effective from May 1, 2016 to April 30, 2017, with a base
rent of $10,015 for the extended period.
We believe that all space is in good condition and that the
property is adequately insured by the Company.
ITEM 3. LEGAL PROCEEDINGS.
From time to time, we may become involved in various lawsuits
and legal proceedings in the ordinary course of our business. Other than as set
forth below, we are currently not aware of any legal proceedings the ultimate
outcome of which, in our judgment based on information currently available,
would have a material adverse effect on our business, financial condition or
operating results.
|
|
In September 20, 2012, a lawsuit was filed against the
Company and other Defendants in Clark County District Court of Nevada for
wrongful death of a motorcycle rider for alleged negligence, product
defect, strict product liability, breach of expressed and implied
warranties, survival and punitive damages. The plaintiffs were seeking
special, compensatory, survival and punitive damages, together with
prejudgment interest, costs and disbursement of suit, reasonable
attorneys fees and other relief. This matter has been settled. |
|
|
|
|
|
On December 28, 2012, a lawsuit was filed against the
Company in Los Angeles Superior Court for wrongful death of a motorcycle
rider. The plaintiffs were seeking damages for wrongful death and other
relief. This matter has been settled. |
|
|
|
|
|
In February 2013, a lawsuit was filed against the Company
on behalf of a motorcycle rider in Clark County District Court of Nevada
for alleged product defect, failure to warn and negligence. The plaintiff
was seeking damages, together with interest and costs of bringing the
action. The Court dismissed this case on Summary Judgment. |
|
|
|
|
|
On November 24, 2014, a lawsuit was filed against the
Company and other defendants in the Circuit Court of Eighth Judicial
Circuit in and for Alachua County, Florida for strict liability and
negligence. This matter has been settled. |
|
|
|
|
|
On February 25, 2015, a lawsuit was filed against the
Company on behalf of a motorcycle rider in the Northern District Court of
Indiana, Lafayette Division for strict liability, breach of warranty,
negligence, punitive damages and deceptive and misleading advertising and
marketing. The litigation is at an early stage and the Company is in the
process of investigating the claim. The Company believes that the lawsuit
is without merit and intends to vigorously defend itself.
|
ITEM 4. MINING SAFETY DISCLOSURES.
Not Applicable.
PART II
ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY, RELATED
STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
Our common stock is quoted on the QB tier of the
over-the-counter electronic bulletin board maintained by the OTC Markets Group
Inc. under the symbol LEAT. The CUSIP number for our common stock is 522132 10
9.
The following table sets forth, for the periods indicated, the
high and low closing prices of our common stock as quoted on the OTC. These
prices reflect inter-dealer prices, without retail mark-up, mark-down or
commission, and may not represent actual transactions.
- 41 -
|
|
Closing Prices (1) |
|
|
|
High
|
|
|
Low |
|
Year Ended
December 31, 2016 |
|
|
|
|
|
|
1st Quarter (January 1, 2016 to
March 7, 2016) |
$ |
4.00 |
|
$ |
3.45 |
|
Year ended December 31,
2015 |
|
|
|
|
|
|
1st Quarter |
$ |
3.25 |
|
$ |
1.30 |
|
2nd Quarter |
$ |
3.91 |
|
$ |
2.08 |
|
3rd Quarter |
$ |
5.36 |
|
$ |
2.17 |
|
4th Quarter |
$ |
5.28 |
|
$ |
2.08 |
|
Year Ended December 31, 2014
|
|
|
|
|
|
|
1st Quarter |
$ |
1.55 |
|
$ |
1.18 |
|
2nd Quarter |
$ |
1.02 |
|
$ |
0.70 |
|
3rd Quarter |
$ |
1.65 |
|
$ |
0.75 |
|
4th Quarter |
$ |
1.55 |
|
$ |
1.18 |
|
(1) The above table sets forth the range of high and low
closing prices per share of our common stock as reported by www.quotemedia.com
for the periods indicated.
Holders
As of March 7, 2016, there were approximately 221 stockholders
of record of our common stock. The number of record holders does not include
persons who held our common stock in nominee or street name accounts through
brokers.
Dividend Policy
We have never declared dividends or paid cash dividends. Our
board of directors will make any future decisions regarding dividends. We
currently intend to retain and use future earnings for the development and
expansion of our business and do not anticipate paying cash dividends in the
immediate future.
Our board of directors has complete discretion on whether to
pay dividends, subject to the approval of our shareholders. Even if our board of
directors decides to pay dividends, the form, frequency and amount will depend
upon our future operations and earnings, capital requirements and surplus,
general financial condition, contractual restrictions and other factors that the
board of directors may deem relevant.
Securities Authorized for Issuance under Equity Compensation
Plans
Our officers and directors are eligible for equity awards in
the form of stock options and restricted stock under the Leatt Corporation
Amended and Restated 2011 Equity Incentive Plan (the 2011 Plan), pursuant to
which the Company is authorized to issue and sell up to 920,000 shares of common
stock of the Company, par value $0.001 per share. Equity awards under the 2011
Plan are granted at the discretion of the Board. The size of an award to any
individual, including named executive officers, depends in part on individual
performance, including the components of our key performance appraisal index
described above and any other indicators of the impact that such employees
productivity may have on stockholder value over time. Other factors include
salary level and competitive data. In addition, in determining the awards
granted to each named executive officer, the Board considers the future benefits
potentially available to the named executive officers from existing awards. We
have no program, plan or practice of granting equity awards that coincide with
the release by the Company of material non-public information.
The following table includes the information as of December 31,
2015 for each category of our equity compensation plan:
Plan category |
Number of securities
to be issued upon exercise of outstanding
options, warrants and rights (a) |
Weighted-average
exercise price of outstanding options,
warrants and rights (b) |
Number of securities
remaining available for future issuance under
equity compensation plans (excluding
securities reflected in column (a)) (c)
|
Equity compensation plans approved by
security holders |
290,200 |
$1.00 |
169,800 |
Equity compensation plans not approved by
security holders |
0 |
-- |
0 |
Total |
290,200 |
-- |
169,800
|
- 42 -
Recent Sales of Unregistered Securities
We have not sold any equity securities during 2015 that were
not previously disclosed in a quarterly report on Form 10-Q or a current report
on Form 8-K that was filed during the period.
Purchases of Equity Securities
No repurchases of our common stock were made during the fourth
quarter of 2015.
ITEM 6. SELECTED FINANCIAL DATA.
Not Applicable.
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
The following managements discussion and analysis should be
read in conjunction with our financial statements and the notes thereto and the
other financial information appearing elsewhere in this report. In addition to
historical information, the following discussion contains certain
forward-looking information. See Special Note Regarding Forward Looking
Statements above for certain information concerning those forward looking
statements. Our financial statements are prepared in U.S. dollars and in
accordance with U.S. GAAP.
Overview of our Business
We were incorporated in the State of Nevada on March 11, 2005
under the name Treadzone, Inc. We were a shell company with little or no
operations until March 1, 2006, when we acquired the exclusive global
manufacturing, distribution, sale and use rights to the Leatt-Brace®, pursuant
to a license agreement between the Company and Xceed Holdings, a company owned
and controlled by the Companys Chairman and founder, Dr. Christopher Leatt. On
May 25, 2005, we changed our name to Leatt Corporation in connection with our
anticipated acquisition of the Leatt-Brace® rights. Leatt designs, develops,
markets and distributes personal protective equipment for participants in all
forms of motor sports and leisure activities, including riders of motorcycles,
bicycles, snowmobiles and ATVs, as well as racing car drivers. The Company sells
its products to customers worldwide through a global network of distributors and
retailers. Leatt also acts as the original equipment manufacturer for neck
braces sold by other international brands.
Leatt designs, develops, markets and distributes personal
protective equipment for participants in all forms of motor sports and leisure
activities, including riders of motorcycles, bicycles, snowmobiles and ATVs, as
well as racing car drivers. The Company sells its products to customers
worldwide through a global network of distributors and retailers. Leatt also
acts as the original equipment manufacturer for neck braces sold by other
international brands.
The Companys flagship products are based on the Leatt-Brace®
system, a patented injection molded neck protection system owned by Xceed
Holdings, designed to prevent potentially devastating injuries to the cervical
spine and neck. The Company has the exclusive global manufacturing,
distribution, sale and use rights to the Leatt-Brace®, pursuant to a license
agreement between the Company and Xceed Holdings, a company owned and controlled
by the Companys Chairman and founder, Dr. Christopher Leatt. The Company also
has the right to use apparatus embodying, employing and containing the
Leatt-Brace® technology and has designed, developed, marketed and distributed
other personal protective equipment using this technology, as well as its own
developed technology, including the Companys new body protection products which
it markets under the Leatt Protection Range brand.
The Companys research and development efforts are conducted at
its research facilities, located at its executive headquarters in Cape Town,
South Africa. The Company employs 4 full-time employees who are dedicated
exclusively to research, development, and testing. The Company also utilizes
consultants, academic institutions and engineering companies as independent
contractors or consultants, from time to time, to assist it with its research
and development efforts. Leatt products have been tested and reviewed internally
and by external bodies. All Leatt products are compliant with applicable
European Union directives, or CE certified, where appropriate. Certain products,
such as the MRX Head and Neck Restraint system, have been certified by SFI
Foundation (USA) and the Moto GPX was tested by BMW Motorrad (Germany) and
reviewed by KTM (Austria). The Company is also in discussions with governing and
racing bodies, such as the Fédération Internationale de l'Automobile (FIA), the
Fédération Internationale de Motocyclisme (FIM) and the National Association for Stock Car
Auto Racing (NASCAR), to have the Leatt-Brace® accredited by these bodies.
- 43 -
Our products are manufactured in China under outsource
manufacturing arrangements with third-party manufacturers located there. The
Company utilizes outside consultants and its own employees to ensure the quality
of its products through regular on-site product inspections. Products purchased
through international sales are usually shipped directly from our manufacturers
warehouses or points of dispatch to customers or their import agents.
Leatt earns revenues through the sale of its products through
approximately 60 distributors worldwide, who in turn sell its products to
retailers. Leatt distributors are required to follow certain standard business
terms and guidelines for the sale and distribution of Leatt products. Two Eleven
and Leatt SA directly distribute Leatt products to retailers in the United
States and South Africa, respectively.
Principal Factors Affecting Our Financial Performance
We believe that the following factors will continue to affect
our financial performance:
|
|
Global Economic Fragility The ongoing
turmoil in the global economy, especially in the U.S. and Europe, may have
an impact on our business and our financial condition, and we may face
challenges if economic conditions do not improve. These economic
conditions impact levels of consumer spending, which have deteriorated and
may remain depressed for the foreseeable future. If demand for our
products fluctuates as a result of these economic conditions or otherwise,
our revenue and gross margin could be harmed. |
|
|
|
|
|
Fuel Prices Significant
fluctuations in fuel prices could have both a positive and negative effect
on our business and operations. A significant portion of our revenue is
derived from international sales and significant fluctuations in world
fuel prices could significantly increase the price of shipping or
transporting our products which we may not be able to pass on to our
customers. On the other hand, fluctuations in fuel prices lead to higher
commuter costs which may encourage the increased use of motorcycles and
bicycles as alternative modes of transportation and lead to an increase in
the market for our protection products. |
|
|
|
|
|
Product Liability Litigation We face an
inherent business risk of exposure to product liability claims arising
from the claimed failure of our products to help prevent the types of
personal injury or death against which they are designed to help protect.
Therefore we have acquired very costly product liability insurance
worldwide. We have not experienced any material uninsured losses due to
product liability claims, but it is possible that we could experience
material losses in the future. After a two-week trial in the United States
District Court for the Northern District of Ohio (Eastern) ending on April
17, 2014, a federal jury returned a defense verdict for the Company in the
first Leatt- Brace® product liability lawsuit to be tried in the United
States. The plaintiffs in that case had alleged that defective product
design and failure to warn had caused a then fifteen year-old motocross
rider, to suffer multiple mid- thoracic spine fractures, causing immediate
and permanent paraplegia, when he crashed at a relatively low speed on
February 13, 2011. When the accident occurred, he was wearing a helmet and
other safety gear from several different companies, including the
Company's acclaimed Leatt-Brace®. The Company produced evidence at trial
showing that his thoracic paraplegia was an unavoidable consequence of his
fall, not the result of wearing a Leatt- Brace®, and that the neck brace
likely saved his life (or saved him from quadriplegia) by preventing
cervical spine injury. The Company had maintained from the onset that this
and a small handful of other lawsuits are without merit and that it will
vigorously defend itself in each case. In this case, the plaintiffs
subsequently appealed the courts decision and the parties reached an
amicable settlement. Although we carry product liability insurance, a
successful claim brought against us could significantly harm our business
and financial condition and have an adverse impact on our ability to renew
our product liability insurance or secure new coverage. |
|
|
|
|
|
Protection of Intellectual Property We
believe that the continued success of our business is dependent on our
intellectual property portfolio consisting of globally registered
trademarks, design patents and utility patents related to the
Leatt-Brace®. We believe that a loss of these rights would harm or cause a
material disruption to our business and, our corporate strategy is to
aggressively take legal action against any violators of our intellectual
property rights, regardless of where they may be. From time to time, we
have had to enforce our intellectual property rights through litigation
and we may be required to do so in the future. Such litigation may result
in substantial costs and could divert resources and management attention
from the operations of our business. |
- 44 -
Results of Operations
Year ended December 31, 2015 compared to the year ended
December 31, 2014
The following table summarizes the results of our operations
during the years ended December 31, 2015 and 2014 and provides information
regarding the dollar and percentage increase or (decrease) from the 2014 year to
the 2015 year.
|
|
Fiscal Year Ended December 31, |
|
|
|
|
|
Percentage |
|
|
|
2015 |
|
|
2014 |
|
|
Increase |
|
|
Increase |
|
Item |
|
|
|
|
|
|
|
(Decrease) |
|
|
(Decrease) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REVENUES |
$ |
18,343,172 |
|
$ |
18,458,928 |
|
$ |
(115,756 |
) |
|
-1% |
|
COST
OF REVENUES |
|
8,741,131 |
|
|
8,636,546 |
|
$ |
104,585 |
|
|
1% |
|
GROSS PROFIT |
|
9,602,041 |
|
|
9,822,382 |
|
$ |
(220,341 |
) |
|
-2% |
|
PRODUCT ROYALTY INCOME |
|
182,485 |
|
|
190,961 |
|
$ |
(8,476 |
) |
|
-4% |
|
OPERATING EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and Wages |
|
2,225,646 |
|
|
2,302,115 |
|
$ |
(76,469 |
) |
|
-3% |
|
Commissions and Consulting |
|
570,937 |
|
|
581,601 |
|
$ |
(10,664 |
) |
|
-2% |
|
Professional Fees |
|
845,575 |
|
|
1,117,887 |
|
$ |
(272,312 |
) |
|
-24% |
|
Advertising and Marketing |
|
1,498,307 |
|
|
1,442,450 |
|
$ |
55,857 |
|
|
4% |
|
Office Rent and Expenses |
|
246,616 |
|
|
244,510 |
|
$ |
2,106 |
|
|
1% |
|
Research and Development Costs |
|
1,180,227 |
|
|
1,222,209 |
|
$ |
(41,982 |
) |
|
-3% |
|
Bad Debt Expense |
|
124,213 |
|
|
75,285 |
|
$ |
48,928 |
|
|
65% |
|
General and Administrative |
|
1,793,698 |
|
|
2,081,339 |
|
$ |
(287,641 |
) |
|
-14% |
|
Depreciation |
|
371,089 |
|
|
304,690 |
|
$ |
66,399 |
|
|
22% |
|
Total Operating Expenses |
|
8,856,308 |
|
|
9,372,086 |
|
$ |
(515,778 |
) |
|
-6% |
|
INCOME
FROM OPERATIONS |
|
928,218 |
|
|
641,257 |
|
$ |
286,961 |
|
|
45% |
|
Other Income |
|
32,304 |
|
|
10,854 |
|
$ |
21,450 |
|
|
198% |
|
INCOME
BEFORE INCOME TAXES |
|
960,522 |
|
|
652,111 |
|
$ |
308,411 |
|
|
47% |
|
Income Taxes |
|
385,590 |
|
|
233,760 |
|
$ |
151,830
|
|
|
65% |
|
NET INCOME |
$ |
574,932 |
|
$ |
418,351 |
|
$ |
156,581 |
|
|
37% |
|
Revenues We earn revenues from the sale of our
Protective gear comprising of Neck braces, Body armor, Helmets and Other
products, Parts and Accessories. Revenues for the year ended December 31, 2015
were $18.34 million, a 0.6% decrease, compared to revenues of $18.46 million for
the year ended December 31, 2014. This decrease in revenues is attributable to a
$2.37 million decrease in neck brace sales that was partially offset by a $0.73
million increase in Body armor sales, $1.43 million increase in Helmet sales and
a $0.09 million increase in sales of Other Products, Parts and Accessories,
respectively, during the year ended December 31, 2015. Changes in prices did not
impact the decrease in revenues as our selling prices have not fluctuated by any
significant level. Initial stocking sales to our primary OEM customers in the
United States that accounted for approximately 10% of sales during the 2014
period were not repeated during the 2015 period.
The following table sets forth our revenues by product line for
the years ended December 31, 2015 and 2014:
- 45 -
|
|
|
|
|
Year Ended December 31, |
|
|
|
|
|
|
2015 |
|
|
% of Revenues |
|
|
2014 |
|
|
% of Revenues |
|
Neck braces |
$ |
7,430,800
|
|
|
40% |
|
$ |
9,799,767
|
|
|
53% |
|
Body armor |
|
8,540,332 |
|
|
47% |
|
|
7,811,511 |
|
|
42% |
|
Helmets |
|
1,431,090 |
|
|
8% |
|
|
- |
|
|
0% |
|
Other Products, Parts and Accessories |
|
940,950 |
|
|
5% |
|
|
847,650 |
|
|
5% |
|
|
$ |
18,343,172 |
|
|
100% |
|
$ |
18,458,928 |
|
|
100% |
|
Sales of our flagship Neck brace accounted for $7.43 million
and $9.80 million, or 40% and 53% of our revenues for the years ended December
31, 2015 and 2014, respectively. The 24% decrease in Neck brace revenues was due
to a decrease in the volume of neck braces sold in the United States and abroad.
In the United States, the decrease in neck brace volumes was primarily as a
result of decreased sales to our primary OEM customers mentioned above. The
decrease in neck brace sales volumes to customers outside of the United States
was primarily the result of significant U.S. dollar strength in relation to the
local currencies of our customers in the respective regions. Sales to these
customers account for 63% of our total revenues, with sales to Europe and
Australasia accounting for 52%. The Company continues to evaluate measures to
remain competitive in these areas.
Our Body armor products are comprised of chest protectors, full
upper body protectors, upper body protection vests, back protectors, knee
braces, gloves and knee and elbow guards. Body armor sales accounted for $8.54
million and $7.81 million, or 47% and 42% of our revenues for the years ended
December 31, 2015 and 2014, respectively. The 9% increase in Body armor revenues
was primarily due to increased sales volume of Body armor products as a result
of the successful market acceptance of our C-Frame Knee Brace as well as our
expanded line of protective gloves.
Our Helmets accounted for $1.43 million, or 8% of our revenues
for the year ended December 31, 2015. The 100% increase in Helmet revenues is
due to the initial shipment of our GPX 5.5 Composite and GPX 6.5 Carbon helmets
that shipped to our customers in the United States and abroad during the fourth
quarter of 2015.
Our Other Products, Parts and Accessories are comprised of
aftermarket support items required primarily to replace worn or damaged parts
through our global distribution network as well as clothing, outerwear and
accessories that include hats, jackets, bags, hydration kits and cooling
garments. Other Products, Parts and Accessories sales accounted for $0.94
million and $0.85 million, or 5% and 5% of our revenues for the years ended
December 31, 2015 and 2014, respectively. The increase in our Other Products,
Parts and Accessories is primarily due to a 20% increase in the volume of
hydration kits sold globally during the period.
Costs of Revenues and Gross Profit Cost of
revenues for the years ended December 31, 2015 and 2014 were $8.74 million and
$8.64 million, respectively. Gross Profit for the years ended December 31, 2015
and 2014 were $9.60 million or 52% of revenues, and $9.82 million, or 53% of
revenues, respectively. While our body armor margins have improved in the 2015
period due to the inclusion of the C Frame knee brace, body armor continues to
generate a lower margin than our neck brace and helmet products. Neck brace
revenues accounted for 40% and 53% of our revenues for the years ended December
31, 2015 and 2014, respectively. Management continues to actively assess all
measures that may reduce the cost of the Company's revenues.
Product Royalty Income Product royalty income is
earned on sales to distributors that have royalty agreements in place as well as
sales of licensed products by third parties that have licensing agreements in
place. Product royalty income for the years ended December 31, 2015 and 2014
were $182,485 and $190,961, respectively. The 4% decrease in product royalty
income is primarily due to a decrease in sales of licensed products by licensees
during the 2015 period.
Salaries and Wages Salaries and wages for the years
ended December 31, 2015 and 2014 were $2,225,646 and $2,302,115, respectively.
This 3% decrease in salaries and wages during the 2015 period was primarily due
to a restructuring of US marketing and operations that took place during the
2015 period. Additionally, salaries and wages paid to the Companys staff
members based at its headquarters were marginally lower due to the weakening of
the ZAR against the U.S dollar.
Commissions and Consulting Expense Commissions and
consulting expense for the years ended December 31, 2015 and 2014 were $570,937
and $581,601, respectively. This 2% decrease in commissions and consulting
expenses is primarily the result of a restructuring of commissions paid to the
Companys U.S. sales staff and a decrease in U.S. sales subject to commission.
Professional Fees Professional fees consist of costs
incurred for audit, tax, regulatory filings and quarterly reporting
requirements, as well as patent maintenance, protection and litigation expenses
incurred as the Company continues to expand. Professional fees for the years
ended December 31, 2015 and 2014 were $845,575 and $1,117,887, respectively. The
24% decrease in professional fees is primarily due to decreased spending on product liability
litigation which was partially offset by an increase in costs associated with
maintaining and expanding the Companys patent portfolio.
- 46 -
Advertising and Marketing The Company places paid
advertising in various motorsport magazines and online media, and sponsors a
number of events, teams and individuals to increase exposure. Advertising and
marketing expenses for the years ended December 31, 2015 and 2014 were
$1,498,307 and $1,442,450, respectively. This $55,857, or 4%, increase in
advertising and marketing expenditure is primarily due to various advertising
and marketing campaigns designed to promote the Companys widening product range
with an emphasis on the Companys range of helmets that shipped during the
fourth quarter of 2015.
Office Rent and Expenses Office rent and expenses for
the years ended December 31, 2015 and 2014 were $246,616 and $244,510,
respectively. The marginal 1% increase in office rent and expenses is primarily
the result of escalation in the rental of warehouse space occupied by Two
Eleven, our US subsidiary. This increase was partially offset by a decrease in
rental expenditure incurred at our South African headquarters as a result of the
weakening of the ZAR against the U.S. dollar.
Research and Development Costs These costs include the
salaries of staff members that are directly involved in the research and
development of protective gear, as well as the direct costs associated with
developing these products. Research and development costs for the years ended
December 31, 2015 and 2014 were $1,180,227 and $1,222,209, respectively. This 3%
decrease in research and development costs is a result of significant cost
incurred in the 2014 period in connection with the development of the Companys
first line of helmets which were not incurred during the 2015 period due to the
phase of development of future products.
Bad Debt Expense - Bad debt expense for the years ended
December 31, 2015 and 2014 were $124,213 and $75,285, respectively. This
increase is primarily as a result of the write off of unrecoverable debts owing
to the Company during the 2015 period.
General and Administrative Expenses General and
administrative costs consist of insurance, travel, merchant fees, communication
costs, office and computer supplies with insurance and travel comprising a
substantial part of these expenses. General and administrative expenses for the
years ended December 31, 2015 and 2014 were $1,793,698 and $2,081,339,
respectively. The 14% decrease in general and administrative expenses is
primarily the result of decreased product liability insurance premiums during
the 2015 period.
Depreciation Expense Depreciation expense for the
years ended December 31, 2015 and 2014 was $371,089 and $304,690, respectively.
The 22% increase in depreciation expense is primarily as a result of the
additional molds and tooling required for the Companys growing product range.
Total Operating Expenses Total operating expenses
decreased by $515,778 to $8,856,308 for the year ended December 31, 2015, or 6%,
compared to $9,372,086 in the 2014 period. This decrease is primarily due to a
decrease in professional fees and general and administrative expenditures that
was partially offset by an increase in advertising and marketing costs as
discussed above.
Net Income The net income after income taxes for the
year ended December 31, 2015 was $574,932, as compared to a net income after
income taxes of $418,351 for the 2014 period. This 37% increase in net income,
despite the 0.6% decrease in Revenues, is primarily due to the 6% decrease in
total operating expenditures discussed above.
Liquidity and Capital Resources
At December 31, 2015, we had cash and cash equivalents of
$1,054 million and short-term investments of $0.06 million, as compared to cash
and cash equivalents of $0.7 million and short-term investments of $0.06 million
at December 31, 2014. The following table sets forth a summary of our cash flows
for the periods indicated:
- 47 -
|
|
December
31, |
|
|
|
2015 |
|
|
2014 |
|
Net cash provided by operating
activities |
$ |
1,239,679 |
|
$ |
759,462 |
|
Net cash used in investing activities |
$ |
(780,564 |
) |
$ |
(456,429 |
) |
Net cash provided by (used in)
financing activities |
$ |
63,710 |
|
$ |
(207,606 |
) |
Effect of exchange rate changes on cash and cash
equivalents |
$ |
(192,782 |
) |
$ |
(205,732 |
) |
Net increase (decrease) in cash
and cash equivalents |
$ |
330,043 |
|
$ |
(110,305 |
) |
Cash and cash equivalents at the beginning of
period |
$ |
724,707 |
|
$ |
835,012 |
|
Cash and cash equivalents at the
end of period |
$ |
1,054,750 |
|
$ |
724,707 |
|
Cash increased by $330,043, or 46%, for the year ended December
31, 2015. The primary sources of cash during fiscal year 2015 were a net income
of $574,932 and a decrease in accounts receivable of $1,309,341. The primary
uses of cash during fiscal year 2015 were increase in inventory of $836,208 and
increased capital expenditures of $813,912 relating primarily to molds to be
used for the Companys increased range of products. As of December 31, 2015, we
did not have any credit facilities or significant amounts owing to third party
lenders.
The Company is currently meeting its working capital needs
through cash on hand as well as internally generated cash from operations.
Management believes that its current cash and cash equivalent balances, along
with the net cash generated by operations are sufficient to meet its anticipated
operating cash requirements for at least the next twelve months. There are
currently no plans for any major capital expenditures in the next twelve months.
Our long-term financing requirements depend on our growth strategy, which
relates primarily to our desire to increase revenue both domestically as well as
internationally.
Obligations under Material Contracts
Pursuant to our Licensing Agreement with Xceed Holdings, a
company owned and controlled by Dr. Christopher Leatt, our founder and chairman,
we pay Xceed Holdings, 4% of all neck brace sales revenue billed and received by
the Company on a quarterly basis, based on sales of the previous quarter. In addition, pursuant to a separate license
agreement between the Company and Mr. J. P. De Villiers, our former director,
the Company is obligated to pay a royalty fee of 1% of all our billed and
received neck brace sales revenue, in quarterly installments, based on sales of
the previous quarter, to a trust that is beneficially owned and controlled by
Mr. De Villiers.
Pursuant to a Premium Finance Agreement, dated October 19,
2015, between the Company and AFCO Acceptance Corporation AFCO, the Company is
obligated to pay AFCO an aggregate sum of $ 852,081 in eleven payments of
$71,952, at an annual interest rate of 2.897%, commencing on November 1, 2015
and ending on September 1, 2016. Any late payment during the term of the
agreement will be assessed a late penalty of 5% of the payment amount due, and
in the event of default AFCO has the right to accelerate the payment due under
the agreement.
Pursuant to a Premium Finance Agreement, dated May 27, 2015,
between the Company and AFCO, the Company is obligated to pay AFCO an aggregate
sum of $55,969 in eleven payments of $5,162 at a 2.897% annual interest rate,
commencing on June 1, 2015 and ending on April 1, 2016. Any late payment during
the term of the agreement will be assessed a late penalty of 5% of the payment
amount due, and in the event of default AFCO has the right to accelerate the
payment due under the agreement. As of December 31, 2015, the Company had not
defaulted on its payment obligations under this agreement.
On July 8, 2015, the Company entered into a consulting
agreement with Innovate Services Limited, or Innovate, a Seychelles limited
company in which, Dr. Leatt is an indirect beneficiary.
Pursuant to the terms of the Consulting Agreement, Innovate has agreed to serve
as the Companys exclusive research, development and marketing consultant, in
exchange for a monthly fee of $35,639; provided that Dr. Leatt personally
performs the services to be performed by Innovate under the Agreement, pursuant
to a separate employment agreement between Innovate and Dr. Leatt. The parties
further agreed that all intellectual property generated in connection with the
services provided under the Consulting Agreement will be the sole property of
the Company. The Consulting Agreement was effective as of May 15, 2015, and will
continue unless terminated by either party in accordance with its terms. Either
party has the right to terminate the Consulting Agreement upon 6 months' prior
written notice, except that the Consulting Agreement may be terminated
immediately without notice if the services to be performed under the
Consulting Agreement cease to be performed by Dr. Leatt, or for any other
material breach of the Agreement. The parties have agreed to settle any dispute
under the Consulting Agreement through arbitration in accordance with the
Commercial Arbitration Rules of the American Arbitration Association (AAA), and
that the resulting arbitration award will be final and binding on both parties
and will not be subject to any appeal. The foregoing description does not
purport to be a complete statement of the parties rights and obligations under
the Consulting Agreement and the transactions contemplated thereby or a complete
explanation of the materials thereof. On July 8, 2015, the Company entered into
a consulting agreement with Innovate Services Limited, or Innovate, a Seychelles
limited company in which, Dr. Leatt is an indirect beneficiary.
- 48 -
Critical Accounting Policies
Our discussion and analysis of financial condition and results
of operations are based upon our consolidated financial statements, which have
been prepared in accordance with accounting principles generally accepted in the
United States of America. The preparation of these financial statements requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and the reported revenues and expenses
during the reporting period. We have identified the following as the items that
require the most significant judgment and often involve complex estimation:
revenue recognition, estimating allowances for doubtful accounts receivable,
inventory valuation, impairment of long-lived assets and accounting for income
taxes.
Revenue and Cost Recognition - All manufacturing
of Leatt-Brace products is performed by third party subcontractors in China. The
Company's products are sold worldwide to a global network of distributors and
dealers, and directly to consumers when there are no dealers or distributors in
their geographic area (collectively the "customers"). Revenues from product
sales are recognized when earned, net of applicable provisions for discounts and
returns and allowances in the event of product defect. Revenue is considered to
be realized or realizable and earned when all of the following criteria are met:
title and risk of loss have passed to the customer, persuasive evidence of an
arrangement exists, delivery has occurred, the price is fixed and determinable
and collectability is reasonably assured. Our distributor payment terms range
from pre-payment in full to 60 days after shipment and subsequent sales of our
products by distributors have no effect on the amount and timing of payments due
to us. Furthermore, products purchased by distributors may not be returned to us
in the event that any such distributor relationship is terminated.
Since the Company (through its wholly-owned subsidiary) serves
as the distributor of Leatt products in the United States, the Company records
its revenue and related cost of revenue for its product sales in the United
States upon shipment of the merchandise to the dealer or to the ultimate
consumer when there is no dealer in the geographic area and the sales order was
received directly from, and paid by, the ultimate consumer. Since the Company
(through its South African branch) serves as the distributor of Leatt products
in South Africa, the Company records its revenue and related cost of revenue for
its product sales in South Africa upon shipment of the merchandise from the
branch to the dealer. International sales (other than in South Africa) are
generally drop-shipped directly from the third party manufacturer to the
international distributors.
Revenue and related cost of revenue is recognized at the time
of shipment from the manufacturer's port when the shipping terms are Free On
Board ("FOB") shipping point. Cost and Freight ("CFR") or Cost and Insurance to
named place ("CIP") as legal title and risk of loss to the product pass to the
distributor. Sales to all customers (distributors, dealers and consumers) are
generally final; however, in limited instances, product may be returned due to
product quality issues. Historically, returns due to product quality issues have
not been material and there have been no distributor terminations that resulted
in product returns. Cost of revenues also includes royalty fees associated with
sales of Leatt-Brace products. Product royalty income is recorded as the
underlying product sales occur, in accordance with the related licensing
arrangements.
Allowance for Doubtful Accounts Receivable -
Accounts receivable consist of amounts due to the Company from normal
business activities. Credit is granted to substantially all distributors on an
unsecured basis. We continuously monitor collections and payments from customers
and maintain an allowance for doubtful accounts receivable based upon historical
experience and any specific customer collection issues that have been
identified. In determining the amount of the allowance, we are required to make
certain estimates and assumptions. Accounts receivable balances that are still
outstanding after we have used reasonable collection efforts are written off as
uncollectible. While such credit losses have historically been minimal, within
our expectations and the provisions established, we cannot guarantee that we
will continue to experience the same credit loss rates that we have in the past.
A significant change in the liquidity or financial position of any of our
significant customers could have a material adverse effect on the collectability
of our accounts receivable and our future operating results.
Inventory Valuation Inventory is stated at the
lower of cost or market. Cost is determined using the first-in first-out (FIFO)
method. Inventory consists primarily of finished goods. Shipping and handling
costs are included in the cost of inventory. In assessing the inventory value,
we make estimates and judgments regarding reserves required for product
obsolescence, aging of inventory and other issues potentially affecting the
saleable condition of products. In performing such evaluations, we utilize
historical experience as well as current market information. The reserve for obsolescence as
of the years ended December, 2015 and 2014 was $160,515 and $161,593,
respectively.
- 49 -
Impairment of Long-Lived Assets Our
long-lived assets include property and equipment. We evaluate our long-lived
assets for recoverability whenever events or changes in circumstances indicate
that an asset may be impaired. In evaluating an asset for recoverability, we
estimate the future cash flow expected to result from the use of the asset and
eventual disposition. If the expected future undiscounted cash flow is less than
the carrying amount of the asset, an impairment loss, equal to the excess of the
carrying amount over the fair value of the asset, is recognized. We have
determined there was no impairment charge during the years ended December, 2015
and 2014.
Income Taxes - As part of the process of
preparing our consolidated financial statements, we are required to estimate our
income tax provision (benefit) in each of the jurisdictions in which we operate.
This process involves estimating our current income tax provision (benefit)
together with assessing temporary differences resulting from differing treatment
of items for tax and accounting purposes. These differences result in deferred
tax assets and liabilities, which are included within our consolidated balance
sheets. We regularly evaluate our ability to recover the reported amount of our
deferred income taxes considering several factors, including our estimate of the
likelihood of the Company generating sufficient taxable income in future years
during the period over which the temporary differences reverse.
Recent Accounting Pronouncements
See Note 2, Summary of Significant Accounting Policies in the
Notes to Consolidated Financial Statements for a full description of recent
accounting pronouncements, including the respective dates of adoption, or
expected adoption and effects of our consolidated financial position, results of
operations and cash flows.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or
are reasonably likely to have a current or future effect on its financial
condition, changes in financial condition, revenues or expenses, results of
operations, liquidity, capital expenditures or capital resources that is
material to its stockholders.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
MARKET RISK.
Some of our operations are carried out in the Republic of South
Africa, or RSA, and we are subject to specific considerations and significant
risks not typically associated with companies in North America and Western
Europe. Accordingly, our business, financial condition and results of operations
may be influenced by the political, economic and legal environments in the RSA,
and by the general state of the RSA economy. Our results may be adversely
affected by changes in governmental policies with respect to laws and
regulations, anti-inflationary measures, currency conversion and remittance
abroad, and rates and methods of taxation, among other things.
Foreign Exchange Risk
While our reporting currency is the U.S. Dollar, a portion of
our consolidated revenues are denominated in South African Rand, or ZAR. Certain
of our assets are also denominated in ZAR. As a result, we are exposed to
foreign exchange risk as our revenues and results of operations may be affected
by fluctuations in the exchange rate between the U.S. Dollar and the ZAR. If the
ZAR depreciates against the U.S. Dollar, the value of our ZAR revenues, earnings
and assets as expressed in our U.S. Dollar financial statements will decline.
Assets and liabilities are translated at exchange rates at the balance sheet
date and revenue and expenses are translated at the spot exchange rate on the
transaction date. Any resulting translation adjustments are not included in
determining net income but are included in determining other comprehensive
income, a component of stockholders equity. We have not entered into any
hedging transactions in an effort to reduce our exposure to foreign exchange
risk. The value of the ZAR against the U.S. dollar and other currencies is
affected by, among other things, changes in the RSAs political and economic
conditions.
Inflation
Inflationary factors such as increases in the cost of our sales
and overhead costs may adversely affect our operating results. Although we do
not believe that inflation has had a material impact on our financial position
or results of operations to date, a high rate of inflation in the future may
have an adverse effect on our ability to maintain current levels of gross margin
and selling, general and administrative expenses as a percentage of net sales if
the selling prices of our products do not increase with these increased costs.
- 50 -
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The full text of our audited consolidated financial statements
as of December 31, 2015 and 2014 begins on page F-1 of this report.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE.
None.
ITEM 9A. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in
Rule 13a-15(e) under the Exchange Act) that are designed to ensure that
information that would be required to be disclosed in Exchange Act reports is
recorded, processed, summarized and reported within the time period specified in
the SECs rules and forms, and that such information is accumulated and
communicated to our management, including to our Chief Executive Officer and
Chief Financial Officer, as appropriate, to allow timely decisions regarding
required disclosure.
As required by Rule 13a-15 under the Exchange Act, our
management, including our Chief Executive Officer and Chief Financial Officer,
Mr. Sean Macdonald, evaluated the effectiveness of the design and operation of
our disclosure controls and procedures as of December 31, 2015. Based on that
evaluation, our Chief Executive Officer and Chief Financial Officer determined
that, as of December 31, 2015, and as of the date that the evaluation was
completed, our disclosure controls and procedures were effective.
Internal Controls over Financial Reporting
Managements Annual Report on Internal Control over
Financial Reporting
Management is responsible for establishing and maintaining
adequate internal control over financial reporting for the Company. Internal
control over financial reporting refers to the process designed by, or under the
supervision of, our Chief Executive Officer and Chief Financial Officer, and
effected by our Board of Directors, management and other personnel, to provide
reasonable assurance regarding the reliability of our financial reporting and
the preparation of financial statements for external purposes in accordance with
U.S. GAAP, and includes those policies and procedures that:
|
(1) |
pertain to the maintenance of records that in reasonable
detail accurately and fairly reflect the transactions and dispositions of
our assets; |
|
|
|
|
(2) |
provide reasonable assurance that transactions are
recorded as necessary to permit preparation of financial statements in
accordance with U.S. GAAP, and that our receipts and expenditures are
being made only in accordance with the authorization of our management and
directors; and |
|
|
|
|
(3) |
provide reasonable assurance regarding prevention or
timely detection of unauthorized acquisition, use or disposition of our
assets that could have a material effect on the financial
statements. |
Management assessed the effectiveness of our internal control
over financial reporting as of December 31, 2015. In making this assessment,
management used the framework set forth in the report entitled Internal Control
- Integrated Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission. Based on that evaluation, our management concluded that
our internal control over financial reporting, as of December 31, 2015 was
effective.
Because the Company is a smaller reporting company, this annual
report does not include an attestation report of our independent registered
public accounting firm regarding internal control over financial reporting.
Managements report was not subject to attestation by our independent registered
public accounting firm.
Changes in Internal Controls over Financial Reporting
There were no changes in its internal controls over financial
reporting in 2015 that would materially affect, or are reasonably likely to
materially affect our internal control over financial reporting.
- 51 -
ITEM 9B. OTHER INFORMATION.
We have no information to disclose that was required to be in a
report on Form 8-K during the period covered by this report, but was not
reported. There have been no material changes to the procedures by which
security holders may recommend nominees to our board of directors.
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE
GOVERNANCE.
Directors, Executive Officers, Promoters and Control
Persons
The following sets forth the name and position of each of our
current executive officers, directors and significant employees and their ages
and titles as of March 7, 2016.
Name |
Age |
Title |
Dr. Christopher James Leatt
|
47 |
Founder, Chairman and Research
& Development Consultant |
Sean Macdonald |
38 |
CEO, CFO, President and Director |
Jeffrey Joseph Guzy |
64 |
Director |
DR. CHRISTOPHER LEATT: Dr. Leatt, aged 47, has served as the
Company's Chairman since 2005 and as the Company's Research and Development
consultant since July 2015. He held positions in General
Surgery and General Medicine/Geriatrics/Gastroenterology before becoming a
General Medical Practitioner and Chairman of ERIPO (Eerste River Independent
Practitioners Association), an organization formed to look after both the
Medical and Business interests of forty Independent Practitioners. Dr. Leatt
then worked in casualty/trauma at various hospitals before becoming a surgical
medical officer. A brief stint as an Orthopedic Registrar at Groote Schuur
Hospital preceded his post as Neurosurgery Registrar at the Department of
Neurosurgery, Tygerberg Academic Hospital. Dr. Leatt's duties as a surgical
registrar in this discipline included ward work, High-Care duties, evaluation of
referrals, outpatient consultations, emergency and elective surgery, logbook of
all surgical procedures completed. He resigned from his post in Neurosurgery in
order to develop and study the benefits and viability of a neck protection
system (the Leatt-Brace®) for helmet clad sport and recreational users in an
attempt to reduce devastating neck injuries. Dr. Leatt is a fixed wing and
helicopter pilot and is an active participant in competitive cross-country
motorcycle endurance races, as well as Super Sport and Battle of the Twins
(BOTTS) track racing events. He won the Western Province BOTTS championship in
2011. When not participating in such events, Dr. Leatt is often involved in
providing medical support there.
SEAN MACDONALD: Mr. Macdonald, CA (SA), aged 38, has served as
the Companys Chief Executive Officer and President since November 2010, as its
Chief Financial Officer since August 2009, and as a Director since May 2010.
Prior to joining the Company, Mr. Macdonald served from August 2004 to December
2009, as the Chief Financial Officer of Cyclelab, the largest bicycle retailer
in South Africa, where he was responsible for operational, financial and
strategic leadership of the business including the implementation of a franchise
model in order to grow the business. Mr. Macdonald holds a Bachelor of Commerce
Degree in Finance and Information Systems from the University of Cape Town, as
well as a Post-Graduate Diploma in Accounting, which included 3 years of
articles at KPMG Cape Town. Mr. Macdonald is also a South Africa registered
Chartered Accountant.
JEFFREY GUZY: Mr. Guzy, aged 64, has served as a director since
April 2007 and serves as a business development consultant and entrepreneur in
Arlington, Virginia. Mr. Guzy is currently working with CENTRAL Oil and Gas
Corporation and Aero-X Golf Inc (dba Polara Golf). Prior to that, Mr. Guzy
served, from October 2007 to August 2010 as our President. Mr. Guzy has a MBA in
Strategic Planning and Management from The Wharton School of the University of
Pennsylvania; a M.S. in Systems Engineering from the University of Pennsylvania;
a B.S. in Electrical Engineering from Penn State University; and a Certificate
in Theology from Georgetown University. Mr. Guzy has served as an executive
manager or consultant for business development, sales, customer service and
management in the telecommunications industry, specifically, with IBM Corp.,
Sprint International, Bell Atlantic Video Services, Loral CyberStar and
FaciliCom International. Mr. Guzy has also started his own telecommunications
company providing Internet services in Western Africa. He serves as an
independent director of Capstone Industries (CAPC) and UBL Interactive (UBLI),
both public corporations.
There are no agreements or understandings for any of our
executive officers, directors or significant employees to resign at the request
of another person and no officer or director is acting on behalf of nor will any
of them act at the direction of any other person.
- 52 -
Qualifications, Attributes, Skills and Experience
Represented on the Board
The Board has identified particular qualifications, attributes,
skills and experience that are important to be represented on the board as a
whole, in light of our current needs and business priorities. The Board believes
that each director is a recognized person of high integrity with a proven record
of success in his or her field. Each director demonstrates innovative thinking,
familiarity with and respect for corporate governance requirements and
practices, an appreciation of multiple cultures and a commitment to the business
and operations of the Company. In addition to the foregoing qualifications, the
Board has assessed the intangible qualities including the directors ability to
ask difficult questions and, simultaneously, to work collegially. The Board also
considers diversity of age, cultural background and professional experiences in
evaluating candidates for Board membership. Diversity is important because a
variety of points of view contribute to a more effective decision-making
process.
Set forth below is a tabular disclosure summarizing some of the
specific qualifications, attributes, skills and experiences of our
directors.
Name |
Title |
Qualifications |
Dr. Christopher James Leatt |
Founder, Chairman and Head of Research &
Development |
|
Dr. Leatt holds a Bachelor of Medicine and Bachelor of
Surgery Degree and is the inventor of the Leatt Brace® and the Founder of
the Company. |
|
|
|
|
|
|
|
He supports the Companys research and development department and has an
intimate knowledge of the Companys innovative products. |
|
|
|
|
|
|
|
He contributes invaluable long-term knowledge of the
Companys business and operations and extensive experience in the
industry. |
Sean Macdonald |
CEO, CFO, President and Director |
|
Mr. Macdonald is a registered Chartered Accountant and
holds a Bachelor of Commerce Degree in Finance and Information Systems and
a Post-Graduate Diploma in Accounting. |
|
|
|
|
|
|
|
His invaluable experience in finance and accounting
provides insight for the implementation of effective operational,
financial and strategic leadership of the Company. |
Jeffrey Joseph Guzy |
Director |
|
Through his Masters Degree in Business Administration in
Strategic Planning & Management and his knowledge of U.S. capital
markets, Mr. Guzy provides invaluable guidance and perspective to the
Board. |
|
|
|
|
|
|
|
He has also served as the Companys President and has
invaluable long-term knowledge of the Companys business and operations.
|
Family Relationships
There are no family relationships among our directors or
officers.
Involvement in Certain Legal Proceedings
To the best of our knowledge, none of our directors or
executive officers has, during the past ten years:
|
|
been convicted in a criminal proceeding or been
subject to a pending criminal proceeding (excluding traffic violations and
other minor offences); |
|
|
|
|
|
had any bankruptcy petition filed by or against
the business or property of the person, or of any partnership, corporation
or business association of which he was a general partner or executive
officer, either at the time of the bankruptcy filing or within two years
prior to that time; |
- 53 -
|
|
been subject to any order, judgment, or decree, not
subsequently reversed, suspended or vacated, of any court of competent
jurisdiction or federal or state authority, permanently or temporarily
enjoining, barring, suspending or otherwise limiting, his involvement in
any type of business, securities, futures, commodities, investment,
banking, savings and loan, or insurance activities, or to be associated
with persons engaged in any such activity; |
|
|
|
|
|
been found by a court of competent jurisdiction in a
civil action or by the SEC or the Commodity Futures Trading Commission to
have violated a federal or state securities or commodities law, and the
judgment has not been reversed, suspended, or vacated; |
|
|
|
|
|
been the subject of, or a party to, any federal or state
judicial or administrative order, judgment, decree, or finding, not
subsequently reversed, suspended or vacated (not including any settlement
of a civil proceeding among private litigants), relating to an alleged
violation of any federal or state securities or commodities law or
regulation, any law or regulation respecting financial institutions or
insurance companies including, but not limited to, a temporary or
permanent injunction, order of disgorgement or restitution, civil money
penalty or temporary or permanent cease-and-desist order, or removal or
prohibition order, or any law or regulation prohibiting mail or wire fraud
or fraud in connection with any business entity; or |
|
|
|
|
|
been the subject of, or a party to, any sanction or
order, not subsequently reversed, suspended or vacated, of any self-
regulatory organization (as defined in Section 3(a)(26) of the Exchange
Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section
1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any
equivalent exchange, association, entity or organization that has
disciplinary authority over its members or persons associated with a
member. |
Except as set forth in our discussion below in Certain
Relationships and Related Transactions, and Director Independence Transactions
with Related Persons, none of our directors, director nominees or executive
officers has been involved in any transactions with us or any of our directors,
executive officers, affiliates or associates which are required to be disclosed
pursuant to the rules and regulations of the SEC.
Significant Employees
Name |
Age |
Position |
Erik Olsson |
48 |
International General Manager and Head of
International Distribution |
Todd Repsher |
45 |
U.S. National Sales Manager
|
ERIK OLSSON: Mr. Olsson, aged 48, has served as our
International General Manager and Head of International Distribution since
January 2012. Prior to that, Mr. Olsson served from January 2010 to December
2011, as European General Manager and later as General Manager of Asia, Europe,
the Middle-East and the Central Pacific (Oceania). Mr. Olsson has over 15 years
experience as a sales and product manager for various companies in the power
sports industry. Prior to joining us he served from January 2003 to December
2009 as Area Manager for Jofrab Ab, a Swedish distributor of motorcycles and
recreational vehicles.
TODD REPSHER: Mr. Repsher, aged 45, has served as our US
National Sales Manager since March 2014. Mr. Repsher is an award- winning sales
executive with over fifteen years experience in the marketing and sales of
sports orientated companies in North America. Prior to joining us he was the
National Sales Manager for Switzerland-based Scott Sports, Inc. from 2011 to
2013, where he managed the sale and distribution of all North American
motorsports (off-road, on-road, snowmobile) apparel and accessories for Scott
Sports. Prior to that, Mr. Repsher served, from 2002 to 2011, as the Outside
Sales Territory Manager for California-based Fox Racing, Inc.
Stockholder Communication with the Board of
Directors
Stockholders may communicate with the Board by sending a letter
to our Board of Directors, c/o Corporate Secretary, 50 Kiepersol Drive, Atlas
Gardens, Contermanskloof Road, Durbanville, Western Cape, South Africa, 7441,
for submission to the board or committee or to any specific director to whom the
correspondence is directed. Stockholders communicating through this means should
include with the correspondence evidence, such as documentation from a brokerage
firm, that the sender is a current record or beneficial stockholder of the
Company. All communications received as set forth above will be opened by the
Corporate Secretary or his designee for the sole purpose of determining whether
the contents contain a message to one or more of our directors.
Any contents that are not advertising materials, promotions of
a product or service, patently offensive materials or matters deemed, using
reasonable judgment, inappropriate for the Board will be forwarded promptly to
the chairman of the Board, the appropriate committee or the specific director,
as applicable.
- 54 -
Code of Ethics
We have adopted a written code of ethics that applies to all of
our officers, directors and employees, including our principal executive officer
and principal financial officer, or persons performing similar functions, a copy
of which is attached as an exhibit to this report.
ITEM 11. EXECUTIVE COMPENSATION
Summary Compensation Table Update
The following table sets forth information concerning all cash
and non-cash compensation awarded to, earned by or paid to the following persons
for services rendered in all capacities during the indicated periods. No other
executive officers received total annual salary and bonus compensation in excess
of $100,000.
Name and Principal
Position |
Year |
Salary ($)
|
Bonus ($)
|
Stock Awards
($) |
Option
Awards ($)(1) |
Non-Equity Incentive
Plan Compensation Earnings ($)
|
Non- qualified
Deferred Compensation Earnings
($) |
All Other
Compensation ($) |
Total ($) |
Dr. Christopher Leatt, Chairman and
Research and Development Consultant(2) |
2013 |
487,668 |
-- |
-- |
160 |
-- |
-- |
9,468 |
497,296 |
2014 |
487,668 |
-- |
-- |
160 |
-- |
-- |
8,956 |
496,784 |
2015 |
182,876 |
5,000 |
-- |
-- |
-- |
-- |
275,691 |
463,567 |
Sean Macdonald, President, CEO, CFO and
Director
|
2013 |
189,502 |
-- |
-- |
240 |
-- |
-- |
10,467 |
200,209 |
2014 |
172,774 |
13,055 |
-- |
240 |
-- |
-- |
10,338 |
196,407 |
2015 |
173,318 |
22,500 |
-- |
-- |
-- |
-- |
5,573 |
201.391 |
Todd Repsher U.S. National Sales
Manager
|
2013 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
2014 |
106,000 |
4,915 |
-- |
-- |
-- |
-- |
-- |
110,915 |
2015 |
140,000 |
5,000 |
-- |
-- |
-- |
-- |
-- |
145,000 |
(1) |
The option awards reflect a 1-for-25 reverse split
effected by the Company on September 20, 2012. |
|
|
(2) |
Also reflects compensation to Dr. Leatt in his capacity
as our Research and Development consultant as discussed under the
Summary of Employment Agreements heading below. Compensation
received by Dr. Leatt in his role as Chairman of the Companys board of
directors is separately reflected under the Compensation heading
below. |
Summary of Employment Agreements
We have entered into an employment agreement, effective as of
January 1, 2014, with Sean Macdonald our President, CEO and CFO, pursuant to
which, as amended, we were obligated to pay him an annual base salary of
$195,000 per annum. This Agreement includes the duty to pay Mr. Macdonalds
directors fees of $650 per month. Mr. Macdonald receives coverage under the
Companys employment benefit plans and is entitled to an annual performance
based bonus at the sole discretion of the Companys Board of Directors. Mr.
Macdonald is also subject to the customary confidentiality covenants and South
African Labor Laws which entitle Mr. Macdonald to one weeks severance pay for
each year of service to the Company. The agreement may be terminated by either
party with six months written notice; provided that Mr. Macdonald will be
obligated to assist in the appointment and orientation of his successor during
such six-month period. Mr. Macdonald may also be terminated by the Company with
no notice for gross misconduct, incapacity or for breach of the employment
agreement.
We have entered into an employment agreement, effective as of
March 3, 2014, with Todd Repsher, our U.S. National Sales Manager, pursuant to
which, we are obligated to pay him an annual base salary of $10,000 per month.
Mr. Repsher receives coverage under the Companys employment benefit plans and
is entitled to a $5,000 annual performance based bonus at the sole discretion of
the Companys Board of Directors. Mr. Repsher is also subject to customary
confidentiality and indemnification requirements. The agreement may be
terminated at any time by the Company and upon three months written notice by
Mr. Repsher, however, in advance of any termination based on neglect of duty or breach
of the employment agreement, the Company may, in its sole discretion, give Mr.
Repsher 15 days advance notice with an opportunity to cure the deficiency. The
agreement is subject to California law and disputes under the agreement are
subject to resolution by arbitration
- 55 -
We had also entered into an employment agreement, effective as
of November 9, 2010, with Dr. Christopher Leatt, in his capacity as our Chairman
and Head of Research and Development, pursuant to which, we were obligated to
pay him an annual base salary of $487,668. Dr. Leatt also received coverage
under the Companys employment benefit plans as well as the mandatory one weeks
severance pay for each year of service to the Company. He was also subject to
the customary confidentiality covenants. However, on July 8, 2015, the Company
terminated this employment agreement and entered into a consulting agreement or
Consulting Agreement, with Innovate Services Limited or Innovate, a Seychelles
limited company in which, Dr. Leatt is an indirect beneficiary. Pursuant to the
terms of the Consulting Agreement, Innovate has agreed to serve as the Companys
exclusive research, development and marketing consultant in exchange for a
monthly fee of $35,639; provided that Dr. Leatt personally performs the services
to be performed by Innovate under the Agreement, pursuant to a separate
employment agreement between Innovate and Dr. Leatt. The parties further agreed
that all intellectual property generated in connection with the services
provided under the Consulting Agreement will be the sole property of the
Company. The Consulting Agreement is effective as of May 15, 2015, and will
continue unless terminated by either party in accordance with its terms. Either
party has the right to terminate the Consulting Agreement upon 6 months' prior
written notice, except that the Consulting Agreement may be terminated
immediately without notice if the services to performed under the Consulting
Agreement cease to be performed by Dr. Leatt or for any other material breach of
the Agreement by any of the parties. The parties have agreed to settle any
dispute under the Consulting Agreement through arbitration in accordance with
the Commercial Arbitration Rules of the American Arbitration Association (AAA),
and that the resulting arbitration award will be final and binding on both
parties and will not be subject to any appeal.
Grants of Plan-Based Awards
The following table sets forth information regarding equity
grants to named executive officers during the fiscal year ended December 31,
2015, including prior year grants that vested during the period.
Name
|
Grant
Date |
All other stock
awards: Number of shares of stock
or units |
All other option
awards: Number of securities
underlying options(1) |
Exercise
or base price of option awards
($/Sh)(1) |
Grant date
fair value of stock and option awards
($) |
Dr. Christopher Leatt |
2/1/2012 |
- |
52,000 |
$1.00 |
$52,000 |
Sean Macdonald |
2/1/2012 |
- |
78,000 |
$1.00 |
$78,000 |
(1) |
The Company effected a one-for-twenty-five reverse stock
split on September 20, 2012, which decreased the number of option shares
and increased the exercise price to $1.00 per
share. |
Outstanding Equity Awards at Fiscal Year End
The following table sets forth the equity awards outstanding at
December 31, 2015 for each of our named executive officers.
|
OPTION
AWARDS |
Name
|
Number
of securities underlying unexercised
options (1) exercisable |
Number
of securities underlying unexercised
options unexercisable
|
Equity
incentive plan awards: number of
securities underlying unexercised
unearned options |
Option
exercise (1) price ($) |
Option
expiration date |
Dr. Christopher Leatt |
52,000 |
-- |
-- |
$1.00 |
February 1, 2017 |
Sean Macdonald |
78,000 |
-- |
-- |
$1.00 |
February 1, 2017 |
(1) The Company effected a one-for-twenty-five
reverse stock split on September 20, 2012, which decreased the number of option
shares and increased the exercise price to $1.00 per share.
- 56 -
On February 1, 2012, the Board of Directors of the Company
approved the grant to Dr. Christopher Leatt, the Companys Chairman, of a 5-year
option to purchase 1,300,000 shares of the Companys common stock at $0.04 per
share under the Companys 2011 Plan. The option to purchase 520,000 of the
shares vested on February 1, 2012, the grant date, and the option to purchase
the remaining shares vested in equal portions on December 31, 2012, 2013 and
2014. After giving effect to the reverse split effected on September 20, 2012,
Dr. Leatt has vested options to purchase 52,000 shares of the Companys common
stock at $1.00 per share.
On February 1, 2012, the Board of Directors of the Company
approved the grant to Sean Macdonald, the Companys Chief Executive Officer and
Chief Financial Officer, of a 5-year option to purchase 1,950,000 shares of the
Companys common stock at $0.04 per share under the Companys 2011 Plan. The
option to purchase 780,000 of the shares vested on February 1, 2012, the grant
date, and the option to purchase the remaining shares vested in equal portions
on December 31, 2012, 2013 and 2014. After giving effect to the reverse split
effected on September 20, 2012, Mr. Macdonald has vested options to purchase
78,000 shares of the Companys common stock at $1.00 per share.
Option Exercises and Stock Vested
No named executive officers exercised stock options, stock
appreciation rights or similar instruments or had vesting stock during the
fiscal year ended December 31, 2015.
Pension Benefits
No named executive officers received or held pension benefits
and the Company does not maintain a pension benefit plan during the fiscal year
ended December 31, 2015.
Nonqualified Deferred Compensation
No nonqualified deferred compensation was offered or issued to
any named executive officer during the fiscal year ended December 31, 2015.
Potential Payments upon Termination or Change in Control
Our named executive officers are not entitled to severance
payments or other benefit upon the termination of their employment agreements or
following a change in control.
Compensation of Directors
The following table sets forth the total director compensation
earned by our directors during our fiscal year ended December 31, 2015:
Name |
Fees earned
or paid in cash ($) |
Stock
awards ($) |
Option
awards ($) |
All other
compensation ($) |
Total ($)
|
Dr. Christopher Leatt |
37,500 |
- |
- |
- |
37,500 |
Jeffrey J. Guzy |
4,507 |
- |
246 |
- |
4,753 |
Sean Macdonald |
4,507 |
- |
- |
- |
4,507 |
Narrative to Director Compensation Table
During the 2015 fiscal year, we paid our directors
approximately ZAR 5,000 (approximately, $375) per month compensation for their
services as our directors. In the future, we may adopt a policy of paying
independent directors a fee for their attendance at board and committee
meetings. We also reimburse our directors for reasonable travel expenses related
to their duties as our directors.
- 57 -
On February 14, 2014, the Board of Directors of the Company
approved the grant to Jeff Guzy, one of the Companys Directors, of a 5-year
option to purchase an aggregate of 15,000 shares of the Companys common stock
at $1.00 per share under the Companys 2011 Plan. The option to purchase an
aggregate of 6,000 of the shares vested on February 14, 2014, the grant date and
option to purchase 6,000 shares vested in equal portions on February 14, 2015
and 2016, respectively. The remaining 3,000 shares will vest on February 14,
2017.
On July 8, 2015, the Company has entered into a Director
Agreement with Board Chairman, Dr. Christopher Leatt, pursuant to which, in
addition to his duties with the Company's Research and Development department,
Dr. Leatt agreed to devote as much time as is necessary to perform the duties of
a director of the Company, including duties as a member of any committees that
he may be appointed to by the Board of Directors, including but not limited to
assisting the Company with the development of business and new business
strategies relating to the objectives of the Company, participation in the
Companys investor relations activities, including road shows and shareholder
communication activities, and participation in corporate strategy decisions of
the Company. Dr. Leatt will receive a base fee of $5,000 per month as
compensation for his services, and the Company has agreed to indemnify him to
the full extent allowed by law except where such indemnification is prohibited
due to intentional misconduct, fraud or knowing violation of law. Either party
may terminate the Director Agreement at any time upon six months' written notice
unless he resigns from his position or is removed by shareholders of the Company
prior to such termination.
Effective January 1, 2016, the Company increased the
compensation amount given to each of Mr. Jeff Guzy and Mr. Sean Macdonald for
their services as directors of the Company to $650 per month.
Limitation of Liability and Indemnification
Section 78.138 of the NRS provides that a director or officer
will not be individually liable unless it is proven that (i) the director's or
officer's acts or omissions constituted a breach of his or her fiduciary duties,
and (ii) such breach involved intentional misconduct, fraud or a knowing
violation of the law.
Section 78.7502 of NRS permits a company to indemnify its
directors and officers against expenses, judgments, fines and amounts paid in
settlement actually and reasonably incurred in connection with a threatened,
pending or completed action, suit or proceeding if the officer or director (i)
is not liable pursuant to NRS 78.138 or (ii) acted in good faith and in a manner
the officer or director reasonably believed to be in or not opposed to the best
interests of the corporation and, if a criminal action or proceeding, had no
reasonable cause to believe the conduct of the officer or director was unlawful.
Section 78.751 of NRS permits a Nevada company to indemnify its
officers and directors against expenses incurred by them in defending a civil or
criminal action, suit or proceeding as they are incurred and in advance of final
disposition thereof, upon receipt of an undertaking by or on behalf of the
officer or director to repay the amount if it is ultimately determined by a
court of competent jurisdiction that such officer or director is not entitled to
be indemnified by the company. Section 78.751 of NRS further permits the company
to grant its directors and officers additional rights of indemnification under
its articles of incorporation or bylaws or otherwise.
Section 78.752 of NRS provides that a Nevada company may
purchase and maintain insurance or make other financial arrangements on behalf
of any person who is or was a director, officer, employee or agent of the
company, or is or was serving at the request of the company as a director,
officer, employee or agent of another company, partnership, joint venture, trust
or other enterprise, for any liability asserted against him and liability and
expenses incurred by him in his capacity as a director, officer, employee or
agent, or arising out of his status as such, whether or not the company has the
authority to indemnify him against such liability and expenses.
Our Articles of Incorporation provide that no director or
officer of the Company will be personally liable to the Company or any of its
stockholders for damages for breach of fiduciary duty as a director or officer;
provided, however, that the foregoing provision shall not eliminate or limit the
liability of a director or officer (i) for acts or omissions which involve
intentional misconduct, fraud or knowing violation of law, or (ii) the payment
of dividends in violation of Section 78.300 of NRS. In addition, our Bylaws
implement the indemnification and insurance provisions permitted by Chapter 78
of the NRS by providing that:
|
|
The Company shall indemnify its directors to the fullest
extent permitted by the NRS and may, if and to the extent authorized by
the board of directors, so indemnify its officers and any other person
whom it has the power to indemnify against liability, reasonable expense
or other matter whatsoever. |
|
|
|
|
|
The Company may at the discretion of the board of
directors purchase and maintain insurance on behalf of any person who
holds or who has held any position identified in the paragraph above
against any and all liability incurred by such person in any such position
or arising out of his status as such. |
- 58 -
Insofar as indemnification by us for liabilities arising under
the Securities Act may be permitted to our directors, officers or persons
controlling the company pursuant to provisions of our articles of incorporation
and bylaws, or otherwise, we have been advised that in the opinion of the SEC,
such indemnification is against public policy as expressed in the Securities Act
and is therefore unenforceable. In the event that a claim for indemnification by
such director, officer or controlling person of us in the successful defense of
any action, suit or proceeding is asserted by such director, officer or
controlling person in connection with the securities being offered, we will,
unless in the opinion of our counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by us is against public policy as expressed in the
Securities Act and will be governed by the final adjudication of such issue.
Other than as disclosed herein, there is no pending litigation
or proceeding involving any of our directors or executive officers to which
indemnification is required or permitted, and we are not aware of any threatened
litigation or proceeding that may result in a claim for indemnification.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
Security Ownership of Certain Beneficial Owners and
Management
The following table sets forth, as of March 7, 2016, the stock
ownership of (i) each of our executive officers and directors, (i) of all our
executive officers and directors as a group, and (iii) of each person known by
us to be a beneficial owner of 5% or more of our common stock. Except as
otherwise noted, each person listed below is the sole beneficial owner of the
shares and has sole investment and voting power of such shares. No person listed
below has any option, warrant or other right to acquire additional securities of
the Company, except as may be otherwise noted. Unless otherwise specified, the
address of each of the persons set forth below is in care of Leatt Corporation,
50 Kiepersol Drive, Atlas Gardens, Contermanskloof Road, Durbanville, Western
Cape, South Africa, 7441.
Title of Class |
Name &
Address of Beneficial Owner |
Office, If Any |
Amount and
Nature of Beneficial
Ownership(2) |
Percent of
Class (3) |
Common Stock, $0.001 par
value |
Class A Voting
Convertible Preferred Stock, $0.001 par
value(1) |
Officers and Directors |
|
|
|
|
|
X |
- |
Dr. Christopher J. Leatt (4) |
Founder, Innovation Officer and |
2,045,903 |
39.34% |
- |
X |
|
Chairman |
96,000 |
80.00% |
X |
- |
Jeffrey J. Guzy(5) |
Director |
35,667 |
0.69% |
- |
- |
Sean Macdonald(6) |
Chief Executive Officer, President and
Director |
78,000 |
1.50% |
X |
- |
All officers and
directors as a group (persons named
above) |
|
2,159,570 |
41.53% |
- |
X |
96,000 |
80.00% |
5% Shareholders |
X |
- |
Jean-Pierre De Villiers |
Advisor
|
488,317 |
9.39% |
- |
X |
24,000 |
20.00% |
X |
|
Alfred Bjorn Christensen |
|
460,800 |
8.86% |
(1) |
The Preferred Stock votes with the Common Stock at a vote
of 100-for-one, subject to adjustments resulting from any future stock
splits. The Preferred Stock has priority over the Common Stock in any
liquidation preferences but no dividend rights (except as may be declared
by the Board). The Common Stock has dividend rights in respect of any
dividend distributions when and if declared and paid by the Company. The
Common Stock has a claim to any liquidation distribution, subject to the
priority claim of the Preferred Stock. No dividends have been paid to date
on any securities. There are no other classes of
equity securities authorized and issued. |
- 59 -
(2) |
Beneficial Ownership is determined in accordance with the
rules of the U.S. Securities and Exchange Commission or SEC and
generally includes voting or investment power with respect to securities.
Each of the beneficial owners listed above has direct ownership of and
sole voting power and investment power with respect to the shares of our
common stock. |
|
|
(3) |
As of the date of this report and after giving effect to
the Companys 1-for-25 reverse stock split effected on September 20, 2012
(the Reverse Split), the Company has 28,000,000 shares of common stock
authorized with 5,231,823 shares issued and outstanding, and 1,120,000
shares of Preferred Stock authorized with 120,000 shares issued and
outstanding. For each Beneficial Owner above, any options exercisable
within 60 days have been included in the denominator. |
|
|
(4) |
Includes a vested 5-year option to purchase 52,000 shares
of the Companys common stock at $1.00 per share, issued to Dr. Leatt
under the Companys 2011 Plan after giving effect to the Reverse
Split. |
|
|
(5) |
Includes a vested 5-year option to purchase 9,000 shares
of the Companys common stock at $1.00 per share, issued to Mr. Guzy under
the Companys 2011 Plan. An additional 6,000 shares are slated to vest in
two equal parts on February 14, 2016 and 2017. |
|
|
(6) |
Represents a vested 5-year option to purchase 78,000
shares of the Companys common stock at $1.00 per share, issued to Mr.
Macdonald under the Companys 2011 Plan after giving effect to the Reverse
Split. |
Changes in Control
We do not currently have any arrangements which if consummated
may result in a change of control of our Company.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND
DIRECTOR INDEPENDENCE.
Transactions with Related Persons
The following includes a summary of transactions since the
beginning of the last fiscal year, or any currently proposed transaction, in
which we were or are to be a participant and the amount involved exceeded or
exceeds $120,000, and in which any related person had or will have a direct or
indirect material interest (other than compensation described under Executive
Compensation). We believe the terms obtained or consideration that we paid or
received, as applicable, in connection with the transactions described below
were comparable to terms available or the amounts that would be paid or
received, as applicable, in arms-length transactions.
On March 1, 2006, we entered into a Licensing Agreement with
Xceed Holdings (formerly, Leatt Brace Holdings), a South African company that is
controlled by Dr. Leatt, the Companys Chairman, and by Mr. De Villiers until
his resignation on August 29, 2006. Under the terms of the Licensing Agreement,
we are obligated to pay Xceed Holdings 4% of all sales revenue billed and
received by us, on a quarterly basis based on sales of the previous quarter. In
addition, pursuant to a separate license agreement between us and Mr. De
Villiers, we are obligated to pay a royalty fee of 1% of all our billed and
received sales revenue, in quarterly installments, based on sales of the
previous quarter, to a trust that is beneficially owned and controlled by Mr. De
Villiers. Royalties totaled $480,689 and $465,316 for the years ended December
31, 2015 and 2014, respectively.
In July 2015, the Company entered into a consulting agreement
with Innovate Services Limited, a Seychelles limited company in which, Dr.
Christopher Leatt, the Companys founder and chairman, is an indirect
beneficiary. Pursuant to the terms of the Consulting Agreement, Innovate has
agreed to serve as the Companys exclusive research, development and marketing
consultant in exchange for a monthly fee of $35,639; provided that Dr. Leatt
personally performs the services to be performed by Innovate under the
Agreement, pursuant to a separate employment agreement between Innovate and Dr.
Leatt. The parties further agreed that all intellectual property generated in
connection with the Services provided under the Consulting Agreement will be the
sole property of the Company. The Consulting Agreement is effective as of May
15, 2015, and will continue unless terminated by either party in accordance with
its terms. Either party has the right to terminate the Consulting Agreement upon
6 months' prior written notice, except that the Consulting Agreement may be
terminated immediately without notice if the Services to performed under the
Consulting Agreement cease to be performed by Dr. Leatt or for any other
material breach of the Agreement by any of the parties. The parties have agreed
to settle any dispute under the Consulting Agreement through arbitration in
accordance with the Commercial Arbitration Rules of the American Arbitration
Association (AAA), and that the resulting arbitration award will be final and
binding on both parties and will not be subject to any appeal.
Simultaneously with the closing of the Consulting Agreement,
the Company also entered into a Side Letter Agreement, dated July 8, 2015, with
Dr. Leatt, pursuant to which the parties agreed to terminate Dr. Leatts
existing employment agreement, dated as of May 15, 2015, with the Company in its
entirety, in lieu of Dr. Leatt undertaking to perform the services under the
Consulting Agreement.
- 60 -
Under the terms of the Side Letter, Dr. Leatt also agreed,
among other things: (1) not to perform services similar to the services provided
under the Consulting Agreement for any current or future, direct or indirect
competitor of the Company or any similar company; (2) not to solicit any current
or future employees of the Company for employment with Innovate or any other
entity with which he may become affiliated, or to contact or solicit any current
or future stockholder or investor of the Company in connection with any matter
that is not directly related to the ongoing or future business operations of the
Company; and (3) that he will apprise the Company of any business opportunity
that he becomes aware of that could benefit the Company so that the Company, can
in its sole discretion, make a determination regarding whether to pursue such
opportunity in the best interest of the Company and its stockholders. Dr. Leatt
further agreed to continue dedicating a majority of his time on matters related
to performance of his duties as a director of the Company and to the fulfillment
of his obligations to the Companys research and development efforts under the
Consulting Agreement, and the Company will have the right to adjust the amount
of the fees payable under the Consulting Agreement to the extent of any
substantial diminution in his fulfillment of such duties and obligations.
Except as set forth in our discussion above, none of our
directors, director nominees or executive officers has been involved in any
transactions with us or any of our directors, executive officers, affiliates or
associates which are required to be disclosed pursuant to the rules and
regulations of the SEC.
Policies and Procedures for Review, Approval or Ratification
of Transactions with Related Persons
As we increase the size of our board of directors to include
additional independent directors, we expect to prepare and adopt a written
related-person transactions policy that sets forth our policies and procedures
regarding the identification, review, consideration and approval or ratification
of related-persons transactions. For purposes of our policy only, a
related-person transaction will be a transaction, arrangement or relationship
(or any series of similar transactions, arrangements or relationships) in which
we and any related person are participants involving an amount that exceeds
$120,000. Transactions involving compensation for services provided to us as an
employee, director, consultant or similar capacity by a related person will not
be covered by this policy. A related person will be any executive officer,
director or a holder of more than five percent of our common stock, including
any of their immediate family members and any entity owned or controlled by such
persons.
We anticipate that, where a transaction has been identified as
a related-person transaction, the policy will require management to present
information regarding the proposed related-person transaction to our audit
committee (or, where approval by our audit committee would be inappropriate, to
another independent body of our board of directors) for consideration and
approval or ratification. Managements presentation will be expected to include
a description of, among other things, the material facts, the direct and
indirect interests of the related persons, the benefits of the transaction to us
and whether any alternative transactions are available.
To identify related-person transactions in advance, we are
expected to rely on information supplied by our executive officers, directors
and certain significant stockholders. In considering related-person
transactions, our board of directors will take into account the relevant
available facts and circumstances including, but not limited to:
|
|
the risks, costs and benefits to us; |
|
|
the impact on a directors independence in the
event the related person is a director, immediate family member of a
director or an entity with which a director is affiliated; |
|
|
the terms of the transaction; |
|
|
the availability of other sources for
comparable services or products; and |
|
|
the terms available to or from, as the case may
be, unrelated third parties or to or from our employees generally.
|
We also expect that the policy will require any interested
director to excuse himself from deliberations and approval of the transaction in
which the interested director is involved.
Promoters and Certain Control Persons
We did not have any promoters at any time during the past five
fiscal years.
Director Independence
Our Board of Directors has determined that our director, Mr.
Jeffery Guzy, is an independent director, as the term independent is defined
by the rules of the Nasdaq Stock Market.
- 61 -
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.
Independent Auditors Fees
The following is a summary of the fees billed to the Company
for professional services rendered for the fiscal years ended December 31, 2015
and 2014:
|
|
Year Ended December 31, |
|
|
|
2015 |
|
|
2014 |
|
Audit Fees |
$ |
96,000 |
|
$ |
96,000 |
|
Audit-Related Fees |
|
12,000 |
|
|
11,714 |
|
Tax Fees |
|
15,950 |
|
|
8,411 |
|
All Other Fees |
|
- |
|
|
- |
|
TOTAL |
$ |
123,950 |
|
$ |
116,125 |
|
Audit Fees consisted of fees billed for professional services
rendered by the principal accountant for the audit of our annual financial
statements and review of the financial statements included in our Form 10-K and
10-Qs or services that are normally provided by the accountant in connection
with statutory and regulatory filings or engagements.
Audit-Related Fees consisted of fees billed for assurance and
related services by the principal accountant that were reasonably related to the
performance of the audit or review of our financial statements and are not
reported under the paragraph captioned Audit Fees above.
Tax Fees consisted of fees billed for professional services
rendered by the principal accountant for tax returns preparation.
All Other Fees consisted of fees billed for products and
services provided by the principal accountant, other than the services reported
above under other captions of this Item 14.
Pre-Approval Policies and Procedures
Under the Sarbanes-Oxley Act of 2002, all audit and non-audit
services performed by our auditors must be approved in advance by our board of
directors to assure that such services do not impair the auditors independence
from us. In accordance with its policies and procedures, our board of directors
pre-approved the audit and non-audit services performed by Fitzgerald & Co,
CPAs, P.C. for our financial statements as of and for the year ended December
31, 2015.
PART IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.
Financial Statements and Schedules
The financial statements are set forth under Item 8 of this
annual report on Form 10-K. Financial statement schedules have been omitted
since they are either not required, not applicable, or the information is
otherwise included.
Exhibit List
The list of exhibits included in the attached Exhibit Index is
hereby incorporated herein by reference.
Exhibit |
Exhibit Title |
Number |
|
2.1 |
Settlement Agreement, dated as of September 25, 2008,
between Leatt Corp., Christopher J. Leatt and J. P. De Villiers
(incorporated by reference to Exhibit 2.1 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
2.2 |
Amendment No. 1 to Settlement Agreement, dated February
4, 2010, between Leatt Corp., Christopher J. Leatt and Jean-
Pierre DeVilliers (incorporated by reference to Exhibit
2.2 to the Companys registration statement on Form 10-12G, filed on
October 9, 2012) |
- 62 -
3.1 |
Amended and Restated Articles of Incorporation, as filed
with the Secretary of State of Nevada on October 28, 2008 (incorporated by
reference to Exhibit 3.1 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
3.2 |
Amended and Restated Bylaws, adopted on October 28, 2008
(incorporated by reference to Exhibit 3.2 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
4.1 |
Certificate of Designation of Series A Voting Convertible
Preferred Stock, as filed with the Secretary of State of Nevada on October
29, 2008 (incorporated by reference to Exhibit 4.1 to the Companys
registration statement on Form 10-12G, filed on October 9, 2012)
|
4.2 |
Leatt Corp. 2011 Equity Incentive Plan (incorporated by
reference to Exhibit 4.5 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
4.3 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Dr. Christopher Leatt (incorporated by reference to
Exhibit 4.6 to the Companys registration statement on Form 10-12G, filed
on October 9, 2012) |
4.4 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Sean Macdonald (incorporated by reference to Exhibit 4.7
to the Companys registration statement on Form 10-12G, filed on October
9, 2012) |
4.5 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Philip Davy (incorporated by reference to Exhibit 4.8 to
the Companys registration statement on Form 10-12G, filed on October 9,
2012) |
4.6 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Erik Olsson (incorporated by reference to Exhibit 4.9 to
the Companys registration statement on Form 10-12G, filed on October 9,
2012) |
4.7 |
Stock Option Agreement, dated February 14, 2014, between
Leatt Corp. and Jeffrey Guzy (incorporated by reference to Exhibit 4.10 to
the Companys annual report on Form 10-K, filed on March 19, 2014)
|
10.1 |
Patent and Royalty License Agreement, dated March 1,
2006, between Leatt Corp., Xceed Holdings (Pty) Ltd. (formerly, Leatt
Brace Holdings (Pty) Ltd.) and J. P. De Villiers Trust (incorporated by
reference to Exhibit 10.1 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
10.2 |
Amendment to Patent and Royalty License Agreement, dated
as of March 1, 2006, between Leatt Corp. and Xceed Holdings (Pty) Ltd.
(formerly, Leatt Brace Holdings (Pty) Ltd.) (incorporated by reference to
Exhibit 10.2 to the Companys registration statement on Form 10-12G, filed
on October 9, 2012) |
10.3 |
Patent Assignment Agreement, dated January 1, 2009,
between Xceed Holdings (Pty) Ltd. and Three Eleven Distribution (Pty) Ltd.
(incorporated by reference to Exhibit 10.3 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
10.4 |
Software License Agreement, dated July 2, 2010, between
Leatt Corp., Esteq Design (Pty) Ltd. and Siemens Industry Software Ltd.
(incorporated by reference to Exhibit 10.4 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
10.5 |
Copyright Licensing Agreement, dated January 31, 2013,
between Silva Mattos & CIA, LTDA and Leatt Corp. (incorporated by
reference to Exhibit 10.5 to the Companys annual report on Form 10-K,
filed on March 19, 2014) |
10.6 |
End User Licensing Agreement, dated June 30, 2011,
between Bluekey Software Solutions and Leatt Corp. (incorporated by
reference to Exhibit 10.6 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
10.7* |
Lease Agreement, dated September 11, 2012, between Two
Eleven Distribution LLC and Center Pointe Properties, LLC as amended.
|
10.8 |
Lease Agreement, dated December 12, 2014, between Leatt
Corp. and AJ Brutus Investments cc. (incorporated by reference to Exhibit
10.8 to the Companys annual report on Form 10-K, filed on March 26, 2015)
|
10.9 |
Storage Rental Agreement, dated December 1, 2014, between
The Storage Spot and Leatt Corp. (incorporated by reference to
Exhibit 10.9 to the Companys annual report on Form 10-K, filed on March
26, 2015) |
10.10 |
Leatt Distributor Form Business Terms, dated February 10,
2010 (incorporated by reference to Exhibit 10.11 to the Companys
registration statement on Form 10-12G, filed on October 9, 2012)
|
10.11 |
Storage Rental Agreement 2, dated January 1, 2012,
between The Storage Spot and Leatt Corp. (incorporated by reference to
Exhibit 10.11 to the Companys annual report on Form 10-K, filed on March
26, 2015) |
10.12* |
Premium Finance Agreement, dated May 27, 2015, between
AFCO Acceptance Corp. and Leatt Corp. |
10.13* |
Employment Agreement, dated January 1, 2014, between
Leatt Corp. and Sean Macdonald (as amended) |
10.14* |
Premium Finance Agreement, dated October 19, 2015,
between AFCO Acceptance Corp and Leatt Corp. |
10.15 |
Service Level Agreement, dated April 24, 2013, between
MikroTik SA and Leatt Corp. (incorporated by reference to Exhibit 10.17 to
the Companys annual report on Form 10-K, filed on March 19, 2014)
|
10.16* |
Storage Rental Agreement 3, dated October 4, 2015,
between The Storage Spot and Leatt Corp. |
10.17 |
Consulting Agreement, dated July 8, 2015, between
Innovate Services Limited and Leatt Corporation (incorporated by reference
to Exhibit 10.1 to the Companys current report on Form 8-K, filed on July
8, 2015) |
10.18 |
Employment Agreement, dated July 8, 2015, between
Innovate Services Limited and Dr. Christopher Leatt (incorporated by
reference to Exhibit 10.2 to the Companys current report on Form 8-K,
filed on July 8, 2015) |
10.19 |
Side Letter Agreement, dated July 8, 2015, between Leatt
Corporation and Dr. Christopher Leatt (incorporated by reference to
Exhibit 10.3 to the Companys current report on Form 8-K, filed on July 8,
2015) |
- 63 -
_______________________
* |
Filed herewith |
|
|
** |
Pursuant to Rule 405 of Regulation S-T, the following
financial information from the Companys Annual Report on Form 10-K for
the period ended December 31, 2015, is formatted in XBRL interactive data
files: (i) Consolidated Balance Sheets at December 31, 2015 and 2014; (ii)
Consolidated Statements of Operations and Comprehensive Income (Loss) for
the years ended December 31, 2015 and 2014; (iii) Consolidated Statements
of Changes in Shareholders Equity as of and for the years ended December
31, 2015 and 2014; (iv) Consolidated Statements of Cash Flows for the
years ended December 31, 2015 and 2014; and (vi) Notes to Consolidated
Financial Statements. Pursuant to Rule 406T of Regulation S-T, these
interactive data files are deemed not filed or part of a registration
statement or prospectus for purposes of Sections 11 or 12 of the
Securities Act of 1933, as amended, or for purposes of Section 18 of the
Securities Act of 1934, as amended, and otherwise are not subject to
liability under those sections. |
- 64 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: March 18, 2016
LEATT CORPORATION
By:
/s/ Sean Macdonald
Sean Macdonald, Chief Executive
Officer and
Chief Financial Officer
(Principal Executive Officer and
Principal Financial and Accounting Officer)
In accordance with the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/ Sean Macdonald
|
|
Chief Executive Officer, Chief |
|
March 18, 2016 |
Sean Macdonald |
|
Financial Officer and Director |
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/ Dr.
Christopher J. Leatt |
|
Chairman |
|
March 18, 2016 |
Dr. Christopher J. Leatt |
|
|
|
|
|
|
|
|
|
/s/ Jeffrey J.
Guzy |
|
Director |
|
March 18, 2016 |
Jeffrey J. Guzy |
|
|
|
|
- 65 -
LEATT CORPORATION
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2015 AND 2014
LEATT CORPORATION
CONSOLIDATED FINANCIAL
STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2015 AND 2014
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders
Leatt
Corporation
We have audited the accompanying consolidated balance sheets of
LEATT CORPORATION as of December 31, 2015 and 2014 and the related
consolidated statements of operations and comprehensive income, changes in
stockholders equity, and cash flows for each of the years in the
two-year period ended December 31, 2015. LEATT CORPORATIONs
management is responsible for these consolidated financial statements. Our
responsibility is to express an opinion on these consolidated financial
statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. The company
is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. Our audit included consideration of
internal control over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the companys internal control
over financial reporting. Accordingly, we express no such opinion. An audit also
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred
to above present fairly, in all material respects, the financial position of
LEATT CORPORATION as of December 31, 2015 and 2014, and the results of
its operations and its cash flows for each of the years in the two-year period
ended December 31, 2015, in conformity with accounting principles generally
accepted in the United States of America.
Vienna, Virginia
March 18, 2016
F-2
LEATT CORPORATION
CONSOLIDATED BALANCE SHEETS
DECEMBER
31, 2015 AND 2014
ASSETS |
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
2014 |
|
Current Assets |
|
|
|
|
|
|
Cash and cash
equivalents |
$ |
1,054,750
|
|
$ |
724,707
|
|
Short-term investments
|
|
58,172 |
|
|
58,153 |
|
Accounts receivable |
|
2,901,699 |
|
|
4,239,298 |
|
Inventory |
|
4,241,140 |
|
|
3,403,854 |
|
Payments in advance |
|
208,030 |
|
|
345,406 |
|
Income tax refunds
receivable |
|
- |
|
|
25,299 |
|
Deferred tax asset |
|
115,000 |
|
|
108,000 |
|
Prepaid expenses and
other current assets |
|
1,070,774 |
|
|
994,003 |
|
Total current
assets |
|
9,649,565 |
|
|
9,898,720 |
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
1,313,325 |
|
|
995,537 |
|
|
|
|
|
|
|
|
Other Assets |
|
|
|
|
|
|
Other receivables |
|
90,000 |
|
|
210,000 |
|
Deposits |
|
16,493 |
|
|
17,980 |
|
Intangible assets |
|
61,273 |
|
|
81,323 |
|
Total other
assets |
|
167,766 |
|
|
309,303 |
|
|
|
|
|
|
|
|
Total Assets |
$ |
11,130,656 |
|
$ |
11,203,560 |
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
Accounts payable
and accrued expenses |
$ |
2,560,980
|
|
$ |
2,980,885
|
|
Income taxes
payable |
|
384,950 |
|
|
331,000 |
|
Short term loan,
net of finance charges |
|
658,639 |
|
|
626,129 |
|
Total current liabilities |
|
3,604,569 |
|
|
3,938,014 |
|
|
|
|
|
|
|
|
Deferred tax liabilities |
|
73,000 |
|
|
88,468 |
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity |
|
|
|
|
|
|
Preferred
stock, $.001 par value, 1,120,000
shares authorized, 120,000 shares issued
and outstanding |
|
3,000 |
|
|
3,000 |
|
Common
stock, $.001 par value, 28,000,000
shares authorized, 5,231,823 and
5,200,623 shares issued and outstanding |
|
130,040 |
|
|
130,008 |
|
Additional paid
- in capital |
|
7,346,782 |
|
|
7,314,136 |
|
Accumulated
other comprehensive loss |
|
(710,032 |
) |
|
(378,431 |
) |
Retained
earnings |
|
683,297 |
|
|
108,365 |
|
Total stockholders' equity |
|
7,453,087 |
|
|
7,177,078 |
|
|
|
|
|
|
|
|
Total Liabilities and
Stockholders' Equity |
$ |
11,130,656 |
|
$ |
11,203,560 |
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-3
LEATT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME
FOR THE YEARS ENDED DECEMBER 31, 2015 AND 2014
|
|
2015 |
|
|
2014 |
|
|
|
|
|
|
|
|
Revenues |
$ |
18,343,172
|
|
$ |
18,458,928
|
|
|
|
|
|
|
|
|
Cost of Revenues |
|
8,741,131 |
|
|
8,636,546 |
|
|
|
|
|
|
|
|
Gross Profit |
|
9,602,041 |
|
|
9,822,382 |
|
|
|
|
|
|
|
|
Product Royalty Income |
|
182,485 |
|
|
190,961 |
|
|
|
|
|
|
|
|
Operating Expenses |
|
|
|
|
|
|
Salaries and wages |
|
2,225,646 |
|
|
2,302,115 |
|
Commissions and
consulting expenses |
|
570,937 |
|
|
581,601 |
|
Professional fees |
|
845,575 |
|
|
1,117,887 |
|
Advertising and
marketing |
|
1,498,307 |
|
|
1,442,450 |
|
Office rent and expenses |
|
246,616 |
|
|
244,510 |
|
Research and
development costs |
|
1,180,227 |
|
|
1,222,209 |
|
Bad debt expense |
|
124,213 |
|
|
75,285 |
|
General and
administrative expenses |
|
1,793,698 |
|
|
2,081,339 |
|
Depreciation |
|
371,089 |
|
|
304,690 |
|
Total operating expenses |
|
8,856,308 |
|
|
9,372,086 |
|
|
|
|
|
|
|
|
Income from Operations |
|
928,218 |
|
|
641,257 |
|
|
|
|
|
|
|
|
Other Income |
|
|
|
|
|
|
Interest and other income, net |
|
32,304 |
|
|
10,854 |
|
Total
other income |
|
32,304 |
|
|
10,854 |
|
|
|
|
|
|
|
|
Income Before Income Taxes
|
|
960,522 |
|
|
652,111 |
|
|
|
|
|
|
|
|
Income Taxes |
|
385,590 |
|
|
233,760 |
|
|
|
|
|
|
|
|
Net Income Available to
Common Shareholders |
$ |
574,932 |
|
$ |
418,351 |
|
|
|
|
|
|
|
|
Net Income per Common Share
|
|
|
|
|
|
|
Basic |
$ |
0.11 |
|
$ |
0.08 |
|
Diluted |
$ |
0.10 |
|
$ |
0.08 |
|
|
|
|
|
|
|
|
Weighted Average Number of
Common Shares Outstanding |
|
|
|
|
|
|
Basic |
|
5,216,483 |
|
|
5,200,623 |
|
Diluted |
|
5,537,476 |
|
|
5,200,623 |
|
|
|
|
|
|
|
|
Comprehensive Income |
|
|
|
|
|
|
Net Income |
$ |
574,932 |
|
$ |
418,351 |
|
Other
comprehensive loss, net of $43,100 and $148,000 deferred income taxes in
2015 and 2014 |
|
|
|
|
|
|
Foreign currency
translation |
|
(331,601 |
) |
|
(266,567 |
) |
|
|
|
|
|
|
|
Total
Comprehensive Income |
$ |
243,331 |
|
$ |
151,784 |
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-4
LEATT CORPORATION
CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS' EQUITY
AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2015 AND
2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
Preferred Stock A |
|
|
Common Stock |
|
|
Additional |
|
|
Comprensive |
|
|
Retained |
|
|
|
|
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Paid - In Capital |
|
|
Income (Loss) |
|
|
Earnings |
|
|
Total |
|
Balance, January 1, 2014 |
|
120,000 |
|
$ |
3,000 |
|
|
5,200,623 |
|
$ |
130,008 |
|
$ |
7,307,515
|
|
$ |
(111,864 |
) |
$ |
(309,986 |
) |
$ |
7,018,673
|
|
Compensation cost recognized in connection
with stock options |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
6,621 |
|
|
- |
|
|
- |
|
|
6,621 |
|
Net income |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
418,351 |
|
|
418,351 |
|
Foreign currency translation adjustment |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(266,567 |
) |
|
- |
|
|
(266,567 |
) |
Balance, December 31, 2014
|
|
120,000 |
|
$ |
3,000 |
|
|
5,200,623 |
|
$ |
130,008 |
|
$ |
7,314,136
|
|
$ |
(378,431 |
) |
$ |
108,365 |
|
$ |
7,177,078
|
|
Compensation cost recognized in connection
with stock options |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1,478 |
|
|
- |
|
|
- |
|
|
1,478 |
|
Exercise of stock options |
|
- |
|
|
- |
|
|
31,200 |
|
|
32 |
|
|
31,168 |
|
|
- |
|
|
- |
|
|
31,200 |
|
Net income |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
574,932 |
|
|
574,932 |
|
Foreign currency translation
adjustment |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(331,601 |
) |
|
- |
|
|
(331,601 |
) |
Balance, December 31, 2015 |
|
120,000 |
|
$ |
3,000 |
|
|
5,231,823 |
|
$ |
130,040 |
|
$ |
7,346,782 |
|
$ |
(710,032 |
) |
$ |
683,297 |
|
$ |
7,453,087 |
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-5
FOR THE YEARS ENDED DECEMBER 31, 2015 AND 2014
LEATT
CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
2015 |
|
|
2014 |
|
|
|
|
|
|
|
|
Cash flows from operating
activities |
|
|
|
|
|
|
Net income |
$ |
574,932 |
|
$ |
418,351 |
|
Adjustments to
reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
Depreciation |
|
371,089 |
|
|
304,690 |
|
Deferred
income taxes |
|
(22,468 |
) |
|
49,788 |
|
Stock-based compensation
|
|
1,478 |
|
|
6,621 |
|
Bad debts
|
|
28,258 |
|
|
44,373 |
|
Inventory reserve |
|
(1,078 |
) |
|
29,938 |
|
Gain on
sale of property and equipment |
|
(27,101 |
) |
|
(4,291 |
) |
(Increase) decrease in: |
|
|
|
|
|
|
Accounts receivable |
|
1,309,341 |
|
|
(1,144,398 |
) |
Inventory |
|
(836,208 |
) |
|
(174,518 |
) |
Payments in advance |
|
137,376 |
|
|
(201,104 |
) |
Prepaid expenses
and other current assets |
|
(76,771 |
) |
|
98,447 |
|
Income tax refunds receivable |
|
25,299 |
|
|
(25,000 |
) |
Other receivables
|
|
120,000 |
|
|
120,000 |
|
Deposits |
|
1,487 |
|
|
1,489 |
|
Increase (decrease) in: |
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
(419,905 |
) |
|
904,076 |
|
Income taxes
payable |
|
53,950 |
|
|
331,000 |
|
Net cash provided by operating activities |
|
1,239,679 |
|
|
759,462 |
|
|
|
|
|
|
|
|
Cash flows from investing
activities |
|
|
|
|
|
|
Capital expenditures |
|
(813,912 |
) |
|
(463,105 |
) |
Proceeds from
sale of property and equipment |
|
33,367 |
|
|
6,699 |
|
Increase in short-term
investments, net |
|
(19 |
) |
|
(23 |
) |
Net cash used in
investing activities |
|
(780,564 |
) |
|
(456,429 |
) |
|
|
|
|
|
|
|
Cash flows from financing
activities |
|
|
|
|
|
|
Issuance of common stock |
|
31,200 |
|
|
- |
|
Proceeds from
(repayments of ) short-term loan, net |
|
32,510 |
|
|
(207,606 |
) |
Net
cash provided by (used in) financing activities |
|
63,710 |
|
|
(207,606 |
) |
|
|
|
|
|
|
|
Effect of exchange rates on cash and cash
equivalents |
|
(192,782 |
) |
|
(205,732 |
) |
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash
equivalents |
|
330,043 |
|
|
(110,305 |
) |
|
|
|
|
|
|
|
Cash and cash equivalents - beginning of year
|
|
724,707 |
|
|
835,012 |
|
|
|
|
|
|
|
|
Cash and cash equivalents - end of year |
$ |
1,054,750 |
|
$ |
724,707 |
|
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION: |
|
|
|
|
|
|
Cash paid for interest
|
$ |
11,645 |
|
$ |
14,095 |
|
Cash paid for income taxes |
$ |
395,672 |
|
$ |
440 |
|
|
|
|
|
|
|
|
Other noncash investing and financing
activities |
|
|
|
|
|
|
Common stock
issued for services |
$ |
1,478 |
|
$ |
6,621 |
|
The accompanying notes are an integral part of these
consolidated financial statements.
F-6
NOTE 1 - |
DESCRIPTION OF BUSINESS AND NATURE OF
OPERATIONS |
Leatt Corporation (the Company)
designs, develops, markets and distributes personal protective equipment for
participants in all forms of motor sports and leisure activities, including
riders of motorcycles, bicycles, snowmobiles and ATVs. The Companys flagship
products are based on the Leatt-Brace® system, a patented injection molded neck
protection system owned by Xceed Holdings CC (Holdings), designed to prevent
potentially devastating injuries to the cervical spine and neck. The Company has
the exclusive global manufacturing, distribution, sale and use rights to the
Leatt-Brace®, pursuant to a license agreement between the Company and Holdings,
a South African incorporated company owned and controlled by the Companys
Chairman and founder, Dr. Christopher Leatt. The Company also has the right to
use apparatus embodying, employing and containing the Leatt-Brace® technology
and has designed, developed, marketed and distributed other personal protective
equipment.
The Companys products are
manufactured in China and sold to customers worldwide through a global network
of distributors and dealers. Leatt also acts as the original equipment
manufacturer for neck braces and other personal protective equipment sold by
other international brands.
The Company was incorporated in the
State of Nevada on March 11, 2005, under the name Treadzone, Inc. On June 17,
2005, the Company changed its name to Leatt Corporation in connection with the
Companys acquisition of rights to use the Leatt neck brace patents and
trademarks. The Company conducts business in South Africa as a foreign
registered branch, and in the United States through the Companys wholly-owned
subsidiary, Two Eleven Distribution, LLC (Two Eleven) a California limited
liability company. Research and development efforts, global sales and global
operations are managed out of the Companys foreign registered branch located in
Cape Town, South Africa. Two Eleven acts as a distributor of Leatt-Brace®
products in the United States. United States sales and marketing are
managed by Two Eleven located in Santa Clarita, California. The Company also has
a wholly-owned subsidiary, Three Eleven Distribution (Three Eleven) which was
an inactive South African incorporated company until December 2008, when it
acquired South African registered patents relating to products unrelated to the
Leatt-Brace® from Holdings. The Company established a wholly-owned
subsidiary, Leatt New Zealand Limited (New Zealand Limited) during the first
quarter of 2009. This Company acted as the distributor of Leatt-Brace®
products in New Zealand, until the 4th quarter of 2011 when
operations of New Zealand Limited ceased. The Company has appointed an unrelated
third party distributor to distribute its products in the New Zealand market.
NOTE 2 - |
SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES |
Principles of Consolidation -
The accompanying consolidated financial statements include the accounts of
Leatt Corporation and its wholly-owned subsidiaries: Two Eleven Distribution,
LLC, Three Eleven Distribution (Pty) Ltd and Leatt New Zealand Limited. All
significant intercompany transactions have been eliminated.
Use of Estimates - The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the amounts of assets and liabilities and
the disclosures of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those
estimates.
Revenue and Cost Recognition -
All manufacturing of Leatt products is performed by third party subcontractors
in China. The Company's products are sold worldwide to a global network of
distributors, dealers and directly to consumers when there are no dealers or
distributors in their geographic area (collectively the "customers"). Revenues
from product sales are recognized when earned, net of applicable provisions for
discounts and returns and allowances in the event of product defect.
F-7
NOTE 2 - |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued) |
Revenue is considered to be realized
or realizable and earned when all of the following criteria are met: title and
risk of loss have passed to the customer, persuasive evidence of an arrangement
exists, delivery has occurred, the price is fixed and determinable and
collectability is reasonably assured. Since the Company (through its
wholly-owned subsidiary) serves as the distributor of Leatt products in the
United States, the Company records its revenue and related cost of revenue for
its product sales in the United States upon shipment of the merchandise to the
dealer or to the ultimate consumer when there is no dealer in the geographic
area and the sales order was received directly from, and paid by, the ultimate
consumer. Since the Company (through its South African branch) serves as the
distributor of Leatt products in South Africa, the Company records its revenue
and related cost of revenue for its product sales in South Africa upon shipment
of the merchandise from the branch to the dealer. International sales (other
than in South Africa) are generally drop-shipped directly from the third party
manufacturer to the international distributors.
Revenue and related cost of revenue is
recognized at the time of shipment from the manufacturer's port when the
shipping terms are Free On Board ("FOB") shipping point, Cost and Freight
("CFR") or Cost and Insurance to named place ("CIP") as legal title and risk of
loss to the product pass to the distributor. Sales to all customers
(distributors, dealers and consumers) are generally final; however, in limited
instances, product may be returned due to product quality issues. If a
distributor relationship were to be terminated by Leatt, then product return may
occur. Historically, returns due to product quality issues have not been
material and there have been no distributor terminations that resulted in
product returns. Cost of revenues also includes royalty fees associated with
sales of Leatt-Brace products.
Product royalty income is recorded as
the underlying product sales occur, in accordance with the related licensing
arrangements.
Short-term investments -
The Companys short-term investments consists of a certificate of deposit with a
maturity of greater than three months but less than twelve months.
Accounts Receivable and Allowance
for Doubtful Accounts - Accounts receivable consist of amounts due to the
Company from normal business activities. Credit is granted to substantially all
distributors on an unsecured basis. The Company continuously monitors
collections and payments from customers and maintains an allowance for doubtful
accounts receivable based upon historical experience and any specific customer
collection issues that have been identified. In determining the amount of the
allowance, management is required to make certain estimates and assumptions.
Accounts receivable balances that are
still outstanding after management has used reasonable collection efforts are
written off as uncollectible. While such credit losses have historically been
minimal, within our expectations and the provisions established, we cannot
guarantee that we will continue to experience the same credit loss rates that we
have in the past. A significant change in the liquidity or financial position of
any of our significant customers could have a material adverse effect on
the collectability of our accounts receivable and our future operating results.
The allowance for doubtful accounts for the years ended December 31, 2015 and
2014 was $131,324 and $103,066, respectively.
Inventory - Inventory is stated
at the lower of cost or market. Cost is determined using the first-in first-out
(FIFO) method. Inventory consists primarily of finished goods. Shipping and
handling costs are included in the cost of inventory. In assessing the inventory
value, the Company must make estimates and judgments regarding reserves required
for product obsolescence, aging of inventory and other issues potentially
affecting the saleable condition of products. In performing such evaluations,
the Company utilizes historical experience as well as current market
information. The reserve for obsolescence for the years ended December 31, 2015
and 2014 was $160,515 and $161,593, respectively.
F-8
NOTE 2 - |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued) |
Property and Equipment -
Property and equipment are recorded at cost. Depreciation is provided using
the straight-line method for financial reporting purposes and accelerated
methods for income tax purposes over the estimated useful lives of the
respective assets. The estimated useful lives of assets for financial reporting
purposes are as follows: moulds and tools, 2 to 5 years; computer equipment and
software, 2 to 5 years; office and other equipment, 3 to 6 years; vehicles, 3 to
5 years; leasehold improvements, 3 years. The costs of improvements that extend
the lives of the assets are capitalized. Repairs and maintenance are expensed as
incurred. When items of property and equipment are sold or retired, the related
costs and accumulated depreciation are removed from the accounts and any gain or
loss is included in income.
Impairment of Long-Lived Assets -
The Company reviews its long-lived assets for impairment whenever events or
changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability of assets to be held and used is measured by a
comparison of the carrying amount of an asset to undiscounted future net cash
flows to be generated by the assets. Based on these reviews, no asset impairment
charges were made to the carrying value of long-lived assets during the years
ended December 31, 2015 and 2014.
Intangible Assets - The
Companys intangible assets consist of acquired patents with an indefinite
useful life and are thus not amortized. Intangible assets are carried at cost
less impairment. There was no impairment of intangible assets at December 31,
2015 or 2014.
Short-term Loan - The Company
carries product liability insurance policies with a U.S. and South African-based
insurance carrier. The Company finances payment of its product liability
insurance premiums over the period of coverage, which is generally twelve
months. The previous short-term loan was payable in monthly installments of
$68,273 over eleven months including interest at 2.647% and has been paid in
full. The current short-term loan is payable in monthly installments of $71,952
over eleven months including interest at 2.897% .
The Company carries directors and
officers liability insurance. The Company finances payment of its short-term
insurance premiums over a period of coverage, which is generally twelve months.
The short-term loan is payable in eleven payments of $5,162 at 2.897% annual
interest rate.
Preferred Stock - The Company's
preferred stock, when issued, is generally convertible to common stock at or
above the then current market price of the Company's common stock and therefore,
contains no beneficial conversion feature. The Preferred Stock is convertible on
a 1:1 ratio to common stock. Each holder of the Preferred Stock is not entitled
to receive dividends and is entitled to 100 votes for each one share of
Preferred Stock.
Shipping and Handling Costs -
The Company includes shipping and handling fees billed to customers in revenues
and shipping and handling costs incurred in cost of revenues.
Advertising - Costs of
advertising and marketing are expensed as incurred.
Patent-related Costs - In
connection with the Companys license agreement with Holdings, and its company
owned patents, the Company incurs legal costs associated with approved patents
and patent applications in various jurisdictions which are expensed as incurred
and classified as professional fees in the consolidated statements of
operations. Patent-related costs totaled $137,549 and $97,525, respectively for
the years ended December 31, 2015 and 2014.
Research and Development -
Research and development costs are expensed as incurred and include the
salaries of those individuals directly involved in research and development
activities.
Foreign Currency Translation and
Foreign Currency Transactions - The U.S. dollar is the Company's reporting
currency. Assets and liabilities of the Companys foreign operations, consisting of its South African Branch and New Zealand,
denominated in local currencies, SA RAND and NEW ZEALAND DOLLAR respectively,
are translated.
F-9
NOTE 2 - |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued) |
Foreign Currency Translation and
Foreign Currency Transactions (Continued) - at the rate of exchange at the
balance sheet date. Revenues and expenses are translated at the rate of exchange
at the date of the transaction in the applicable period. Adjustments resulting
from translating foreign functional currency financial statements into U.S.
dollars are included in the foreign currency translation adjustment, a component
of accumulated other comprehensive income in stockholders' equity. Gains and
losses generated by transactions denominated in foreign currencies are recorded
in the accompanying statement of operations in the period in which they occur.
Net unrealized gains (losses) on foreign currency translation adjustments
totaled ($331,601) and ($266,567), respectively, during the years ended December
31, 2015 and 2014.
Stock-Based Compensation - The
Company accounts for stock-based compensation in accordance with the
fair-value-base method set forth in FASB ASC Topic 718-10, Stock-Based
Compensation, which requires the measurement and recognition of compensation
expense for all stock-based awards made to employees and directors, including
employee stock options, based on the estimated fair values on the date of grant
or the fair value of the services performed. The Company recognizes these
compensation costs, net of an estimated forfeiture rate, on a pro rata basis
over the requisite service period of each vesting tranche of each award. The
Company considers voluntary termination behavior as well as trends of actual
option forfeitures when estimating the forfeiture rate.
Income Taxes - The Company uses
the asset and liability approach to account for income taxes. Deferred tax
assets and liabilities are determined based on the differences between the
financial statement carrying amounts and the income tax basis of assets and
liabilities. A valuation allowance is applied against any net deferred tax asset
if, based on available evidence, it is more likely than not that some or all of
the deferred tax assets will not be realized. The provision for income taxes
included taxes currently payable, if any, plus the net change during the year in
deferred tax assets and liabilities recorded by the Company.
The Company applies the provisions of
FASB ASC Topic 740-10, Accounting for Uncertainty in Income Taxes (Standard),
which provides that the tax effects from an uncertain tax position can be
recognized in the consolidated financial statements only if the position is more
likely than not of being sustained upon an examination by tax authorities. An
uncertain income tax position will not be recognized if it has less than a 50%
likelihood of being sustained. Additionally, the standard provides guidance on
derecognition, classification, interest and penalties; accounting in interim
periods, disclosure and transition, and any amounts when incurred would be
recorded under these provisions.
The Companys practice is to recognize
interest and/or penalties related to income tax matters in income tax expense.
As of December 31, 2015 and 2014, the Company has no unrecognized tax
benefits.
Net Income Per Share of Common
Stock - Basic net income per common share is computed using the
weighted-average number of common shares outstanding during the period. Diluted
net income per share is computed using the weightedaverage number of common
stock shares and dilutive potential common shares outstanding during the period.
For the years ended December 31, 2015 and 2014, the Company had 379,000
potential common shares, consisting of 120,000 preferred shares and 259,000
stock options outstanding that were included in diluted net income per
share.
Comprehensive Income -
Comprehensive income is defined as the change in equity of a business
enterprise during a period from transactions and other events and circumstances
from non-owner sources, including foreign currency translation adjustments and
unrealized gains and losses on marketable securities. Accumulated comprehensive
income/loss at December 31, 2015 and 2014 represents cumulative translation
adjustments related to the Companys foreign registered branch office and subsidiaries. The Company
presents comprehensive income in the consolidated statements of operations and
comprehensive income.
F-10
NOTE 2 - |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued) |
Fair Value of Financial Instruments
- The carrying amount reported in the consolidated balance sheets for cash
and cash equivalents, short-term investments, accounts receivable, inventory,
payments in advance, accounts payable and accrued expenses approximate fair
value because of the immediate or short-term maturity of these financial
instruments.
Concentration of Credit Risk -
The Company maintains cash and cash equivalent balances at several financial
institutions that are insured by the Federal Deposit Insurance Corporation
(FDIC) up to $250,000. As of December 31, 2015 and 2014, the Companys uninsured
bank balances totaled $834,299 and $535,090, respectively. The Company has not
experienced any significant losses on its cash and cash equivalents.
The Companys trade receivables are
derived from sales to distributors and dealers. The Company has adopted credit
policies and standards intended to accommodate industry growth and inherent
risk. Management believes that credit risks are moderated by the diversity of
the Companys end customers and geographic sales areas. The Company performs
ongoing credit evaluations of its customers financial condition and requires
collateral as deemed necessary. The Company maintains allowances for potential
credit losses as needed.
The Company has derived, and believes
that it will continue to derive, a significant portion of its revenue from a
limited number of customers. For the year ended December 31, 2014, the Company's
U.S. revenue was concentrated in one customer that accounted for approximately
13%, of annual U.S. revenue. This was not the case for the year ended December
31, 2015.
As of December 31, 2014, $738,780, or 17% of the Company's
accounts receivable, respectively, were due from this customer. For the years
ended December 31, 2015 and 2014, the Company's international revenue was
concentrated in two customers that accounted for approximately 24% and 24%,
respectively, of annual international revenue. As of December 31, 2015 and 2014,
$344,589, or 11%, and $699,127, or 16%, of the Company's accounts receivable,
respectively, were due from these international customers.
The Company generates revenue both in
the United States and internationally. For the years ended December 31, 2015 and
2014, annual revenues associated with international customers were $11,642,970
and $11,025,185, or 63% and 60% of total revenue, respectively.
Statement of Cash Flows - The
Company considers all highly liquid debt instruments and other short-term
investments with an initial maturity of three months or less from the date of
purchase to be cash equivalents.
F-11
Recent Accounting
Pronouncements - In May 2014, the FASB issued Accounting Standards
Update No. 2014-09, Revenue from Contracts with Customers, (ASU
2014-09). ASU 2014-09 outlines a new, single comprehensive model for entities
to use in accounting for revenue arising from contracts with customers and
supersedes most current revenue recognition guidance, including
industry-specific guidance. This new revenue recognition model provides a
five-step analysis in determining when and how revenue is recognized. The new
model will require an entity to recognize revenue when it transfers promised
goods or services to customers in an amount that reflects what it expects in
exchange for the goods or services. It also requires more detailed disclosures
to enable users of financial statements to understand the nature, amount,
timing, and uncertainty of revenue and cash flows arising from contracts with
customers. On August 12, 2015, the FASB issued ASU 2015-14, Revenue from
Contracts with Customers (Topic 606): Deferred of the Effective Date". The
amendments in this update defer the effective date of Update 2014-09 for all
entities by one year. The ASU, as amended, is effective for annual periods
beginning on or after December 15, 2017. The Company is currently assessing the
impact that adopting this new accounting guidance will have on the consolidated
financial statements and footnote disclosures.
F-12
NOTE 2 - |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued) |
In February 2015, the FASB issued ASU
2015-02 Consolidation (Topic 810) Amendments to the Consolidation
Analysis. This ASU is intended to improve targeted areas of the
consolidation guidance for legal entities such as limited partnerships, limited
liability corporations and securitization structures. These amendments affect
the consolidation evaluation for reporting organizations. In addition, the
amendments simplify and improve current U.S. GAAP by reducing the number of
consolidation models. The ASU is effective for fiscal years, and for interim
periods within those fiscal years, beginning after December 15, 2015. The
Company does not expect the adoption of this ASU to have a material impact on
its consolidated financial statements.
In April 2015, the FASB issued ASU
2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the
Presentation of Debt Issuance Costs. This ASU requires debt issuance costs
related to a recognized debt liability to be presented in the balance sheet as a
direct deduction from the carrying amount of the related debt liability instead
of being presented as an asset. The recognition and measurement of debt issuance
costs are not affected by this amendment. This ASU is effective for annual
periods and interim periods beginning after December 15, 2015, and early
adoption is permitted. The Company does not expect the adoption of this ASU to
have a material impact on its consolidated financial statements.
In July 2015, the FASB issued ASU
2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. This
ASU simplifies the subsequent measurement of inventories by replacing the lower
of cost or market test with a lower of cost or net realizable value test. The
ASU is effective for fiscal years beginning after December 15, 2016. Early
adoption is permitted. The Company does not expect the adoption of this ASU to
have a material effect on the consolidated financial statements.
In September 2015, the Financial
Accounting Standards Board ("FASB") issued ASU 2015-16, Business Combinations:
Simplifying the Accounting for Measurement-Period Adjustments guidance to
simplify the accounting for adjustments made during the measurement period to
provisional amounts recognized in a business combination. This ASU is effective
for fiscal years and interim periods beginning after December 15, 2015, and
requires prospective application. Early adoption is permitted. The Company does
not expect this ASU to have a material impact on its consolidated financial
statements.
In November 2015, the FASB issued ASU No. 2015-17, "Income
Taxes (Topic 740): Balance Sheet Classification of Deferred Taxes." This ASU
requires that deferred tax assets and liabilities be classified as non-current
on the balance sheet rather than being separated into current and non-current.
This ASU is effective for fiscal years and interim periods within those years,
beginning after December 15, 2016. Early adoption is permitted. The Company does
not expect this ASU to have a material impact on its consolidated financial
statements.
In February 2016, the FASB issued ASU
No. 2016-02, Leases (Topic 842). This ASU is a comprehensive new lease
standard that amends various aspects of existing accounting guidance for leases.
The core principle of this ASU will require lessees to present the assets and
liabilities that arise from leases on their balance sheets. The ASU is effective
for public companies for annual periods beginning after December 15, 2018, and
interim periods within those fiscal years. Early adoption is permitted. The
Company is evaluating the new standard to determine the impact on the Companys
consolidated financial statements.
The Company does not believe there are
any other recent accounting pronouncements that would have a material impact on
its financial position or results of operations.
F-13
Inventory consists primarily of
finished goods. Shipping and handling costs are included in the cost of
inventory. In assessing the inventory value, the Company must make estimates and
judgments regarding reserves required for product obsolescence, aging of
inventory and other issues potentially affecting the saleable condition of
products.
In performing such evaluations, the
Company utilizes historical experience as well as current market information.
All products are manufactured by third parties in China and shipped to either a
warehouse in California, the corporate offices in South Africa or to
distributors throughout South America, Africa, Europe, Asia, Australia and New
Zealand. The reserve for obsolescence for the years ended December 31, 2015 and
2014 was $160,515 and $161,593, respectively. During the year ended December 31,
2015 and 2014 the Company wrote off and destroyed $356,369, and $345,744,
respectively, of product which was deemed to be obsolete.
NOTE 4 - |
PROPERTY AND EQUIPMENT
|
Property and equipment as of December
31, 2015 and 2014 consisted of the following:
|
|
|
2015 |
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
Land |
$ |
314,994
|
|
$ |
418,064
|
|
|
Moulds and tools |
|
2,507,494 |
|
|
1,849,673 |
|
|
Computer equipment and
software |
|
441,744 |
|
|
682,537 |
|
|
Office and other equipment |
|
361,582 |
|
|
435,216 |
|
|
Vehicles |
|
174,118 |
|
|
175,034 |
|
|
Leasehold improvements |
|
84,579 |
|
|
82,159 |
|
|
|
$ |
3,884,511
|
|
$ |
3,642,683
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation |
|
(2,571,186 |
) |
|
(2,647,146 |
) |
|
Property and equipment, net |
$ |
1,313,325 |
|
$ |
995,537 |
|
NOTE 5 - |
PAYMENTS IN ADVANCE |
Payments in advance represent upfront
payments made to contract manufacturers for the manufacturing of the Companys
products. Payments in advance of $208,030 and $345,406 as of December 31, 2015
and 2014 are recorded in current assets on the consolidated balance sheets.
NOTE 6 - |
OTHER RECEIVABLES |
In October 2013, the Company entered
into a confidential settlement agreement to resolve alleged patent infringement
claims and counter claims, under which the Company will receive a series of
payments over time. The amount included in other receivables as of December 31,
2015 represents the amount of payments to be received in 2017 and thereafter.
NOTE 7 - |
STOCKHOLDERS EQUITY
|
On December 6, 2011, the Board of
Directors adopted and the shareholders subsequently approved the 2011 Equity
Incentive Plan (the "Plan") which provides for, among other incentives, the
granting to employees, directors and consultants incentive stock options, non
statutory stock options, restricted stock, restricted stock units, stock
appreciation rights, performance units and performance shares as the Plan
Administrator may determine. The maximum number of shares of common stock which
may be issued under the Plan is 920,000.
F-14
NOTE 7 - |
STOCKHOLDERS EQUITY (Continued)
|
In June 2013, the shareholders
approved an increase in the maximum shares from 260,000 to 460,000. In December
2015, the shareholders approved an increase in the maximum shares from 460,000
to 920,000. The maximum number of shares of common stock that may be awarded to
an individual participant in any one fiscal year is 78,000 shares. Options are
generally exercisable at the fair market value or higher on the date of grant
over a five year period. Shares are generally issued at the fair market value on
the date of issuance.
During the year ended December 31,
2014, 90,000 options were granted to key employees and to the outside director
at the exercise price of $1.00 per share, exercisable over a 5 year period. 40%
of the shares were immediately vested with a compensation expense of $2,426 and
60% of the shares were unvested with unrecognized compensation values of $3,640.
During the year ended December 31, 2015 an additional 20% of the shares vested
with a compensation expense of $1,478. The fair value of the stock options
granted was estimated at the date of grant using the Black Sholes option-pricing
model. Based on the list of assumptions presented below, the fair value of the
options granted during the year ended December 31, 2014, was $0.07 per share. In
addition, 7,800 options were forfeited during the year ended December 31, 2014.
During the year ended December 31,
2012, 208,000 stock options were granted at an exercise price of $1.00 per
share, exercisable over a 5 year period. Of the options granted in 2012, 60% of
the shares were vested with a compensation expense of $15,487 and 40% of the
shares were unvested with unrecognized compensation values of $10,325. During
the year ended December 31, 2013 an additional 20% of the shares vested with a
compensation expense of $5,163. During the year ended December 31, 2014 the last
20% of the shares vested with a compensation expense of $ 4,194.
|
|
|
2012 |
|
|
2014 |
|
|
|
|
Options |
|
|
Options |
|
|
|
|
Granted |
|
|
Granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected term in years |
|
5 |
|
|
5 |
|
|
Years Risk-free interest rate |
|
2.65% |
|
|
3.38% |
|
|
Expected volatility |
|
0.90% |
|
|
22.85% |
|
|
Expected dividend yield |
|
0.00% |
|
|
0.00% |
|
The expected volatility was determined
with reference to the historical volatility of the Company's stock. The Company
uses historical data to estimate option exercise and employee termination within
the valuation model. The expected term of options granted represents the period
of time that the options granted are expected to be outstanding. The risk-free
interest rate for periods within the contractual life of the option is based on
the U.S. Treasury rate in effect at the time of grant.
F-15
The Companys income tax expense
(benefit) for the years ended December 31, 2015 and 2014 consists of the
following components:
|
|
|
2015 |
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current |
|
|
|
|
|
|
|
Federal |
$ |
406,458 |
|
$ |
330,372 |
|
|
State |
|
1,600 |
|
|
1,600 |
|
|
|
|
408,058 |
|
|
331,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred |
|
|
|
|
|
|
|
Federal |
|
(22,468 |
) |
|
(98,212 |
) |
|
|
|
(22,468 |
) |
|
(98,212 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
$ |
385,590 |
|
$ |
233,760 |
|
The Companys effective income tax
expense (benefit) differs from the federal statutory amount because of the
effect of the following items:
|
|
|
2015 |
|
|
2014 |
|
|
Federal tax statutory rate
|
|
34.00% |
|
|
34.00% |
|
|
Effect of prior year (over) under provision
|
|
2.00% |
|
|
0.00% |
|
|
Timing and permanent
differences |
|
4.00% |
|
|
2.00% |
|
|
|
|
40.00% |
|
|
36.00% |
|
Deferred income taxes (benefit)
reflect the net tax effects of temporary differences between the carrying
amounts of assets and liabilities for financial reporting purposes and the
amounts used for income tax purposes, and the tax effects of net operating
losses that are available to offset future taxable income. Significant
components of the Companys deferred tax assets (liabilities) at December 31,
2015 and 2014 consist of the following:
F-16
NOTE 8 - |
INCOME TAXES (Continued)
|
|
|
|
2015 |
|
|
2014 |
|
|
Deferred tax assets: |
|
|
|
|
|
|
|
Accounts receivable |
$ |
45,000 |
|
$ |
35,000 |
|
|
Inventory |
|
54,000 |
|
|
55,000 |
|
|
Vacation accrual |
|
16,000 |
|
|
18,000 |
|
|
Net operating loss
carryforwards |
|
1,434,000 |
|
|
1,257,000 |
|
|
Less valuation allowance |
|
(1,434,000 |
) |
|
(1,257,000 |
) |
|
Deferred tax assets,
net |
$ |
115,000 |
|
$ |
108,000 |
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilites: |
|
|
|
|
|
|
|
Depreciation |
$ |
73,000 |
|
$ |
88,468 |
|
|
Deferred tax
liabilities, net |
$ |
73,000 |
|
$ |
88,468 |
|
In assessing the ultimate realization
of deferred tax assets and liabilities, management considers whether it is more
likely than not that some or all of them will not be realized. Based on the
Companys anticipation of fluctuations in the Companys net earnings for state
tax purposes, the Company has established a valuation allowance due to the
uncertainty as to the realization of the net operating loss carryforwards. As of
December 31, 2015 and 2014, the Company has approximately $16,220,800 and
$14,221,000 of net operating loss carryforwards to offset certain future state
taxable income, expiring in 2029.
The Company files a consolidated
federal and separate company state income tax returns in the United States. The
Companys 2011 U.S. income tax return was under examination and has been
completed with an immaterial adjustment to the tax liability as originally
reported. As of
December 31, 2015, the tax years that remain subject to examination are 2012 to
2015 for federal and 2012 to 2015 for state tax purposes.
The Company has reviewed its open tax
positions and determined that no exposures exist that require an adjustment as
of December 31, 2015 or 2014. While the Company believes that it has performed
adequate procedures to identify all reasonably identifiable exposures, it is
possible that exposures exist and that these exposures will need to be assessed
and may potentially have a material impact on the Companys consolidated
financial statements.
NOTE 9 - |
RELATED PARTY TRANSACTIONS
|
Royalty fees associated with sales of
Leatt-Brace® products are paid to Holdings, a company owned by a
director, and a related individual who is a shareholder. Royalties are based on
5% of the cash received from net sales of the neck braces worldwide and totaled
$437,349 and $480,689 for the years ended December 31, 2015 and 2014. The term
of the royalty agreement is for the life of the intellectual property. As of
December 31, 2015 and 2014, accrued royalties totaled $22,598 and $69,790.
Consulting fees in connection with
product research, development and marketing are paid to Innovate, a company in
which the Companys founder and chairman is an indirect beneficiary. Monthly
consulting fees amounting to $35,639 are payable in terms of the agreement
effective, May 15, 2015 and totaled $267,293 for the year ended December 31,
2015.
F-17
NOTE 10 - |
COMMITMENTS AND CONTINGENCIES
|
Office / Warehouse
Lease
The Companys California entity is
leasing office and warehouse space in Santa Clarita, California. The lease was
renewed on March 16, 2015 and continues through April 30, 2016. The lease
agreement calls for monthly base rent in the amount of $9 734. The lease has
been renewed again on March 1, 2016 to be effective from May 1, 2016 to April
30, 2017. The base rent will be $10,015 for this extended period.
In addition, the Companys South
African branch leases space in South Africa. The lease was renewed on December
12, 2014 and continues through December 15, 2016. The lease agreement calls for
an initial monthly rent of $3,795.
Minimum lease payments under non
cancellable operating lease agreements in each of the years subsequent to
December 31, 2015 are as follows:
2016 |
$ |
162,697 |
|
2017 |
$ |
40,060 |
|
Rent expense totaled $207,849 and
$210,185, respectively, for the years ended December 31, 2015 and 2014.
Litigation/Potential
Litigation
In the ordinary course of business,
the Company is involved in various legal proceedings involving product liability
and personal injury and intellectual property litigation. The Company is insured
against loss for certain of these matters. The Company will record contingent
liabilities resulting from asserted and unasserted claims against it when it is
probable that a liability has been incurred and the amount of the loss is
reasonably estimable. The Company will disclose contingent liabilities when
there is a reasonable possibility that the ultimate loss will exceed the
recorded liability. While the outcome of the currently pending litigation is not
yet determinable, the ultimate exposure with respect to these matters cannot be
ascertained. However, based on the information currently available to the
Company, the Company does not expect that any liabilities or costs that might be
incurred to resolve these matters will have a material adverse effect on the
financial condition, results of operations, liquidity or cash flow of the
Company.
NOTE 11 |
SUBSEQUENT EVENTS |
The Company has evaluated all
subsequent events through March 18, 2016, the date the financial statements were
released.
F-18
EXHIBIT INDEX
Exhibit |
Exhibit Title |
Number |
|
2.1 |
Settlement Agreement, dated as of September 25, 2008,
between Leatt Corp., Christopher J. Leatt and J. P. De Villiers
(incorporated by reference to Exhibit 2.1 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
2.2 |
Amendment No. 1 to Settlement Agreement, dated February
4, 2010, between Leatt Corp., Christopher J. Leatt and Jean- Pierre
DeVilliers (incorporated by reference to Exhibit 2.2 to the Companys
registration statement on Form 10-12G, filed on October 9, 2012)
|
3.1 |
Amended and Restated Articles of Incorporation, as filed
with the Secretary of State of Nevada on October 28, 2008 (incorporated by
reference to Exhibit 3.1 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
3.2 |
Amended and Restated Bylaws, adopted on October 28, 2008
(incorporated by reference to Exhibit 3.2 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
4.1 |
Certificate of Designation of Series A Voting Convertible
Preferred Stock, as filed with the Secretary of State of Nevada on October
29, 2008 (incorporated by reference to Exhibit 4.1 to the Companys
registration statement on Form 10-12G, filed on October 9, 2012)
|
4.2 |
Leatt Corp. 2011 Equity Incentive Plan (incorporated by
reference to Exhibit 4.5 to the Companys registration statement
|
|
on Form 10-12G, filed on October 9, 2012) |
4.3 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Dr. Christopher Leatt (incorporated by reference to
Exhibit 4.6 to the Companys registration statement on Form 10-12G, filed
on October 9, 2012) |
4.4 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Sean Macdonald (incorporated by reference to Exhibit 4.7
to the Companys registration statement on Form 10-12G, filed on October
9, 2012) |
4.5 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Philip Davy (incorporated by reference to Exhibit 4.8 to
the Companys registration statement on Form 10-12G, filed on October 9,
2012) |
4.6 |
Stock Option Agreement, dated February 1, 2012, between
Leatt Corp. and Erik Olsson (incorporated by reference to Exhibit 4.9 to
the Companys registration statement on Form 10-12G, filed on October 9,
2012) |
4.7 |
Stock Option Agreement, dated February 14, 2014, between
Leatt Corp. and Jeffrey Guzy (incorporated by reference to Exhibit 4.10 to
the Companys annual report on Form 10-K, filed on March 19, 2014)
|
10.1 |
Patent and Royalty License Agreement, dated March 1,
2006, between Leatt Corp., Xceed Holdings (Pty) Ltd. (formerly, Leatt
Brace Holdings (Pty) Ltd.) and J. P. De Villiers Trust (incorporated by
reference to Exhibit 10.1 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
10.2 |
Amendment to Patent and Royalty License Agreement, dated
as of March 1, 2006, between Leatt Corp. and Xceed Holdings (Pty) Ltd.
(formerly, Leatt Brace Holdings (Pty) Ltd.) (incorporated by reference to
Exhibit 10.2 to the Companys registration statement on Form 10-12G, filed
on October 9, 2012) |
10.3 |
Patent Assignment Agreement, dated January 1, 2009,
between Xceed Holdings (Pty) Ltd. and Three Eleven Distribution (Pty) Ltd.
(incorporated by reference to Exhibit 10.3 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
10.4 |
Software License Agreement, dated July 2, 2010, between
Leatt Corp., Esteq Design (Pty) Ltd. and Siemens Industry Software Ltd.
(incorporated by reference to Exhibit 10.4 to the Companys registration
statement on Form 10-12G, filed on October 9, 2012) |
10.5 |
Copyright Licensing Agreement, dated January 31, 2013,
between Silva Mattos & CIA, LTDA and Leatt Corp. (incorporated by
reference to Exhibit 10.5 to the Companys annual report on Form 10-K,
filed on March 19, 2014) |
10.6 |
End User Licensing Agreement, dated June 30, 2011,
between Bluekey Software Solutions and Leatt Corp. (incorporated by
reference to Exhibit 10.6 to the Companys registration statement on Form
10-12G, filed on October 9, 2012) |
10.7* |
Lease Agreement, dated September 11, 2012, between Two Eleven Distribution LLC and Center Pointe Properties, LLC as amended. |
10.8 |
Lease Agreement, dated December 12, 2014, between Leatt
Corp. and AJ Brutus Investments cc. (incorporated by reference to Exhibit
10.8 to the Companys annual report on Form 10-K, filed on March 26, 2015)
|
10.9 |
Storage Rental Agreement, dated December 1, 2014, between
The Storage Spot and Leatt Corp. (incorporated by reference to
Exhibit 10.9 to the Companys annual report on Form 10-K, filed on March
26, 2015) |
10.10 |
Leatt Distributor Form Business Terms, dated February 10,
2010 (incorporated by reference to Exhibit 10.11 to the Companys
registration statement on Form 10-12G, filed on October 9, 2012)
|
10.11 |
Storage Rental Agreement 2, dated January 1, 2012,
between The Storage Spot and Leatt Corp. (incorporated by reference to
Exhibit 10.11 to the Companys annual report on Form 10-K, filed on March
26, 2015) |
10.12* |
Premium Finance Agreement, dated May 27, 2015, between
AFCO Acceptance Corp. and Leatt Corp. |
10.13* |
Employment Agreement, dated January 1, 2014, between
Leatt Corp. and Sean Macdonald (as amended) |
10.14* |
Premium Finance Agreement, dated October 19, 2015,
between AFCO Acceptance Corp and Leatt Corp. |
10.15 |
Service Level Agreement, dated
April 24, 2013, between MikroTik SA and Leatt Corp. (incorporated by
reference to Exhibit 10.17 to the Companys annual report on Form 10-K,
filed on March 19, 2014) |
10.16* |
Storage Rental Agreement 3, dated October 4,
2015, between The Storage Spot and Leatt Corp. |
10.17 |
Consulting Agreement, dated
July 8, 2015, between Innovate Services Limited and Leatt Corporation
(incorporated by reference to Exhibit 10.1 to the Companys current report
on Form 8-K, filed on July 8, 2015) |
10.18 |
Employment Agreement, dated July 8, 2015,
between Innovate Services Limited and Dr. Christopher Leatt (incorporated
by reference to Exhibit 10.2 to the Companys current report on Form 8-K,
filed on July 8, 2015) |
10.19 |
Side Letter Agreement, dated
July 8, 2015, between Leatt Corporation and Dr. Christopher Leatt
(incorporated by reference to Exhibit 10.3 to the Companys current report
on Form 8-K, filed on July 8, 2015) |
10.20 |
Director Agreement, dated July 8, 2015, between
Leatt Corporation and Dr. Christopher Leatt (incorporated by reference to
Exhibit 10.4 to the Companys current report on Form 8-K, filed on July 8,
2015) |
14.1 |
Code of Ethics (incorporated by reference to
Exhibit 14.1 to the Companys registration statement on Form 10-12G, filed
on October 9, 2012) |
21 |
List of subsidiaries of the
registrant (incorporated by reference to Exhibit 21 to the Companys
registration statement on Form 10-12G, filed on October 9, 2012) |
31.1* |
Certifications of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2* |
Certifications of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1* |
Certifications of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
32.2* |
Certifications of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
101** |
Interactive data files pursuant to Rule 405 of
Regulation S-T |
_______________________
* |
Filed herewith |
|
|
** |
Pursuant to Rule 405 of Regulation S-T, the following
financial information from the Companys Annual Report on Form 10-K for
the period ended December 31, 2014, is formatted in XBRL interactive data
files: (i) Consolidated Balance Sheets at December 31, 2015 and 2014; (ii)
Consolidated Statements of Operations and Comprehensive Income (Loss) for
the years ended December 31, 2015 and 2014; (iii) Consolidated Statements
of Changes in Shareholders Equity as of and for the years ended December
31, 2015 and 2014; (iv) Consolidated Statements of Cash Flows for the
years ended December 31, 2015 and 2014; and (vi) Notes to Consolidated
Financial Statements. Pursuant to Rule 406T of Regulation S-T, these
interactive data files are deemed not filed or part of a registration
statement or prospectus for purposes of Sections 11 or 12 of the
Securities Act of 1933, as amended, or for purposes of Section 18 of the
Securities Act of 1934, as amended, and otherwise are not subject to
liability under those sections. |